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SUMMARY 
Vanuatu, a Pacific archipelago, 2,000 km east of northern Australia, is the world’s most 
diverse nation in terms of the number of actively spoken indigenous languages per head of 
population. The resulting cultural diversity and its great biodiversity compared to other 
islands in this region made it a unique target for an ethnobotanical survey. 
During five months of fieldwork 130 plant species used in traditional medicine were 
documented together with 420 individual use reports. Along with the voucher specimen, 
information on treatment methods, healing concepts and diseases was collected, and 
subsequently qualitatively and quantitatively analysed. Dermatological and gastrointestinal 
complaints, followed by respiratory ailments and diseases related to the urogenital system 
were the categories most commonly indicated, reflecting a prevalence of these illnesses in 
the study areas.  
18 plants with indications towards immunomodulatory effects were selected on site and 
material of 21 plant parts was collected and subsequently screened for antibacterial, 
antifungal, and antiprotozoal activities. In addition the extracts were subjected to a detailed 
analysis on cytotoxic effects towards human cancer cell lines, designed as a smaller version 
of the NCI60 screen. Patterns of relative drug sensitivity and resistance reflect possible 
mechanisms of drug action, which gives the opportunity for molecular-targeted anticancer 
drug discovery. In total the screenings yielded moderate antibacterial activity for one and 
antifungal for four extracts, five extracts were shown to be moderately active against 
Trypanosoma brucei brucei, three extracts have displayed good and specific activities 
against Trypanosoma cruzi, and three extracts significantly killed Plasmodium falciparum. 
Intriguingly 15 plant extracts exhibited strong cytotoxic effects specific for only one cancer 
cell line.  
Also a phytochemical investigation was carried out for Baccaurea stylaris MUELL. ARG. 
(Phyllanthaceae) leading to the discovery of seven pure compounds, one of them a new 
diterpenoid with neoclerodane-skeleton.  
SAMARI 
Vanuatu, wan aelan long pasifik wanem i klosap ostrelia, hemia wan kantri wetem plante we 
plante derfen lanwis. Fromwe i gat fulap lanwis, i gat fulap defren kalja, tu mo i gat plante 
kaenkaen planem; olsem i no gat long narafala aelan long Saot si, taswe hemia wan gudfala 
ples blong mekem wan risej long lif meresin mo long Kastom blong kantri ia.  
Long wan filwok kasem faef manis, tok save long 130 planem wanem oli yusum long kastom 
meresin i bin klektem long wan kleksen kasem 420 ripot. Olgeta planem oli bin draem, bin 
gluim long lif pepa mo bin givim nem long letin. Tugeta wetem wanem kaen sik i gat long 
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aelan, tok save long hao olgeta hila oli tritim evri kaen sik bin klektem finis. Folem se wan 
save faenemaot, taswe long Vanuatu i gat plante sik blong skin mo blong basket blong sitsit, 
afta i gat fulap sik blong lang mo basket blong pispis mo sik blong mama.  
18 planem wanem oli save tritim ol kaen sik olsem fiva o kof bin jusumaot mo 21 pat blong 
planem nomo oli bin klektem mo wan skrin i bin mekem blong faenemaot sapos oli save hilim 
ol kaen sik long Vanuatu olsem kansa, fiva o kof. Blong faenem aot long kansa wan bigfala 
skrin i bin mekem mo difren kaen kansa oli bin jekem ap. Riseja i save faenem wan planem 
wanem yu save yusum blong tritim sora blong devel, fo blong sik olsem kof, faef planem oli 
save tritim wan sik long afrika oli singaotem sik blong slip long hem, tri planem oli save 
yusum sipos oli kasem wan sik wanem i nogud mo oli long saot amerika singaotem jagas 
long hem, tri planem oli gud taem we yu kasem malaria mo fiftin planem riseja oli save 
yusum blong mekem wan meresin blong kansa.  
Wan planem nomo, olgeta long Aneityum oli singaotem nithtschaub long hem, hemi bin 
putum long wan wota olsem alikol traem faenemaot, wanem kaen tingting blong planem ia i 
mekem hemia wan meresin. 
ZUSAMMENFASSUNG 
Vanuatu, ein pazifischer Archipel, 2.000 km östlich von Nord-Australien gelegen, ist das 
Land mit der weltweit pro Kopf größten Vielfalt an aktiv gesprochenen indigenen Sprachen. 
Die daraus resultierende kulturelle zusammen mit einer im Vergleich zu anderen Inseln in 
dieser Region enormen Bio-Diversität, machte es zu einem einzigartigen Ziel für eine 
ethnobotanische Studie.  
Während einer fünfmonatigen Feldstudie wurden 130 in der traditionellen Medizin 
Verwendung findende Pflanzenspezies zusammen mit 420 Einzel-Nutzungsberichten 
dokumentiert. Neben Herbarexemplaren wurden ebenfalls Informationen zu 
Behandlungsmethoden, Heilungskonzepten und Krankheiten gesammelt und die 
ethnobotanischen Daten anschließend qualitativ und quantitativ analysiert. Dermatologische 
und gastrointestinale Beschwerden, gefolgt von Erkrankungen des Respirationstraktes und 
Krankheiten, welche dem Urogenitalsystem zugeordnet werden können, waren die 
Kategorien, für welche die meisten Indikationen genannt wurden, welches eine Prävalenz 
dieser Krankheiten im Untersuchungsgebiet widerspiegelt.  
18 Pflanzen mit Indikationen in Richtung immunmodulatorischer Aktivität wurden vor Ort 
ausgewählt und insgesamt 21 Pflanzenteile gesammelt. Daraus gewonnene Extrakte wurden 
anschließend auf antibakterielle, antifungale und antiprotozoale Eigenschaften hin gescreent.  
In einer kleinen Version des NCI60 Screenings wurden die Extrakte außerdem einer 
detaillierten Analyse ihrer cytotoxischen Aktivität gegenüber humanen Krebszell-Linien 
unterzogen. Sensitivitäts- und Resistenzmuster gegenüber einem Arzneistoff spiegeln dabei 
ZUSAMMENFASSUNG 
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mögliche Wirkungsmechanismen dieses Stoffes auf molekularer Ebene wider, was die 
gezielte molekülgerichtete Suche nach Antitumor-Wirkstoffen ermöglicht.  
Insgesamt zeigten ein Extrakt moderate antibakterielle und vier Extrakte moderate 
antifungale Aktivitäten, fünf Extrakte wiesen moderate Aktivität gegenüber Trypanosoma 
brucei brucei auf, drei Extrakte zeigten gute und spezifische Aktivität gegenüber 
Trypanosoma cruzi und drei Extrakte waren sehr effektiv gegenüber Plasmodium falciparum. 
15 Extrakte zeigten gute cytotoxische Effekte spezifisch für nur eine Zell-Linie.  
Für die Pflanze Baccaurea stylaris MUELL. ARG. (Phyllanthaceae) wurde außerdem eine 
phytochemische Untersuchung durchgeführt, welche zur Isolierung von sieben 
Reinsubstanzen führte, eine davon ein neues Diterpenoid mit Neoclerodanskelett.  
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ABBREVIATIONS 
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µg   microgram 
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A2780   human ovarian cancer cell line 
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CFU   colony forming unit 
ChAT   choline acetyltransferase 
CHN   Chinese Herb Nephropathy 
CML   chronic myelogenous leukaemia 
CNS   Central Nervous System 
COSY   correlated spectroscopy (2D NMR method) 
COX   cyclooxygenase 
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DMSO   dimethylsulfoxide 
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IC50   50% inhibition concentration 
IPCB   International Program of Cooperation for Biodiversity 
K-562   human CML cell line 
KB   human HeLa contaminant cell line 
LaCiTo  Laboratoire de Langues et civilisations à tradition orale 
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min.   minute 
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MeOH   methanol 
MHz   megahertz 
MIC   minimum inhibitory concentration 
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NCI   National Cancer Institute, Bethesda, MD, USA 
NCI-H522  human non-small lung cancer cell line 
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No.   number 
NSCLL-N6  human non-small lung bronchiopulmonary cancer cell line 
NUCG   human stomach cancer cell line 
NMDA   N-methyl-D-aspartate 
NMR   nuclear magnetic resonance 
NOESY  nuclear Overhauser enhanced spectroscopy (2D NMR method) 
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p.   page 
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Pf GHA  Plasmodium falciparum 1/GHA strain 
PNG   Papua New Guinea 
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INTRODUCTION 
1. PLANTS IN TRADITIONAL AND MODERN MEDICINE 
The empirical use of plants as medicine can be traced back over five millennia to ancient 
documents of early civilizations such as in China, Egypt, India, and the Near East, but is 
certainly as old as mankind.1 These medicines initially took the form of crude drugs such as 
tinctures, teas, poultices, powders, and other herbal formulations.2 
Although indigenous knowledge systems rapidly disappear under the influence of Western 
culture, the World Health Organization (WHO) estimates that even today 80% of the world’s 
population exclusively rely on traditional medicine; especially in developing countries 
resources to build up a primary health care system are still lacking.3 In industrialised 
countries medicinal plant research had its ups and downs in the last decades. It was not until 
the early 19th century that the isolation of active principles marked a new era in the use of 
medicinal plants and one particular landmark, the discovery of the alkaloid quinine from 
Cinchona bark by the French scientists Caventou and Pelletier in 1820 led to a new attention 
towards plants from the New World. An interesting fact is that Cinchona was once provided 
by Peruvian indigenous people to Spanish conquerors. The Peruvians used it as a treatment 
of intermittent fever or malaria since generations and quinine and the later discovered 
quinidine and their analogues, isomers and (semi)synthetics are still widely used due to their 
ability to treat malaria, heart conditions, and other ailments, being a blessing for millions 
suffering.4 In the following “expedition boom” researchers dispersing all over the world 
scoured almost impenetrable jungles in search of new medicines in journeys sometimes 
lasting for years. The industrial revolution and progress made in organic chemistry somehow 
slowed this development causing a preference of synthetic drugs in western communities. 
These soon got an excellent reputation, originating from the fact that pure compounds could 
easily be obtained and structural modifications yielding in more active and less toxic and 
therefore safer drugs could simply be performed. But in recent years the tide has turned and 
the interest in alternative medicine and natural products, especially of plant origin revived 
due to several reasons, namely conventional medicine can cause strong side effects or can 
be inefficient if incorrectly used and the term “natural” products falsely pretends that they are 
generally harmless.5 The WHO considers that in Germany for example 90% of the population 
have used a natural remedy at least once in their life and the global market for herbal 
medicines currently stands at over US$ 60 billion per annum (2003) and is growing steadily. 
But the organization also cautions against the dangers of unregulated or inappropriate use of 
complementary medicine and stresses the need for more stringent controls of herbal 
preparations by pointing out two examples: in Belgium at least 100 female patients 
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developed Chinese Herb Nephropathy (CHN), an extensive intestinal fibrosis of the kidneys 
after having followed a weight-loss regimen that included the use of a herbal preparation 
made from the wrong species. The prescribed Chinese herb “Fangji” (Stephania tetrandra, 
Menispermaceae) was, in fact, inadvertently replaced by another Chinese herb, namely 
“Guang fangji” (Aristolochia fangchi, Aristolochiaceae) containing aristolochic acid, a well 
known nephrotoxic. In the second example, the herb “Ma Huang” (Ephedra sinica, 
Ephedraceae), widely used in Traditional Chinese Medicine (TCM) to treat respiratory 
congestion, was marked as a dietary aid in the US. Over-dosage led to at least a dozen 
deaths, heart attacks, and strokes.6 
However at least 119 chemical substances from 90 plant species are important drugs used 
all over the world, many of them containing compounds derived from or modelled after 
naturally occurring lead molecules7 and 74% of these come from traditional medicinal plants.3 
Of the 252 drugs considered as basic and essential by the WHO, 11% are exclusively of 
plant origin e.g. digoxin from Digitalis spp. (Plantaginaceae), quinine and quinidine from 
Cinchona spp. (Rubiaceae), vincristine and vinblastine from Catharanthus roseus 
(Apocynaceae), or morphine and codeine from Papaver somniferum (Papaveraceae), 
furthermore a significant number are synthetic drugs obtained from natural precursors.5 
It is further estimated that 60% of anti-cancer and anti-infectious drugs already on the market 
or under clinical trials are of natural origin.8 Indeed the already mentioned 
Catharanthus-alkaloids are two of the most important cancer chemotherapeutic agents 
currently in use, followed by the podophyllotoxin-derivative etoposide, isolated from 
Podophyllum peltatum (Berberidaceae). In 2000 worldwide over ten million new cases of 
cancer occurred and six million suffering died. A 22% increase was observed for cancer 
incidence as well as mortality since 1990,9 making it to the second leading cause of death in 
high income countries, surpassed only by cardiovascular diseases (WHO fact-sheet No. 310, 
The top ten causes of death, 2007). There have been several efforts to discover new 
anticancer agents of plant origin, the most prominent is the National Cancer Institute (NCI) 
program initiated by Dr. Jonathan Hartwell. It was him too, who between 1969 and 1971 
assembled a list containing over 3,000 different species of plants traditionally used against 
cancer describing their uses in considerable detail, remaining today as the only compilation 
of the ethnomedicinal use of anticancer plants.10-18 Altogether, the NCI, Bethesda, MD, 
U.S.A. has screened 33,000 plant samples for anti-tumour and more than 50,000 for anti-HIV 
activity but they have not been screened for other pharmacological activities yet.1 However, 
of the estimated 350,000 plant species worldwide only a small percentage has been 
investigated phytochemically and an even smaller percentage has been properly studied in 
terms of their pharmacological properties.5 
2. SCOPE AND OBJECTIVES OF THE PRESENT WORK 
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But what makes plants produce biologically active secondary metabolites? As entrenched 
organisms with no escapism, plants had to develop other mechanisms to defend themselves 
against microbial attack and predators, including morphological adaptations such as thorns 
or spikes, as well as chemical such as toxic or irritant secondary metabolites. Competition for 
light, space, pollinators, and nutritients also influences the spectrum of these substances. 
Lacking a growth pause as in winter in temperate zones, tropical plants always have to be 
defensive and due to the greater biodiversity in tropical regions plants are more exposed to 
competition. For these reasons a greater portion of tropical plants contains potentially useful 
compounds,19 so tropical forests are most likely the best source of potentially active natural 
products.  
2. SCOPE AND OBJECTIVES OF THE PRESENT WORK 
The aims of this project were to collect and preserve ethnobotanical knowledge and to 
screen some selected plants whose ethnobotanical use, and/or taxonomic affiliation 
suggested promising immunomodulatory activities in several biological assays, and a 
detailed phytochemical investigation of a selected plant.  
Vanuatu has been chosen as study area due to its large linguistic and cultural diversity 
combined with a great biodiversity compared to other islands in this region. In addition, only 
little ethnobotanical research has been conducted in this place yet, the ethnopharmacopoeia 
of some islands has actually never been studied so far. 
The screening regimen performed in this thesis included: 
(1) Antibacterial, antifungal, and antiprotozoal assays, 
(2) a cytotoxicity screening on a variety of cell lines, a smaller version of the NCI60 disease 
oriented screening program developed by the National Cancer Institute (NCI), 
(3) a screening for drugs which may be effective against Alzheimer’s disease, and  
(4) assays targeting at various anti-inflammatory processes (ongoing).  
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THEORETICAL PART 
1. VANUATU 
1.1 GEOGRAPHY, GEOLOGY, AND CLIMATE 
Vanuatu (meaning “our land”; the word for land vanua, fanua or fenua is one of the most 
common Pacific words) is a Y-shaped archipelago about 2,000 km east of Northern Australia 
located between latitude 12° and 23° south and longitude 166° (Fig. 2) ( 
Fig. 1 Map of Vanuatu. Research areas are marked with arrows (from LaCiTo). Its closest 
neighbours are the Solomon Islands (170 km north), New Caledonia (230 km south), and Fiji 
(800 km east). The total area of Vanuatu is approximately 860,000 km2, of which only 
12,334 km2 (1.4%) are land, consisting of about 80 islands and numerous islets of which 67 
are inhabited. Only twelve islands can be regarded as significant in terms of economy and 
population and the eight largest islands contribute 87% of the total land area.20, 21 The capital 
city, Port Vila, is located on the island of Efate. 
 
Fig. 1 Map of Vanuatu. Research areas are 
marked with arrows (from LaCiTo) 
 
 
 
Fig. 2 Location of Vanuatu in the Pacific (from 
LaCiTo)
Geologically young, the islands mainly comprise volcanic mountains, but some raised reef 
islands and a few low coral islands and reefs are also found. Vanuatu is part of the Pacific 
ring of fire and is an island arc, a result of tectonic activity, as a subduction zone of around 
1,500 km long marks the convergence of the Indian-Australian tectonic plate and the Pacific 
plate. Corollaries of the tectonic activity are the numerous volcanoes which contribute to the 
very active seismicity experiences in this region.22 
The climate varies from wet tropical in the northern part with about 4,000 mm annual rainfall 
to dryer subtropical climate in the southern part with less than 2,000 mm rainfall per year.23 
Average temperatures range between 21 and 27°C and average humidity between 75 and 
Loh 
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80%.21 During the wet (and warmer) season from November to April an average of four to six 
tropical cyclones of hurricane strength can be expected.24  
1.2 HISTORY 
At least 40,000 years ago Australoid people began moving towards Australia and the 
Solomon Islands. A subsequent wave of people from Southeast Asia finally crossed the huge 
(for people only using outrigger canoes) distance from the Solomon Islands to the Vanuatu 
and settled the archipelago about 3,000 B.C.E.. The oldest archaeological evidence in 
Vanuatu, Lapita pottery from the island Malo, is dating back to 2,000 B.C.E.. Prehistoric life was 
marked by inter-tribal warfare and strong spiritual beliefs. All natural and human-induced bad 
luck or calamities were attributed to sorcery and lavish festivals which even claimed human 
sacrifice were staged to appease the gods. In April 1606 with the Portuguese explorer Pedro 
Fernández de Qu(e)irós the first European set foot on the islands. He discovered Mera Lava 
(San Marcos) of Banks group (Fig. 3), followed by Maewo (Margaritana), Merig Island 
(Vergel), Mota (Las Lagrimas de San Pedro), Vanua Lava (Portales de Belen) and Gaua 
(Virgen Maria) of Banks group, Aoba (Cardona), Pentecost (La Clementina), Malekula 
(Malicolo) and Ambrym. In 3 May 1606 he anchored in Espirito Santo, believing to have 
found Terra Australis.25  
 
Fig. 3 Map of Quiros' journey 
Europeans did not return until 1768, when Louis Antoine de Bougainville sailed between 
Espiritu Santo and Malekula on his frigate La Boudeuse and so disproved Qu(e)irós’ theory 
of Terra Australis. He rediscovered the islands of Aoba, Pentecost, and Maewo and named 
them “Les Grandes Cyclades”.26 
On his second Voyage, on 17 July 1774, Captain James Cook visited several islands and 
named them the New Hebrides27, a term lasting till independence in 1980. 
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In 1839 Europeans began settling the islands bringing various disasters on the inhabitants: 
whalers, sandalwood-, and sea slug-traders unscrupulously exploited the resources at the 
cost of the indigenous population, missionaries foisted their beliefs upon the people, 
penalising indigenous customs and traditions, and in addition their infection-ridden vessels 
brought diseases the people of the Pacific had little resistance to: influenza, measles, 
venereal diseases to name just a few examples, even the common cold wiped out whole 
populations. But by far the greatest misery inflicted on the islanders was “blackbirding” - the 
South Seas' version of slavery that continued into the early years of the 20th century where 
thousands of Ni-Vanuatu (meaning “of Vanuatu”) were persuaded or downright kidnapped to 
work on the sugarcane and cotton plantations of Queensland (Australia) and Fiji, and many 
never returned. 
In 1887 the two declared enemies England and France settled uneasily next to each other in 
the New Hebrides and - forced to cooperate in a far-flung outpost of the European empire - 
they formed probably the weirdest colonial administration the world has ever seen crowned 
with the Anglo-French Condominium in 1906 as a response to German expansionism in the 
Pacific region.28 
In 1942 in WWII US troops were stationed in Efate and Espiritu Santo, which became crucial 
bases in the Pacific War. The country was awash with American know-how and dollars, and 
many Ni-Vanuatu received respect and earned real wages for the first time in their lives. 
More importantly, the islanders were astounded at the apparent equality with which black 
and white military personnel were treated, and this played no small part in their agitation for 
independence. At the end of the war, in 1945, the Americans left as swiftly as they had 
arrived.  
Now, land ownership became Vanuatu’s central political concern. After several partly violent 
conflicts full sovereignty was finally granted by both European nations on 30 July 1980 and 
Vanuatu became a republic with the Commonwealth of Nations.29  
1.3 POPULATION AND LANGUAGES 
94% of the 211,971 (July 2007) Ni-Vanuatu are Melanesians; furthermore there are 
Europeans, Australians, New Zealanders, Vietnamese, Chinese, and people from other parts 
of the Pacific. 
In addition to the three official languages in Vanuatu: English, French, and Bislama at least 
80 indigenous ones are spoken, which makes it to linguistically (and resulting from this also 
culturally) the world’s most diverse nation in terms of the number of actively spoken 
indigenous languages per head of population, with an average of only about 2,500 speakers 
(minority languages) each.30 All of these languages are members of the Oceanic subgroup of 
the Austronesian language family, which extends from Easter Island in the east, New 
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Zealand in the south, Hawaii in the north, and parts of Irian Jaya in the west, including 
Newaweteme, the language spoken in Lungharighi, Loh, Torres Islands and Rallglëin, the 
language spoken in Southwest Ambrym, two of the research areas with Newaweteme being 
an extreme example of a minority language with only about 75 speakers. The whole 
population of Loh representing about 150 people is almost equally distributed to two villages 
speaking two different languages. Rather distinct from the languages of the rest of the 
country and suggested to be more closely related linguistically to those of neighbouring New 
Caledonia are the southern languages spoken in Erromango and Tanna including Indass 
Khermo, the language of Aneityum (the third research area). There are also three languages 
in Vanuatu that are of Polynesian origin (Mele-Fila, the language of the village Mele on Efate, 
Emae, the language of the island Emae, which belongs to the Shepherd’s group and West-
Futunan or Futuna –Aniwa, the language of Futuna and Aniwa).31 
According to Crowley, Bislama is English based Creole which contains many French and 
Melanesian loan words due to Vanuatu’s history: it has evolved as a result of multilingual 
contact in camps of recruited labourers in the islands of Southern Vanuatu around the 
mid-1800s, when sea slugs and sandalwood were processed for sale by a work force 
recruited from different speech communities. In this situation an English-lexifier pidgin rapidly 
emerged and became the lingua franca of these camps. It was named Biche-de-mer-English 
after the French word for sea slug, rapidly abbreviated to simply Bichelamar (or Beach-la-
Mar to English-speakers), eventually yielding modern Bislama. During the blackbirding-
period Bislama rapidly became the lingua franca of overseas plantations in Queensland 
(Australia) and Fiji, too. When returning to Vanuatu, people began to move as plantation 
labourers within Vanuatu for the first time, resulting in the continuation of the spread of this 
language as a plantation lingua franca to many parts of the country where it had previously 
been unknown or little known.32 
THEORETICAL PART 
 22
1.4 TERRESTRIAL FLORA AND ITS USES 
THE PACIFIC REGION 
By geographers, four major regions have been delimited in the Pacific Ocean; these are 
Melanesia, Micronesia, Polynesia, and New Zealand. (Fig. 4) Vanuatu is part of the 
Melanesian region, located immediately east of the floristically rich Indo-Malaysian region 
and essentially continuous with it, but also containing elements of the Pacific flora. The 
relatively large land areas and physiographic and geological diversity led to large and diverse 
floras, relative to those of the other three Pacific regions.  
 
Fig. 4 Map of the Pacific region 
The Melanesian region can be further divided into Eastern and Western Melanesia. The 
western part comprises Papua New Guinea (PNG), the Bismarck Archipelago, and the 
Solomon Islands; the eastern includes the Santa Cruz Islands, Vanuatu, Fiji, and New 
Caledonia.24 Mallick says that compared to the other Eastern Melanesian islands Vanuatu is 
geologically young: 90% of its present land surface originates from late Pliocene-Pleistocene 
volcanism and the growth of Pleistocene coral reef platforms combined with uplifting, about 
1.8 million years ago, thus only 10% of the landmass was formed between 10 and 38 million 
years ago.22 So Vanuatu as the youngest of the four island groups supports the most recent 
vegetation as well as a poor biodiversity compared to its neighbours (but not in comparison 
with the other major Pacific regions), resulting not only from its geological youth but also from 
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the islands’ size, their relative isolation from large expands of land, and frequent damages 
inflicted by cyclonic, seismic, and volcanic activity.24. Nevertheless, a certain number of 
endemics at species level have evolved but not all have been identified and catalogued yet33 
and more prospecting is likely to be required, because unfortunately up to date no review 
article dealing with Vanuatu’s flora exists and so only controversial statements concerning 
biodiversity are on hand. Personally counting Vanuatu’s species yielded 1,124 species by 
examining even the tiniest bit of literature on this subject (Mourgues, 200421 speaks of 
around 1,000 and Chew, 197533 of ca. 870) including 172 endemics, with a level of endemics 
of 15.3% (Mourgues assumes 150 and a level of 15%). Approximately 700 species of 
bryophytes and about 250 pteridophytes are also found21. As for plant identification in the 
field, only one field guide to common trees34 is obtainable, based on other studies,35, 36 but it 
only covers about 100 species and only trees, however the included list of vernacular plant 
names is pretty helpful. Therefore an own field guide was developed by collecting vernacular 
names, phytogeographic distributions, and uses of the 1,124 species in the list (literature 
used see LIST OF ETHNOBOTANICAL AND TAXONOMIC SURVEYS IN VANUATU), 
including photos of most species. By means of this guide plants were identified in the field 
and – back in the capital city Port Vila – verified in the herbarium.  
FOREST TYPES AND DESCRIPTION OF THE RESEARCH AREAS 
So far there have been no comprehensive descriptions created for the vegetation of Vanuatu 
as a whole, maybe related to a change in floristic patterns from north to south, but the 
studies available for Vanuatu (from 33, 36-56) most of them an outcome of the Condominium 
Era from 1906 - 1980, when many French and English researchers visited the islands, were 
analysed by Mueller-Dombois and Fosberg (1998) resulting in six vegetation types: 
Lowland rain forest 
This forest type provides the natural vegetation of all south-eastern windward sides inland of 
the coastal zone up to about 500 to 600 m. It can be further divided into six variations, but to 
go into this in detail would take us too far afield and will not be discussed in this study. 
Montane cloud forest and related vegetation 
Practically only excluding the Torres Islands, montane forest is found everywhere in 
Vanuatu, beginning at approximately 500 m (300 m on smaller islands). Mueller-Dombois 
and Fosberg wrote that it is characterized by stunted trees with gnarled crowns and by trunks 
and branches covered with bryophytes and filmy ferns, which paints a vivid portrait of this 
kind of forest. Treeless low-scrub and herbaceous patches make up part of the summit 
vegetation. 
Seasonal forest, scrub, and grassland 
This type is found on the Northwest side of most islands. Three variations in vegetation 
pattern can be recognised: First of all the semideciduous transition forest, whose soil, often 
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strongly enriched with organic matter, forms a favourite habitat for indigenous tree gardens. 
The second variation, the so called gaiac (Acacia spirobis) forest, mainly consists of low to 
medium sized trees with wide branching crowns. The last variation, the Leucaena thickets, 
savannas, and grassland are found in the drier strongly wind- and rain-sheltered habitats on 
the western and north-western sides of the islands. 
Vegetation of new volcanic surfaces 
Vanuatu’s volcanoes seem to be colonised first by lichens and herbaceous ferns, followed by 
tree ferns, pandanas, and palms associated with tall grasses and shrubby trees of the 
families Cunoniaceae and Moraceae. 
Coastal vegetation, including mangroves 
The beach vegetation is composed of a frontal herb zone, followed by a shrub zone, and 
littoral forest. However, in most coastal areas it has been replaced by human habitation and 
coconut plantations. Mangroves are even more rarely found, only on some sheltered coasts 
there are small areas left. 
Secondary and cultivated woody vegetation 
Secondary vegetation develops in response to shifting cultivation and disturbances by 
cyclones (characterized by a predominance of fast-growing, heliophytic colonisers) or 
indigenous uses of the forests in form of tree gardens and bush fallow. The cultivated woody 
vegetation mostly refers to coconut plantations. 
Loh, Torres Islands, the first research area, located in Vanuatu’s wet and hot north, is a 
raised limestone island with a maximum height of 139 m (Mt. Luwovunea), with most of its 
interior surfaces formed about 1.8 million years ago, while its coastal areas developed during 
Holocene. The inner part is predominantly covered with rain forest, the outer with littoral 
forest and thickets. Plants were collected in all of these ecosystems. 
Ambrym, the second research area, situated in the middle of the archipelago, has two active 
volcanoes, Mt. Marum (1,270 m) and Mt. Benbow (1,159 m), surrounded by a large area 
denuded of vegetation. Downslope, extending to about 200 m altitude and nearly 
surrounding the island is a sparse cover dominated by ferns, frequently disturbed by ash 
fallout. The next lower elevational zone, extending to about 100 m altitude is covered with 
open, arborescent scrub, mixed with tree and herbaceous ferns, followed by a dense forest 
scrub, disrupted by coconut plantations, mainly in the South. The research took place in all of 
the described ecosystems, except from – of course - the ash covered and vegetation-free 
zone surrounding the volcanoes. 
The third and last research area, Aneityum or Anatom, is the southernmost island of the 
archipelago and has a subtropical climate resembling that of New Caledonia. Its degraded 
and deforested mountainous interior is dominated by three mountains, two of them extinct 
volcanoes, Mt Inrerow Atahein (835 m) and Mt Tahentchai (794 m). The highly eroded old 
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volcanic soils of the interior which support only impoverished vegetation have been 
interpreted to be the result of a large population of up to 12,000 people that inhabited the 
island prior to the severe post-proselytization depopulation that resulted in a low of 550 
people in these days. The mountainous region, extending to 300 m altitude is covered by 
cloud forest with tree crowns often colonised by epiphytic orchids and ferns: Pandanaceous 
climbers are also locally common. A subtype of the lowland rain forest, the so called Agathis-
Calophyllum, or Kauri-forest is unique in the southern islands Erromango and Aneityum. Its 
altitudinal range extends from 100 to 500 m, often mixing with montane forest in the upper 
parts. It has to a large extent been disturbed and exploited by human activity. Downslope 
gaiac forest, occasionally containing sandalwood (Santalum austro-caledonicum), another 
victim of extensive forest exploitation, is followed by thickets of Hibiscus tiliaceus and coastal 
vegetation. In addition to coconut plantations lining the coasts pine (Pinus caribaea) 
plantations, initially planted to assist erosion control, but are now being managed by the 
community for timber production are also found here.24 The research took place in all 
mentioned areas. 
PLANTS IN TRADITIONAL LIFE 
Some literature illustrating life in Vanuatu’s countryside is already available. The studies 
“Magic gardens in Tanna”57, “Agriculture in Vanuatu”20, “Knowledge for survival: traditional 
tree farming in Vanuatu”58, “Plantes magiques, plantes protectrices: quelques techniques 
d’horticulture traditionelle à Vanuatu”,59 and “Jardins d’Océanie”60 describe traditional 
agricultural plant uses in Vanuatu, whereas “Ethnobotanique à Vanuatu et substances 
naturelles nématicides” copes with plants used in traditional agriculture to protect crops from 
parasitic infestation.61 
In rural communities starchy root- or fruit vegetables like maniok (Manihot esculenta), yam  
(Dioscorea sp.), kumala (Ipomoea batatas), taro (Colocasia esculenta), or bredfrut 
(Artocarpus altilis) predominantly or exclusively form the traditional diet. An example is nelot 
(Fig. 5) prepared from Artocarpus altilis. 
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Fig. 5 Diana preparing nelot (Loh) 
It is supplemented with various nuts like navale (Barringtonia edulis), nangai (Canarium 
vulgare), or natapoa (Terminalia catappa), several vegetables like aelan kabis (Abelmoschus 
manihot), or bolkabis (Brassica oleracea) and fruits e.g. popo (Carica papaya), nagavika 
(Syzygium malaccense), a number of Annona species and a variety of Citrus fruits. Very 
seldom food of animal origin, e.g. chicken, beef, pork, flying fox, or coconut crab, except from 
fish is part of the menu (Fig. 6, Fig. 7). The composition varies highly between the islands 
because of differences in habitats and remoteness. Islands close to Efate and Santo and of 
tourist interest generally have well-stocked stores, remote places like e.g. Loh are strongly 
dependent on island resources, as there is at the utmost one maintenance ship per year 
(when staying in Loh this ship had not come for more than a year and there was only one 
spool of scotch tape left in the shop, which by the way became very handy in the end when 
using it to tinker bags for the plant transport, which had been intended to buy on site).  
 
Fig. 6 Krab kokonas (coconut crab) a delicacy (Loh) 
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Fig. 7 William with longmaot (Loh) 
Some species or places have special importance in Kastom (pidjin word used to refer to 
traditional culture, including religion, economics, art, and magic in the Pacific islands, 
originating from the English custom), which is still very strong in Vanuatu.62 Tree ferns 
(Cyatheaceae spp.) are used for carving nimangaki (grade taking)-figures (Fig. 8.), some 
sorts of timber are used for carving of the so called tamtams (slit-gongs) used e.g. as a 
medium in the delivery of messages, leaves of Cycas sp. are used to signify taboos and are 
also represented on Vanuatu’s flag and Piper methysticum (Kava) is the most important 
Kastom plant as it is used in a nakamal (central meeting place in the village) (Fig. 9.) in 
various situations of  traditional life, in other words it is the most fancied drug in this spot. 
   
 
Fig. 9 Nakamal in Lélé, Ambrym 
          
1.5 TRADITIONAL MEDICINE AND ITS PLANTS 
Traditional medicine in Vanuatu has already been studied to a certain extent: The medicinal 
systems of Espiritu Santo63, Malekula64, Tongoa,65 and Erromango66 have previously been 
investigated, but no plant collections took place in this context. A review article about the 
Fig. 8 Nimangaki figures, Kew 
Gardens, London 
THEORETICAL PART 
 28
work of ORSTOM (“L’institut français de recherché scientifique pour le développement”),67 
talking of a preliminary screening of about 300 plants native in Vanuatu for presence or 
absence of certain medically interesting chemical drugs (a list of the screened plants is not 
available) of which 30 have been subject of biological screenings: these studies cope with 
antiprotozoal68 and antimycobacterial69 effects of plants traditionally used in New Caledonia 
and Vanuatu. In “Maternity and medicinal plants in Vanuatu I. The cycle of reproduction”70 13 
different islands of all climate regions including Aneityum, (which has also been investigated 
in this thesis) were examined exclusively dealing with plants utilised in a clearly defined 
therapeutic context (plants used by women during pregnancy and delivery and for birth 
control), and “Maternity and medicinal plants in Vanuatu II. Pharmacological screening of five 
selected plants”71 describes a screening of five plants collected in this context. One study, 
“Les usages médicinaux de quelques plantes communes de la flore des îles Banks 
(Vanuatu)72 gives an overview about plants traditionally used in the Banks Islands. 
So, why is there still need for further studies in this region? First of all, because of strong 
cultural differences between the islands, as mentioned previously in this study, different kinds 
of medicinal systems can be expected. Furthermore the floral composition varies from island 
to island, on the one hand a result of the comparatively great inter-island distances, on the 
other hand originating from soil and climate differences found in the archipelago as 
previously mentioned in this text. So people are maybe forced to use different kinds of plants 
because of the variety of floras and maybe also because the illnesses diverge, e.g. 
dermatophytic complaints are due to be more frequent in the hotter and more humid northern 
part. Moreover there could be a difference between places that are close to the more 
developed islands Efate and Espiritu Santo or with a touristy infrastructure (e.g. Aneityum) 
and those which are very remote and where connections are often unsteady and expensive 
and the people were not already influenced by tourism, leading to a loss of their traditional 
habits and knowledge: on one side people are thereby capable of earning (higher) wages in 
the cities or in the tourism industry, which could (but unfortunately not always does) result in 
a better education and therefore better conservation of traditional wisdom. On the other side 
they gain a better accessibility of Western doctors, hospitals, and drugs, which may lead to 
the adaptation of the as “new and better” considered Western style, resulting in the loss of 
traditional medicine, regrettably observed in Aneityum. Another reason for why Vanuatu is 
still an interesting place for an ethnobotanical/ethnopharmaceutical study is that the islands 
carefully chosen for this survey have never (Ambrym and Torres Islands) or only poorly 
(Aneityum) been investigated before. At last former studies either simply concentrated on 
collection of medicinal data without a subsequent screening or they only dealt with medicinal 
plant uses in a very narrow therapeutic context, e.g. the studies of Bourdy and Walter,70, 71 
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concentrating on plants used in gynaecology. A wide screening including various biological 
assays has never been performed before. 
2. BACCAUREA STYLARIS MUELL. ARG. (PHYLLANTHACEAE) 
2.1 THE PHYLLANTHACEAE 
The Phyllanthaceae, a diverse cosmopolitan family with greatest diversity in the tropics is the 
largest segregate from Euphorbiaceae sensu lato (largely congruent with 
Euphorbiaceae-Phyllanthoideae in previous classifications) and comprises about 60 genera 
and approx. 2,000 species.73, 74 The circumscription of Phyllanthaceae was modified from 
Webster’s Euphorbiaceae-Phyllanthoideae to include Croizatia (from Euphorbiaceae-
Oldfieldoideae), Dicoelia (from Euphorbiaceae-Acalyphoideae), and Tacarcuna (previously 
incertae sedis in Euphorbiaceae). The genera Drypetes and Putranjiva are excluded as 
Putranjivaceae, Centroplacus as Centroplacaceae, and Phyllanoa as Violaceae.75 
2.2 TAXONOMIC POSITION OF B. STYLARIS MUELL. ARG. 
The Phyllanthaceae fall into two major clades (Phyllanthoideae and Antidesmatoideae) now 
recognized at subfamilial level and characterized by inflorescence and leaf anatomical 
features.76 The subfamily Phyllanthoideae sensu stricto covers four tribes: Poranthereae, 
Bridelieae, Wielandieae, and Phyllanthoideae. They lack tanniniferous cells in leaf epidermis, 
usually have contracted inflorescence axes, and predominantly explosively dehiscent fruits. 
The subfamily Antidesmatoideae includes six tribes: Antidesmateae, Scepeae, Jablonskieae, 
Spondiantheae, Uapaceae, and Bischofieae. They are characterised by tanniniferous cells in 
the leaf epidermis, usually elongated inflorescence axes, and predominantly indehiscent or 
tardily dehiscent fruits; almost all taxa are dioecious.  
The tribe Antidesmateae e.g. holds the genera Antidesma, Martretia, Thecacoris, and 
Apodiscus and Scepeae consists of Aporosa and Baccaurea. The smaller tribes only contain 
one genus: Spondiantheae (Spondianthus), Uapaceae (Uapaca), and Bischofieae 
(Bischofia), except from Jablonskoieae, which includes Jablonskia and Celianella. 
Division  Angiospermae 
Subdivision  Eudicots 
Clade   Eurosids I (Fabids) 
Order   Malpighiales 
Family  Phyllanthaceae 
Subfamily  Antidesmatoideae 
Tribe   Scepeae 
Genus   Baccaurea LOUR.77 
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2.3 MORPHOLOGY OF B. STYLARIS MUELL. ARG.:  
Baccaurea stylaris MUELL.ARG. (Phyllanthaceae) is an evergreen shrub or tree 2–20 m high 
with usually weak Terminalia branching pattern growing in Vanuatu, Fiji, and the Solomon 
Islands. Cut bark strongly smells of pepper. The discolorous leaves are simple with entire 
margins, rounded base, and retuse apex (Fig. 10). The petioles are slightly pulvinate and 
winged. The inflorescences are reduced thyrses with white actinomorphic flowers, which are 
pleasantly scented. The fruits are globose to ovoid, 1- (or 2- ) seeded, fleshy capsules. 
 
Fig. 10 Baccaurea stylaris MUELL. ARG. (whole plant, cut bark, leaves) 
2.4 ECONOMIC USES OF B. STYLARIS MUELL. ARG. AND OTHER 
MEMBERS OF THE PHYLLANTHACEAE 
Some taxa are regionally cultivated as ornamentals or for their fleshy edible fruits, B. dulcis 
(JACK) J.VOIGT, B. motleyana (MUELL. ARG.) MUELL. ARG., or B. ramiflora LOUR., the 
(Indo) Malesian species Antidesma bunius (L.) SPRENGEL, the South American Phyllanthus 
acidus (L.) SKEELS (one of the richest sources of natural Vitamin C), the African Uapaca 
guineensis MUELL. ARG., and Uapaca kirkiana MUELL. ARG. to mention just a few.78. Some 
provide also timber, weaving material, dyes, and fish poison or insecticides, or they show 
medicinal promise, e.g. the already mentioned Malesian B. motleyana (MUELL.ARG.) MUELL. 
ARG., whose squeezed inner bark is applied to sore eyes in Thailand, B. courtallensis 
(WIGHT) MUELL. ARG., which is used as an antipyretic by Kani tribes in South India79, B. 
ramiflora LOUR., utilised in Chinese Dai medicine as an antiphlogistic and anodyne against 
rheumatoid arthritis, cellulites, abscesses, and to treat injuries80 and also used as medicine 
by hill-tribes in Northern Thailand. An ethanolic extract of the leaves evidently shows 
antioxidant activities.81 The leaves of the Malesian B. lanceolata (MIQ.) MUELL. ARG. are 
pounded in bamboo, mixed with water, and drunk as a remedy against stomach-ache in 
Thailand. Some Antidesma spp. and Phyllanthus spp are also used in Thai medicine: the 
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leaves of the in Indomalesia and Australia distributed Antidesma montanum BL. var. 
montanum are applied to ulcers and lumber pains, and the roots are also externally used to 
treat stomach-ache, whereas the fruits or tea made from the leaves are drunk as a tonic after 
childbirth. The juice from fruits of the Malesian Antidesma orthogyne (HOOK.F.) AIRY SHAW 
are utilised as an antiseptic and the chewed roots of Antidesma tomentosum BL. 
var. tomentosum are used to treat internal pain by external application of the mush. A 
decoction of the whole plant of the pantropical Phyllanthus amarus SCHUM. & THONN., whose 
ethanolic extract also shows antiviral activity against hepatitis B82 can be used to treat 
stomach complaints or is freshly applied as a diaphoretic just as the Malesian species 
Phyllanthus pulcher WALL. EX MUELL. ARG. and Phyllanthus urinaria L. 
(http://www.nationaalherbarium.nl, Flora of Thailand, National Herbarium Nederland, Leiden, 
NL). 
2.5 ETHNOBOTANY OF B. STYLARIS MUELL. ARG. 
In the indigenous language of Aneityum, Indass Khermo, the plant is called nithtschaub 
[nιθ’t∫aub]. A handful of leaves and/ or inner bark respectively are boiled in water and the 
whole body is bathed in the chilled decoction once or twice a day. The medicine is used to 
treat asthma or cough.  
This plant seems to be unique to the people of Aneityum, since no other ethnomedicinal uses 
of this species were found during systematic biographic research elsewhere, both in Vanuatu 
and elsewhere in the world. 
2.6 PHYTOCHEMISTRY AND PHARMACOLOGY OF BACCAUREA 
LOUR. AND OTHER PHYLLANTHACEAE 
As mentioned previously in this text, the family Phyllanthaceae is further divided into two 
subfamilies: Phyllanthoideae sensu stricto, covering the four tribes: Bridelieae, 
Phyllanthoideae, Poranthereae, and Wielandieae, and the subfamily Antidesmatoideae 
which includes the six tribes Scepeae, Antidesmateae, Bischofieae, Uapaceae, 
Jablonskieae, and Spondiantheae. 
For the genus Baccaurea LOUR., belonging to the tribe Scepeae, so far only one study 81 
exists, in which ten compounds, comprising among others a prenylated flavonol, a flavonoid 
and a lignan, isolated from the leaves of Baccauera ramiflora LOUR. were screened for their 
antioxidant activities. For another member of the tribe Scepeae, Aporosa lindleyana BAILL., 
the antioxidant activity of a root extract, maybe due to the presence of glycosides, saponins, 
tannins, and phenols83 and hypoglycaemic effects84 has been described. 
Members of the tribe Antidesmateae demonstrate e.g. antimicrobial85 and antiplasmodial86 
activities. Some interesting compounds have been reported in this tribe, too, e.g. alkaloids, a 
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lupeolactone, and triterpenoids87. In the Bischofieae the presence of for example alkaloids, 
flavonoids, saponins, sterols, and triterpenoids showing anti-microbial activities88 and a 
strong activity as DNA topoisomerase II inhibitors, originating from the presence of the 
lupan-type triterpene betulinic acid and its derivatives89 have been demonstrated. Some 
members of the tribe Uapaceae display antiprotozoal activity90, 91 partly due to their content of 
betulinic acid92 and antimicrobial effects93. Representatives of the genera Jablonskieae and 
Spondiantheae have not been studied so far. 
Compared to Antidesmatoideae, the members of the second subfamily Phyllanthoideae 
sensu stricto have intensely been investigated concerning their bioactive secondary 
metabolites. In Bridelieae phenolic compounds with radical scavenging and xanthine oxidase 
inhibitory activity94, quinic acid derivatives, flavonoids and flavanols with antibacterial 
activity95, or complement-inhibiting substances96, beta-lactamase97 inhibitors, triterpenoids 
with significant inhibitory activity against snake venom phosphodiesterase-I, 98  and 
tetraterpenglycosides99 have been identified, to mention just a few. A great variety of species 
belonging to the Phyllanthoideae has also been phytochemically investigated, leading to 
many compounds, including alkaloids, coumarins, monoterpenoids as well as highly 
condensed sterols, flavonoids, lactones, lignans, and others 100. Members of this tribe have 
also intensely been investigated for further pharmacological activities and so analgesic, 
anti-allergic, antiinflammatory, antineoplastic, antiviral, and anti-lipoxygenase activities could 
be shown.100 In addition moderate antifungal and antiplasmodial effects were described.101 
From members of the Poranthereae alkaloids102 and flavonoids103 have already been isolated 
and antibacterial, antifungal,104 and lipoxygenase-inhibition activities105 have been reported 
and finally even in the small tribe Wielandieae, alkaloids have already been described.106
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EXPERIMENTAL PART 
1. ETHNOBOTANY 
Ethnobotany, a sub-field of ethnological as well as botanical sciences investigates the 
relationships between ethnic groups and their herbal environment, including plants used as 
food, medicine, and raw materials for construction and other applications.107 The term was 
coined by the botanist J. W. Harshberger during a lecture in Philadelphia in 1895 and defined 
as the study of “plants used by primitive and aboriginal people”.108 Ethnomedicine in turn a 
sub-field of ethnobotany studies the pharmacopoeia of an ethnic group which is orally 
transmitted from generation to generation. Ethnopharmacology eventually investigates 
pharmacological mechanisms of plants used in traditional medicine by indigenous groups.107  
There are three major objectives in the investigation of ethnopharmacopoeias: 
(1) The botanical and pharmacological purpose, trying to find new plants and potent chemical 
compounds respectively, together with sanitary and economic interests (empirical use of 
plants over generations by indigenous people facilitates the selection of particularly useful 
species and exclusion of toxic or ineffective ones).7 
(2) The ethnobotanical and ethnomedicinal objective, with the aim to understand cultural 
concepts and believes as well as classification of plants and illnesses. 
(3) The intention to preserve traditional knowledge and healing concepts as well as respect 
and protection of indigenous cultures and conservation of natural resources as legally 
stipulated in 1992 in the Convention on Biological Diversity (Rio “Earth Summit”). While 
forests all over the world continue to fall – the Amazon alone lost 200,000 miles since 1970 - 
too often undiscovered maybe pharmaceutically useful species simply disappear from the 
world, their secrets dying with them. An almost loss occurred recently with Calanolide A from 
Calophyllum lanigerum var. austrocoriaceum (Guttiferae), first collected in 1987 on a 
NCI-sponsored expedition in Sarawak, Malaysia, Borneo, reported by Rhett Butler from 
mongabay.com in 2005. Once determined, that the compound showed significant activity 
against HIV, researchers returned to the place of collection to get more plant material. The 
tree was gone and its disappearance led to a wild search by botanists for further specimen 
finally fruitful in Singapore Botanical Garden which contains a collection of several plants 
once gathered by the British. Calanolide A was successfully synthesised by Sarawak 
MediChem Pharmaceuticals but it is not approved by the U.S. Food and Drug Administration. 
However, when biological material is chosen to be screened for active compounds it is 
crucial both for the development of flora rich areas and the pharmaceutical industry to protect 
and promote the rational exploitation of the resources. If possible cultivated plants should be 
preferred, because they guarantee the production of chemical homogenous material and 
allow the preservation of threatened species. As an example for both, the importance of 
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natural products for the investigation new pharmacologically active agents and the necessity 
to find alternative ways for their production can serve the diterpenoid paclitaxel (Taxol®), 
isolated from Taxus brevifolia (Taxaceae), one of the most important chemotherapeutic 
agents currently in use. At the beginning obtaining the material was very complicated, 
because in order to produce 2.5 kg of Paclitaxel, 27,000 tons of bark were required, viz. 
12,000 trees had to be cut. Due this threat of extinction, alternative ways to obtain paclitaxel 
were developed, including partial synthesis from precursors found in the European yew 
Taxus baccata.109 
1.1 LEGAL COVER OF THE SURVEY 
The commitment of the researcher to the indigenous healer should always be remembered in 
every stage of the study. It is essential to win the trust of healers and chiefs, which can be a 
long way. Hence, before conducting an ethnobotanical research it is very important to obtain 
agreements among all parties, addressing prior informed consent, confidentiality, ownership 
of intellectual properties, and tangible biological materials, collecting area scope, 
conservation of medicinal plants as well as their habitats, responsibilities for parties, benefit 
sharing (in this case a popular scientific book of all plants collected in the three main 
languages of Vanuatu, English, French, and Bislama, had to be made), compensation due 
parties at all stages of the research, development and commercialisation and supplier of 
materials.110 In the present survey negotiations had to be conducted and contracts had to be 
made with the Vanuatu National Cultural Council (Vanuatu Cultural Centre) and the Vanuatu 
government, represented by the Environment Unit, part of the Ministry of Lands, Survey, 
Environment, Energy, Minerals, and Water as well as the Ministry of Health. 
1.2 COLLECTION OF DATA 
During five months between May and November 2006 an ethnobotanical survey was 
conducted on three different islands of Vanuatu: Loh in Torres Islands, Ambrym, and 
Aneityum.  
The specialists in traditional medicine were first asked about their healing experiences and 
about themselves. Next, during an excursion to the surroundings, the healer chose the plants 
he knew and was willing to show. On-site the specialist was interviewed about use(s), 
preparation, application(s), plant name(s), as well as his healing concepts (Fig. 42, p. 173). 
Representative pictures of the plant were taken and herbarium specimens were prepared. In 
addition information about illnesses and their causes were collected (Fig. 43, p. 174). 
The interviews were conducted in Bislama, in a few cases a fieldworker was consulted, to 
translate from vernacular language. Data were collected in an oral interview, using the 
questionnaires mentioned above as a matrix for the interviewer. 
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1.3 PREPARATION OF HERBARIUM SPECIMENS 
The voucher specimens were directly dried in the field using a conventional plant press. A 
number tag was added to each specimen and it was placed on an 
open folder (wrapping-paper or newspaper) and sandwiched 
between pieces of newspaper and corrugated paper. The straps 
were fastened tightly and the press was hung up in the house to 
allow a steady flow of warm air and to avoid ants. The papers were 
changed regularly to keep the moisture content as low as possible 
(to avoid mould and decay) and to check for insect attack.  
1.4 IDENTIFICATION OF THE SPECIMENS 
Voucher specimen had to be identified directly in the field. The correct classification, where a 
self-made field guide (see 1.5 Traditional medicine and its plants) was used, was essential, 
as it had to be decided on-site, which plant to collect for the screening regimen, as a second 
visit on the islands was not possible. Back in the capital city, the plants were verified at the 
National Herbarium in Port Vila, Vanuatu and back in Europe in the Royal Botanic Gardens, 
Kew, London, Great Britain and are deposited at the University of Regensburg. 
1.5 COLLECTION OF PLANT MATERIAL 
Eighteen plants with immunomodulatory properties were chosen for the screening procedure 
and between 500 and 1,000 g dry weight were collected: 
Acalypha grandis BENTH. (leaves), Aidia racemosa (CAV.) D.D. TIRVENG. (leaves), Allophylus 
timoriensis DC. BL. (leaves), Dysoxylum arborescens (BL.) MIQ. (leaves), Euodia latifolia DC. 
(leaves), Pipturus argenteus WEDD. (inner bark), Syzygium malaccense (L.) MERR. & L.M. 
PERRY (leaves), and Tabernaemontana pandacaqui LAM. I (leaves) were collected and dried 
in Lungharigi, Loh, Torres Islands, Vanuatu between June and July 2006. The plant material 
was smoke dried at about 40°C using a self-made dryer built of stems of coconut wood which 
are very hard and heat resisting, a grid of lengthwise splitted bamboo stalks covered with 
bamboo mats.  
Zingiber zerumbet (L.) SM. (rhizome), Dracontomelon vitiense ENGL. (inner bark), 
Gyrocarpus americanus JACQ. (leaves), Intsia bijuga (COLEBR.) O. KTZE. (leaves), 
Macaranga dioica MUELL. ARG. (inner bark and leaves), Macaranga tanarius (L.) MUELL. ARG. 
(inner bark and leaves), Macropiper latifolium (L.F.) (stems), and Tabernaemontana 
pandacaqui LAM. II (leaves) were collected and dried in Lélé, Ambrym, Vanuatu between July 
and August 2006. Here the plant material was slowly heat dried at about 40°C using a copra 
dryer. 
Fig. 11 Plant press 
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Baccaurea stylaris MUELL. ARG. (inner bark and leaves), Bidens pilosa L. (whole plant), and 
Grewia inmac GUILL. (leaves) were collected and smoke dried in Anelcauhat, Aneityum, 
Vanuatu in August 2006 using the same method as in Loh.  
           
Fig. 12 Drying in Loh, Ambrym, and Aneityum (from left to right) 
1.6 QUANTITATIVE ETHNOBOTANY 
A database of ethnobotanical information collected during the six months of fieldwork was 
generated, consisting of 420 use reports on 130 species of 54 plant families, contributed by 
27 informants of different age, gender, occupation, education, and class to ensure that the 
data collected were not biased in favour of any social group. They included 16 men and 11 
women, aged between 25 and 79 years. Four people were interviewed at least twice. 
Information on the medicinal system and ethnological background were obtained by 
interviewing high-ranking community members, the priests, doctors, the community leaders, 
and the fieldworkers. 
In order to analyse the relative frequency of certain diseases and the cultural importance of a 
species the reports were divided into 17 categories of use. The reports were grouped 
according to their medicinal affiliation or sociocultural relevance, whereas a species can be 
listed in more than one category. 
2. BIOLOGICAL ASSAYS 
Biological targets in the screening of crude extracts or pure compounds for bioactivity can be 
classified into five major groups: (1) lower organisms, such as microorganisms, insects, 
crustaceans, and molluscs, (2) cultivated cells of human or animal origin, (3) isolated organs 
of vertebrates (e.g. guinea pig ileum or rat tail artery), (4) whole animals, and (5) isolated 
subcellular systems, such as enzymes, receptors, and organelles. Most of the biological 
assays require specialised facilities and know how, so only in a few cases it makes sense to 
built up such an assay intramural within a phytochemical laboratory, and therefore 
collaborations with other groups are useful, even became necessary.1 
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In this study the regimen consisted of four major parts: (1) a screening for cytotoxicity has 
been carried out in this lab, (2) assays for antibacterial, antifungal, and antiprotozoal 
activities were carried out in the Laboratory for Microbiology, Parasitology and Hygiene 
(LMPH), Antwerp, Belgium, (3) assays in the development of drugs effective against 
Alzheimer’s disease (AChE and BChE-inhibitors, and NMDA-antagonists) were performed in 
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, University of 
Jena, Germany or Department of Pharmaceutical Biology, Institute of Pharmacy, University 
of Jena, Germany, respectively, and (4) assays targeting at anti-inflammatory processes 
were carried out at Division of Cell- and Neurobiology, Institute of Anatomy, University of 
Zurich, Switzerland. 
2.1 CYTOTOXICITY ASSAY 
In this project a screening regimen on the basis of the disease oriented so called NCI60 
(panel of 60 human tumour cell lines, organized into subpanels representing leukaemia, 
melanoma, and cancers of the breast, central nervous system, colon, kidney, lung, ovary, 
and prostate) was developed. In the early years the NCI had screened compounds in a 
murine model, but as the seemingly positive molecules were showing a relative lack of 
activity against common human adult solid tumours this system was replaced by the NCI60. 
This in vitro “disease-oriented”, drug-discovery screen was developed between 1986 and 
1990, ran as a primary drug screen between 1990 and 2000 and since 2000 it operates as a 
screening service to the research community. The primary intention was to identify 
compounds with growth-inhibitory or toxic effect on particular tumour types but the patterns 
of relative drug sensitivity and resistance generated with standard anticancer drugs were 
soon showing mechanisms of drug action giving the opportunity for molecular-targeted 
anticancer drug discovery.111 This screen already yielded in many plant-derived anticancer 
drugs, e.g. camptothecin from Camptotheca acuminata (Nyssaceae).112-114 
In the present study a subpanel of the NCI60 consisting of eight cell-lines was used because 
of two reasons: (1) profiles of cell line sensitivity can give information of selective activity on 
particular tumour types - meaning that a cell line can be inhibited to a given extent at a lower 
drug concentration than required to exert the same effect on other cell lines 111 - which may 
provide information about molecular mechanisms of growth inhibition and cell killing115 as the 
cell lines included into the NCI60 screen are (2) better characterised pharmacologically and 
at the molecular level than any other set of cell lines. Their cytogenetical characterisation by 
chromosome banding in 1970 by Walter Nelson-Rees and colleagues has for instance 
unearthed the true origin of the KB cell line, thought to be derived from an epidermoid 
carcinoma of the oral cavity111 and many other relatively widely used tumour cell models of 
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various tumours to be in fact derivatives of the well established HeLa cervical carcinoma cell 
line. 
The assessment of in vitro cytotoxicity was determined using the MTT assay, a quantitative 
colorimetric method to determine cell proliferation, viability, and cytotoxicity. It utilises the 
yellow tetrazolium salt 3-(4,5–Dimethyl–2-thiazolyl)-2,5–diphenyl-2H-tetrazolium bromide) 
which is predominantly metabolised by mitochondrial succinic dehydrogenase activity of 
proliferating cells to form insoluble purple formazan crystals, but many non-mitochondrial 
dehydrogenases and flavin oxidases also seem to be able to reduce MTT.116-118 The crystals 
are then solubilised by the addition of a detergent and the colour can be quantified by 
spectrophotometric means, whereas the amount of colour produced is directly proportional to 
the number of viable cells.119 Secondary plant metabolites like phytoestrogens and 
antioxidants were also shown to interfere with the assay by extracellular reduction of the 
MTT.120 
Leukaemia was not included into the screening, because the MTT assay is difficult to apply 
to suspension cell lines and neither HL-60 nor Jurkat cells could be established for an 
alternative assay, using WST-1 instead of MTT-reagent.  
CELL LINES 
786-0    human renal cell adenocarcinoma 
A549    human epithelial cell lung carcinoma 
HT-29    human colorectal adenocarcinoma 
MCF7    human breast adenocarcinoma (from metastatic site pleural effusion) 
OVCAR-3:NIH  human ovarian adenocarcinoma 
PC-3    human prostate carcinoma cells (from metastastatic site bone) 
SK-MEL-28   human malignant melanoma cells 
SNB-19   human glioblastoma cells 
All cell lines were obtained from the Cell Lines Service (CLS) (Eppelheim, Germany; 
http://www.cell-lines-service.de), except from SNB-19 cell line, which was obtained from 
Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ) (Braunschweig, 
Germany; http://www.dsmz.de). 
CELL LINE MAINTENANCE 
The cells were splitted weekly. The culture medium was removed and the cells were rinsed 
with 2.5 mL PBS to remove all traces of serum that contains trypsin inhibitor. The monolayer 
was coated with 1.5 mL Trypsin-EDTA (0.025%/ 0.03%) and the flasks were placed at 37°C 
for up to 10 min. until the cell layer was dispersed. 5 mL of the appropriate complete growth 
medium was added, the cells were separated into single-cell suspensions by gentle pipetting 
and an aliquot of 1x106 cells (cell number was determined in a haemocytometer via the well 
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known Trypan Blue dye exclusion method) was transferred to a new culture flask containing 
24 mL of fresh medium.  
786-0 RPMI 1640 supplemented with 10% FBS, 1 mM sodium pyruvate, 
10 mM HEPES buffer, 100 U/mL penicillin, and 50 U/mL streptomycin 
A549  Ham’s F12K supplemented with 10% FBS, 2 mM L-glutamine, 
100 U/mL penicillin, and 100 µg/mL streptomycin 
HT-29  RPMI 1640, supplemented with 10% FBS, 50 U/mL penicillin, and 
50 U/mL streptomycin 
MCF7  DMEM, supplemented with 10% FBS, 2 mM L-glutamine, 1% 
non-essential amino acids, 100 U/mL penicillin, and 100 µg/mL 
streptomycin 
OVCAR-3:NIH  RPMI 1640 supplemented with 20% FBS, 2 mM L-glutamine, 1 mM 
sodium pyruvate, 10 mM HEPES, 1.5 g/L sodium bicarbonate, 4.5 g/L 
glucose, 0.01 mg/mL bovine insulin, 100 U/mL penicillin, and 
100 µg/mL streptomycin 
PC-3  Ham’s F12K supplemented with 10% FBS, 2 mM L-glutamine, 
100 U/mL penicillin, and 100 µg/mL streptomycin 
SK-MEL-28 DMEM, supplemented with 10% FBS, 2 mM L-glutamine, 1% 
non-essential amino acids, 100 U/mL penicillin, and 10 µg/mL 
streptomycin 
SNB-19 DMEM, supplemented with 10% FBS, 100 U/mL penicillin, and 
100 µg/mL streptomycin 
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MEDIA, SUPPLEMENTS, BUFFERS, AND ENZYMES 
Dulbecco’s modified Eagle’s medium  Biochrom AG, Berlin, D
Ham’s F12K Biochrom AG, Berlin, D 
RPMI 1640 Biochrom AG, Berlin, D 
Foetal bovine serum (FBS) Biochrom AG, Berlin, D 
D-(+) -glucose, anhydrous Fluka, Buchs, CH 
L-glutamine Biochrom AG, Berlin, D 
HEPES-buffer Biochrom AG, Berlin, D 
Insulin, bovine Biochrom AG, Berlin, D 
Non-essential amino acids (NEA) 
Penicillin 
Penicillin-streptomycin 
Sodium bicarbonate 
Sodium pyruvate 
Streptomycin 
Biochrom AG, Berlin, D 
Biochrom AG, Berlin, D 
Invitrogen, Karlsruhe, D 
Merck KG aA, Darmstadt, D 
Biochrom AG, Berlin, D 
Biochrom AG, Berlin, D
PBS solution with Ca/Mg Biochrom AG, Berlin, D 
Titriplex III (EDTA) Merck KG a. A., Darmstadt, D 
Trypsin Biochrom AG, Berlin, D
COLORIMETRIC MTT ASSAY 
Cells were inoculated in a volume of 100 µL per well onto 96-well microtiter plates (Techno 
Plastic Products AG, Trasadingen, Switzerland) at densities between 2.6x103 and 47.5x103 
cells per well (Tab. 1) to form a confluent cell layer, whereas the cell number was determined 
using the well known Trypan Blue exclusion method. The microtiter plates were preincubated 
for approximately 24 h at 37°C to allow stabilisation prior to drug addition. 
For initial screening 50 µL of a solution of 150 µg/mL (0.1% DMSO) crude extract in cell 
culture medium (final DMSO content 0.033%) were added to each well and the plates were 
incubated in a humidified atmosphere (37°C, 5% CO2). After 72 h stock MTT solution 
(dissolved in PBS at 4 mg/mL and filtered to sterilise and remove a small amount of insoluble 
residue) at a concentration of 15 µL per 150 µL medium was added and incubated for 4 h 
under the same conditions. The medium was evacuated and sodium dodecyl sulphate (SDS) 
(10% in Millipore H2O) was added to all wells to lyse the cells. After 24 h at room temperature 
in the dark to ensure, that all formazan crystals have been dissolved, the plates were 
measured at 560 nm against a background control (150 µL SDS), using a microplate reader 
(Tecan Spectrafluor plus, Tecan Deutschland GmbH, Crailsheim, Germany). Every test was 
performed at least in triplicates and all experiments have been repeated three times (n=4).  
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The cell viability for each experiment was calculated as a ratio of treated cells 
( )( BTT ODxODxy −= against an untreated control ( )( BUU ODxODxy −= , yielding the 
viability in % after multiplication with the factor 100: 
[ ] 100% ×=
U
T
y
yviability  
Fig. 13 )( BTT ODxODxy −= : average optical density of treated cells minus average OD of 
blank-wells (medium without cells) 
)( BUU ODxODxy −= : average OD of untreated cells minus average OD of blank-wells (untreated 
cells = aliquot of cells in medium plus 15 µL MTT, which was set to 100% viability). 
Extracts showing a decrease of cell viability greater than 50% were further tested at a 
concentration of 25 µg/mL (0,02% DMSO; final DMSO content 0.017%) and for those 
showing a cell viability less than 50% under these conditions, IC50 values were determined 
with six three-fold dilutions, starting from a maximum concentration of 50 µg/mL. This 
step-by-step measuring procedure had to be applied to minimise costs and effort. 
CELL INOCULATION DENSITIES 
Cells were inoculated in a volume of 100 µL per well at twelve densities between 825 and 
20.000 (SNB-19 between 2.000 and 47.500) cells per well. The cells were preincubated for 
24 h to allow stabilisation and after this period 50 µL of medium were added and the assay 
was performed as described above. Every test was performed in quintuplicates and all 
experiments have been replicated twice (n=3). The results were compared to inoculation 
densities used in the NCI60 in vitro screen performed by the National Cancer Institute, 
Frederick, MD, USA (http://dtp.nci.nih.gov/docs/misc/common_files/cell_list.html) and values 
with strongest consensus were chosen, if meeting the criteria above. 
Tab. 1 Human tumour cell lines and inoculation densities used in the in vitro drug screen (n=3) 
   
Cell Line cells/well NCI60 panel 
786-0 20x103 10x103 
A549 11.25x103 7.5x103 
HT-29 2.6x103 5x103 
MCF7 11.25x103 10x103 
OVCAR-3:NIH 11.25x103 10x103 
PC-3 15x103 7.5x103 
SK-MEL-28 15x103 10x103 
SNB-19 47.5x103 15x103 
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CONTROLS 
Negative control experiments were performed as described above with 0.033% DMSO, 
representing the final assay concentration.  
The positive control experiments were conducted with podophyllotoxin or parthenolide, 
respectively and the IC50 values had to be established for each cell line prior implementation. 
Both substances were initially solubilised in DMSO and tested at nine ten-fold dilutions, 
starting from a maximum concentration of 100 µM and the assay was performed as 
described above, only using these except from the crude extract solutions. The IC50 values 
were determined for an incubation time of 48 h and 72 h respectively. The dose response 
curves for the incubation period of 48 h are not shown in the section “2.1 Cytotoxicity Assay, 
Establishment of a positive control”, because an incubation period of 72 h was finally chosen 
for the assay as described above. Every test was performed in triplicates and all experiments 
have been replicated twice (n=3).  
Tab. 2 Human tumour cell lines and concentrations of the positive controls used in the in vitro drug 
screen (n=3). Data expressed as mean ± SD. 
Cell Line Positive Control 
 c Podophyllotoxin ± SD [µM] c Parthenolide ± SD [µM] 
 48 h 72 h 48 h 72 h 
786-O - 0.005 ± 0.0005  -   -  
A549 0.074 ± 0.001 0.038 ± 0.005  -   -  
HT-29 0.651 ± 0.025 0.624 ± 0.017  -   -  
MCF7 1.021 ± 0.004 0.961 ± 0.041  -   -  
OVCAR-3:NIH 1.187 ± 0.033 0.778 ± 0.021  -   -  
PC-3 1.154 ± 0.033 0.455 ± 0.024  -   -  
SK-MEL-28  -   -  0.518 ± 0.010 0.427 ± 0.035 
SNB-19  -   -  4.111 ± 0.584 0.780 ± 0.063 
INTERACTION OF EXTRACTS AND MTT IN CELL-FREE SYSTEM 
The direct reduction of MTT by the plant extracts was tested to exclude false negative 
results. 100 µL PBS per well were put in first onto 96-well microtiter plates, 50 µL of a 
solution of 150 µg/mL crude extract in PBS and 15 µL stock MTT solution were added to 
each well and the plates were incubated in a humidified atmosphere (37°C, 5% CO2) 4 h. 
150µL SDS (10% in Millipore H2O) were added to all wells to solve the formazan crystals and 
after 24 h at room temperature in the dark to ensure, that all formazan crystals were 
dissolved, the plates were measured at 560 nm against a background control (blank plus 
150 µL SDS), using a microplate reader (Tecan Spectrafluor plus, Tecan Deutschland 
GmbH, Crailsheim, Germany). Every test was performed at least in triplicates and replicated 
twice (n=3). 
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DATA ANALYSIS 
The results were expressed as mean ± SD (processed with Graph Pad). To compare more 
than two groups, data were analysed by two way ANOVA, followed by Dunnet’s multiple 
comparison test, using Graph Pad; p<0.05 was considered to be significant, p<0.01 as very 
significant and p<0.001 as extremely significant). 
REAGENTS 
Dimethyl sulfoxide (DMSO) Merck KG aA, Darmstadt, D
Sodium dodecyl sulphate (SDS) Sigma-Aldrich, Steinheim, D 
MTT (3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-
diphenyl-2H-tetrazolium bromide 
Fluka, Buchs, CH 
Parthenolide Calbiochem, San Diego, USA 
PBS solution with Ca/Mg Biochrom AG, Berlin, D 
Podophyllotoxin Sigma-Aldrich, Steinheim, D 
Trypan Blue Sigma-Aldrich, Steinheim, 
2.2 ANTIBACTERIAL AND ANTIFUNGAL ASSAYS 
Infectious diseases caused by bacteria, viruses, and fungi are still a major threat to public 
health, with an impact particularly large in developing countries due to poor access of drugs 
and the emergence of widespread drug resistance.121 Current research on natural molecules 
and products with antimicrobial activity primarily focuses on microorganisms, but plants are 
also of interest due to two reasons: they are easy to source and as they are often part of 
ethnopharmacopoeias all over the world, a pre-selection of plants due to their traditional use 
may enhance the success in new drug-finding efforts. Even if no plant derived compound has 
been found which can compete with clinically used antibiotics yet, the search of novel lead 
structures remains a task to be pursued.1 
Due to an increasing incidence of opportunistic mycoses associated with AIDS or 
immunosuppressive drugs, the search for antifungal drugs has been revived in the last years, 
as there are currently only a few antifungal agents with very limited efficacy indicated for the 
treatment of systemic mycoses.1 
In the present study the antiprotozoal, antifungal, and antibacterial assays have been 
performed together at the Laboratory of Microbiology, Parasitology and Hygiene (LMPH), 
Antwerp University, Belgium, because their use of an integrated in vitro screening, including 
a cytotoxicity evaluation on the host cell lines and different microbial screens, allows the 
exclusion of false-positives as a result of aspecific cell toxicity.122  
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ANTIBACTERIAL ASSAYS 
The Gram-positive Staph. aureus and Gram-negative E. coli served as model organisms in 
the evaluation of potentially antibacterial properties of the plant extracts tested in this study. 
Staph. aureus can cause a range of illnesses from minor skin infections, such as boils, 
carbuncles, or abscesses to life-threatening diseases, like pneumonia, meningitis, 
osteomyelitis, endocarditis, Toxic Shock Syndrome, and septicaemia. The development of 
“multi-resistant” strains, namely MRSA (methicillin-resistant Staph. aureus) is especially 
troublesome in hospital-associated (nosocomial) infections, as patients with open wounds, 
invasive devices, and weakened immune systems are especially prone to infections.123 
Most Escherichia coli strains - commonly part of the normal gut flora - are harmless, but 
some can cause serious food poisoning, urinary tract infections, neonatal meningitis, 
peritonitis, mastitis, septicaemia, and Gram-negative pneumonia or are also responsible for 
the severe Haemolytic-Uraemic Syndrome.123  
The resazurin assay, the method of choice in this study, a simple, sensitive, rapid, robust, 
and reliable method is widely used to determine the minimum inhibitory concentration (MIC) 
values of natural products, including crude extracts against various bacteria and fungi. 
Resazurin, an oxidation–reduction indicator used for the evaluation of cell growth, is a blue 
non-fluorescent and non-toxic dye becoming pink coloured and fluorescent when reduced to 
resorufin by oxidoreductases within viable cells.124 
Staph. aureus (ATCC6538) and E. coli (ATCC8739) were maintained in TSB (Tryptone Soy 
Broth) and on TSA (Tryptone Soy Agar) and all cultures and assays were conducted under a 
humidified atmosphere (37°C, 4% CO2, 3% O2, and 93% N2). Assays were performed in 
sterile 96-well microtiter plates, each well containing 10 µL of the watery extract dilution 
(DMSO final content <1%) together with 190 µL of bacteria inoculum (5x103 CFU/mL). 
Bacterial growth was compared to untreated-control wells (100% cell growth) and medium-
control wells (0% cell growth). After an incubation of 17 h (or longer – depending on the 
organism), bacterial viability was assessed fluorimetrically (λex 550 nm, λem 590 nm) 0.5 h 
after addition of 20 µL resazurin per well. The results were expressed as % reduction in 
bacterial growth/viability compared to control wells and an IC50 was determined. The extracts 
were tested at five concentrations (64; 16; 4; 1 and 0.25 µg/mL) and an extract was classified 
as inactive with an IC50 > 15 µg/mL. Between 5 and 15 µg/mL it was regarded as moderately 
active. An IC50 < 5 µg/mL was classified as highly active. Standard bacterial reference 
compounds included ampicillin (Staph. aureus) and doxycyclin (E. coli). 
ANTIFUNGAL ASSAYS 
The dermatophytic fungus Trichophyton rubrum is the most common cause of athlete’s foot, 
ringworm, and jock itch (Tinea cruris). Microsporum canis, another dermatophytic fungus is 
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usually found in cats, but it is also sometimes transmitted to humans and if so it is very 
contagious and causes a severe form of hair-loss. Candida albicans, often associated with 
opportunistic oral or genital infections in humans, can also be the causal agent for severe 
fungaemias (systemic fungal infections), particularly common in immunocompromised 
patients. Infections with Aspergillus fumigatus are also common in these individuals, 
sometimes eliciting severe illnesses: acute invasive aspergillosis in the lung or disseminated 
invasive aspergillosis widespread in the body.123  
The antifungal assays were performed the same way as the antibacterial assays, only using 
Sabouraud agar or broth instead of TSB or TSA. Models utilised in the antifungal screen 
were Trichophyton rubrum strain 68183 and Microsporum canis as representatives of the 
dermatophytes, the opportunistic yeast Candida albicans, and the opportunistic filamentous 
fungus Aspergillus fumigatus strain 42928. Standard reference compounds included 
econazole (T. rubrum), terbinafine (M. canis and A. fumigatus), or flucytosine (C. albicans), 
respectively. 
2.3 ANTIPROTOZOAL ASSAYS 
Malaria is without doubt one of the major scourges of humanity, with about 1.5 to 2.7 million 
deaths per annum (most of them children) and chemotherapy is hindered by the increase in 
drug resistant strains, particularly of Plasmodium falciparum, which causes Malaria tropica, 
the most severe form (WHO, 1997). It is transmitted by female mosquitoes of the genus 
Anopheles. Among synthetic drugs quinine, the first effective drug against malaria is still in 
clinical use. Another plant derived drug, artemisinin, an unusual sesquiterpen endoperoxide 
has been isolated as the active principle from Artemisia annua “Qing hao” (Asteraceae), an 
herb used as a febrifuge and against malaria in China for almost two millennia. Together with 
its derivatives it was found to be effective against multi drug resistant strains of Plasmodium 
falciparum and created a breakthrough in preventing almost a million deaths from severe 
malaria per year.4 
Leishmaniasis is a group of usually tropical diseases caused by representatives of the genus 
Leishmania, affecting about 12 million people each year.125 As transmitters have been 
identified female flying insects of the genus Phlebotomus (Old World leishmaniasis) and 
Lutzomya (New World leishmaniasis).126 The WHO has classified leishmaniasis in four 
clinical forms: visceral, muco-cutaneous, cutaneous diffuse or disseminated, and cutaneous. 
Although a number of drugs have been developed to date, only the recently launched 
miltefosine has demonstrated to be fully effective against Leishmania parasites.127 
Sleeping sickness or African Trypanosomiasis is a parasitic disease caused by subspecies of 
Trypanosoma brucei which are transmitted by the Tsetse fly (Glossina sp.). The disease is 
endemic in certain regions of Sub-Saharan Africa and it is estimated that 50,000 to 70,000 
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people are currently infected (WHO, 2006). The four drugs registered for the treatment of 
sleeping sickness are of synthetic origin.  
Chagas disease or (South-) American Trypanosomiasis is caused by subspecies of 
Trypanosoma cruzi transmitted mostly by blood-sucking assassin bugs of the family 
Reduviidae, subfamily Triatominae. It is estimated, that 11-18 million people are infected in 
South America and 100,000 are at risk acquiring this disease.128 Drugs of choice in its 
treatment are the very toxic azole or nitroderivatives such as benznidazole, which causes 
many side effects and in addition resistances have also already been observed. Studies on 
natural products have already taken place, so dermaseptins from the frog species 
Phyllomedusa oreades and Phyllomedusa distincta129 have shown some effects as well as 
the sesquiterpene lactone dehydroleucodine isolated from an Artemisia species.130 
CYTOTOXICITY 
Although many other cell types can be used, MRC-5SV2 cells are utilised by the LMPH 
because of their receptiveness and sensitivity for many viruses and parasites and therefore 
possible standardisation across different bioassays. The cells were cultured in Earl’s MEM 
supplemented with 5% heat-inactivated FCS, 20 mM L-glutamine, and 16.5 mM sodium 
bicarbonate. Assays were performed in 96-well microtiter plates, each well containing 1x104 
cells. Compounds were tested at five concentrations (64; 16; 4; 1 and 0.25 µg/mL) and after 
an incubation of 72 h in a humidified atmosphere (37°C, 5% CO2) and addition of resazurin 
(see also “2.3 ANTIBACTERIAL AND ANTIFUNGAL ASSAYS”); cell viability was assessed 
fluorimetrically (λex 550 nm, λem 590 nm). The results were expressed as % reduction in cell 
growth/viability compared to untreated control wells and IC50s were determined. An extract 
was classified as inactive with an IC50 > 15 µg/mL. Between 5 and 15 µg/mL it was regarded 
as moderately active. An IC50 < 5 µg/mL was classified as highly active. Tamoxifen was 
included as reference drug.  
IN VITRO ANTI-PLASMODIUM FALCIPARUM ACTIVITY 
The chloroquine-sensitive 1/ GHA (P.falGHA) Plasmodium falciparum strain - derived from a 
Ghanese patient - was used: It was maintained in RPMI-1640 medium supplemented with 
0.37 mM hypoxanthine, 25 mM HEPES-buffer, 25 mM sodium bicarbonate, and 10% human 
0+ serum together with 2 - 4% washed human 0+ erythrocytes.131 All cultures and assays 
were conducted under a humidified atmosphere (37°C, 4% CO2, 3% O2, and 93% N2) with the 
assay being an adaptation of the procedure described by Desjardins et al., 1979.132 Assays 
were performed in 96-well microtiter plates, each well containing 10 µL of the watery extract 
dilutions together with 190 µL of the malaria parasite inoculum (1% parasitaemia, 2% 
haematocrit). After an incubation of 72 h at 37°C, plates were frozen and stored at -20°C. 
After thawing, 20 µL of each well was transferred into another plate together with 100 µL 
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Malstat® reagent and 20 µL of a 1/1 mixture of PES (phenazine ethosulphate, 2 mg/mL) and 
NBT (Nitro Blue Tetrazolium Grade III, 0.1 mg/ml). The plates were kept in the dark for 2 h 
and change in colour was measured spectrophotometrically at 655 nm. The results were 
expressed as % reduction in parasitaemia compared to control wells. The extracts were 
tested at five concentrations (64; 16; 4; 1 and 0.25 µg/mL) and an extract was classified as 
inactive with an IC50 > 15 µg/mL. Between 5 and 15 µg/mL it was regarded as moderately 
active. An IC50 < 5 µg/mL was classified as highly active. Chloroquine was included as 
reference drug.  
IN VITRO ANTI-LEISHMANIA INFANTUM ACTIVITY 
In this study the visceral species Leishmania infantum was chosen, because visceral show a 
higher sensitivity to available reference drugs than cutaneous forms, validated models are 
available, and they represent a greater medicinal need.122 The strain Leishmania infantum 
MHOM/MA (BE)/67 was maintained in the golden hamster and spleen amastigotes were 
collected for preparing infection inocula. Primary peritoneal mouse macrophages were used 
as host cells and collected 48 h after peritoneal stimulation with a 2% potato starch 
suspension. Assays were performed in 96-well microtiter plates, each well containing 10 µL 
of the extract dilutions together with 190 µL of macrophage/parasite inoculum (3x105 cells 
and 3x106 parasites/well in RPMI-1640 + 5% heat-inactivated FCS). After an incubation of 
120 h in a humidified atmosphere (37°C, 5% CO2), parasite burdens (mean numbers of 
amastigotes/macrophage) were microscopically assessed after Giemsa staining. The results 
were expressed as % reduction in parasite burden compared to untreated control wells and 
IC50s were calculated. The extracts were tested at five concentrations (64; 16; 4; 1 and 
0.25 µg/mL) and an extract was classified as inactive with an IC50 > 15 µg/mL. Between 5 
and 15 µg/mL it was regarded as moderately active. An IC50 < 5 µg/mL was classified as 
highly active. Miltefosine was included as reference drug.  
IN VITRO ANTI-TRYPANOSOMA BRUCEI BRUCEI ACTIVITY  
Because of its non-pathogenicity for humans, a drug sensitive strain of Trypanosoma brucei 
brucei is used in the primary screening performed in the LMPH. The strain Trypanosoma 
brucei brucei Squib 427 (suramin-sensitive) was maintained in HMI-9-medium supplemented 
with 10% heat-inactivated FCS. Assays were performed in 96-well microtiter plates, each 
well containing 10 µL of the extract dilution together with 190 µL of the parasite suspension 
(7x104 parasites/mL). After incubation in a humidified atmosphere (37°C, 5% CO2) for 72 h, 
resazurin (see also “2.3 ANTIBACTERIAL AND ANTIFUNGAL ASSAYS”) was added and 
24 h later under the same conditions the parasite growth was assessed fluorimetrically 
(λex 550 nm, λem 590 nm). The results were expressed as % reduction in parasite 
growth/viability compared to control wells and IC50s were calculated. The extracts were tested 
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at five concentrations (64; 16; 4; 1 and 0.25 µg/mL) and an extract was classified as inactive 
with an IC50 > 15 µg/mL. Between 5 and 15 µg/mL it was regarded as moderately active. An 
IC50 < 5 µg/mL was classified as highly active. Suramin was included as reference drug. 
IN VITRO ANTI-TRYPANOSOMA CRUZI ACTIVITY  
As a model for Chagas disease the biohazard class-3 pathogen Trypanosoma cruzi was 
used. The nifurtimox-sensitive Trypanosoma cruzi, Tulahuen CL2, β galactosidase strain was 
maintained on MRC-5SV2 cells in MEM medium, supplemented with 200 mM 
L-glutamine,16.5 mM sodium bicarbonate, and 5% heat-inactivated FCS. All cultures and 
assays were conducted under a humidified atmosphere (37°C, 5% CO2). Assays were 
performed in 96-well microtiter plates, each well containing 10 µL of the watery extract 
dilutions together with 190 µL of MRC-5SV2 cell/parasite inoculum (2x104 cells/mL and 2x105 
parasites/mL). After an incubation of 168 h parasite growth was compared to 
untreated-infected controls (100% growth) and non-infected controls (0% growth). Parasite 
burdens were assessed after adding of the substrate: 50 µL/well of a stock solution 
containing 15.2 mg CPRG (chlorophenolred ß-D-galactopyranoside) and 250 µL Nonidet in 
100 ml PBS. The change in colour was measured spectrophotometrically at 540 nm after an 
incubation of 4 h at 37°C. The results were expressed as % reduction in parasite burdens 
compared to control wells and IC50s were calculated. The extracts were tested at five 
concentrations (64; 16; 4; 1 and 0.25 µg/mL) and an extract was classified as inactive with an 
IC50 > 15 µg/mL. Between 5 and 15 µg/ml it was regarded as moderately active. An 
IC50 < 5 µg/mL was classified as highly active. Benznidazol was included as reference drug.  
2.4 INFLICTIONS OF THE CENTRAL NERVOUS SYSTEM (CNS) - 
ASSAYS 
There still remains an urgent need for drugs effective in diseases caused by malfunctions of 
the central nervous system (CNS), e.g. pain disorders such as migraine, sleeping disorders, 
epilepsy, dementia like Alzheimer’s disease (AD), Parkinson’s disease, and Huntington’s 
chorea, and affective disorders like bipolar, schizophrenia, depression, and anxiety. Natural 
products have already shown CNS activities, e.g. caffeine, codeine, or nicotine and it is likely 
that there are further such drugs still to be found in nature.4  
AD is a degenerative and terminal disease whose cause and progression are only poorly 
understood, but research indicates that it is associated with plaques and tangles in the brain. 
Three major competing hypotheses exist to explain the cause of the disease, the cholinergic, 
the amyloid, and the tau hypothesis. 
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ACETYLCHOLINESTERASE- AND BUTYRYLCHOLINESTERASE-INHIBITORS  
The oldest hypothesis is the “cholinergic hypothesis”, stating that AD begins as a deficiency 
in the production of acetylcholine (ACh), a vital neurotransmitter.133 Usually acetylcholine is 
synthesized by the enzyme choline acetyltransferase (ChAT) from choline and acetyl-CoA. 
The discovery of a correlation between the loss of ChAT and a decline in mental status 
scores134 lead to the cholinergic hypothesis of cognitive impairment in AD. Cholinesterases 
are a ubiquitous class of serine hydrolases and apart from their classical role in cholinergic 
transmission they are involved in cell proliferation, differentiation, responses to various 
insults including stress, and amyloid formation.135 Two forms occur in vertebrates, the 
acetylcholinesterase (AChE) and the butyrylcholinesterase (BChE). AChE catalyzes the 
cleavage of ACh in the synaptic cleft after depolarization and whereupon 
acetylcholinesterase-inhibitors are frequently used in the pharmacotherapy of AD, the less 
specific BChE has only recently got into focus of research, because BChE concentration 
stays the same or is even up-regulated while AChE concentration is dramatically 
down-regulated in brains of patients suffering from AD.136 Some natural or naturally-derived 
structurally different AChE-inhibitors are already in use, e.g. the Amaryllidaceae-alkaloid 
galantamine (isolated from the Caucasian snowdrop Galanthus woronowii), the 
physostigmine-derivative rivastigmine, the piperidin-congener donepezil-HCl, 
desoxyvasicine, an alkaloid isolated from Peganum harmala (Nitrariaceae), and 
dehydroevodiamine, an alkaloid from Euodia rutaecarpa (Rutaceae)137 which are not able to 
stop AD, but may slow its progression and hippocampal atrophy and may have at least 
disease-modifying effects.138  
More recent hypotheses focus upon the effects of the misfolded and aggregated peptides 
amyloid beta (Aβ) and tau. Soluble and harmless Aβ monomers can undergo a dramatic 
conformational change forming beta-sheet rich tertiary structures that aggregate to 
neurotoxic amyloid fibrils, which deposit outside neurons as so called senile or neuritic 
plaques, a process promoted by AChE139 and BChE.140 
In AD patients hyper-phosphorylated microtubule associated and stabilizing tau proteins 
accumulate as paired helical filaments and aggregate into neurofibrillary tangles, associated 
with amyloid plaques.141 
To date the approved therapeutical options to AD are extremely limited to only four AChE 
inhibitors, namely galantamine, rivastigmine, donepezil-HCl, and tacrine, whereas the last 
one seems to have hepatotoxic properties, and the NMDA receptor antagonist memantine, 
so research in this area is highly eligible. 
Ellman Test 
This assay has been performed in the Department of Pharmaceutical/Medicinal Chemistry, 
Institute of Pharmacy, University of Jena, Germany. 
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The Ellman Test is a photometric method to determine cholinesterase-activity of tissue 
extracts, homogenates, cell suspensions, etc., whereas the enzymatic activity correlates with 
the formation of a yellow coloured product, based on the following formula:142 
colouryellowteitrobenzoadithiobisnethiocholin
acetateethiocholincholineacetylthio rasecholineste
→+
+⎯⎯⎯⎯ →⎯
 
100 µL extract (final concentration 160 µg/mL), 3 mL phosphate buffer pH 8, 100 µL 
5,5’-dithiobis-2-nitrobenzoate, and 100 µL AChE (or BChE respectively) were mixed in a 
cuvette and the self-absorption of the extract (blank) was measured at 412 nm. 20 µL 
acetyl-thiochinolineiodide (or butyryl-thiochinolineiodide) were added, the probe was 
measured at 412 nm, and after subtraction of the blank the actual inhibition-value was 
obtained. Cloudy and yellow-coloured probes were excluded from the test. Inhibition-values 
greater than 70% were considered as positive. Each test has been performed in triplicates, 
but was not replicated yet. 
NMDA RECEPTOR ANTAGONISTS 
The NMDA (N-methyl D-aspartate) receptor is an ionotropic receptor for glutamate. Its 
activation causes the opening of an ion channel, resulting in Na+- and Ca2+- influx and 
K+-efflux. The Ca2+-influx is thought to play a role in synaptic plasticity, a cellular mechanism 
for memory and learning. 
NMDA receptor antagonists are used as anaesthetics, e.g. ketamine and also often as 
recreational drugs, e.g. ibogaine because of their hallucinogenic properties. Since NMDA 
receptors play an important role in excitotoxicity, a pathological process in which nerve cells 
are damaged or killed by glutamate and similar substances, their antagonists are promising 
agents in the treatment of traumatic brain injury, stroke, or neurogenerative diseases, such 
as AD, Parkinson’s disease, or Huntington’s chorea.  
NMDA-Assay 
This assay has been performed in the Department of Pharmaceutical Biology, Institute of 
Pharmacy, University of Jena, Germany. 
The utilised murine L12-G10 cells were obtained by stable transfection of murine fibroblast 
L(tk-) cells with the subunits NR1-1a and NR2a of the human NMDA-receptor (generously 
provided by Prof. D. Steinhilber, University of Frankfurt am Main, Germany), in which the 
receptor expression is regulated by addition of dexamethasone, mediated by a 
glucocorticoid-responsive element. The cells were cultivated in Earl’s MEM supplemented 
with 10% heat-inactivated FCS, 0.5 mM sodium pyruvate, 1% penicillin and streptomycin, 
80 µg/mL G418 (geneticin), and 100 µM ketamine. The assay was performed according to 
Steinmetz et al. (2002)143 (slightly modified) in 96-well microtiter plates, each well containing 
1x104 cells in 200 µL cultivation medium. The cells were preincubated for 30 h in a humidified 
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atmosphere (37°C, 5% CO2); the medium was removed and substituted with fresh medium 
(plus 4 µM dexamethasone). After an incubation time of 18 h under the same conditions the 
cells were washed twice with MEM (without Phenol red) containing 1% bovine serum 
albumin (BSA) and once with MEM (with Phenol red) to remove the ketamine. 200 µL of an 
extract-dilution at a concentration of 50 µg/mL in MEM without Phenol red were added to 
each well (DMSO final content <0.1%) and after a pre-incubation of 30 min. under the same 
conditions as above for 30 min., a mixture of glycine and L-glutamate (10 µM) was added 
and the cells were incubated for 4 h. Excitotoxicity was determined by detection of LDH 
(lactate dehydrogenase) release into culture supernatants using the Cytotoxicity Detection 
Kit® (Roche Diagnostics, Mannheim, D) 100 µL of the supernatant were mixed with 100 µL 
reaction reagent (containing iodonitrotetrazoliumchloride (INT)) and after an incubation of 
35 min. in the dark, allowing the formation of a red coloured formazan product, metabolised 
by LDH from INT, the plates were measured at 492 nm (HTS 7000 plate reader, Perkin 
Elmer). Every test was performed at least in hexaplicates and all experiments have been 
repeated only once yet (n=2). Memantine [4.4 µM] and ketamine [6.4 µM] were included as 
reference drugs. 
The calculation of the excitotoxicity was carried out using the following formula: 
[ ] 100
...
..% x
ctrlAnegctrlApos
ctrlAnegAextractcityexcitotoxi −
−=  
..ctrlAneg Absorption of the negative control, containing 100 µM ketamine in Earl’s MEM 
without Phenol red; excitotoxicity = 0% 
..ctrlApos  Absorption of the positive control, containing Earl’s MEM without Phenol red; 
excitotoxicity = 100% 
Aextract : Absorption of the extract-dilution (50 µg/mL extract in Earl’s MEM without Phenol 
red)  
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3. EXTRACTION 
The heat-dried plant material used in the biological assays (30 g) was ground to powder 
(RETSCH ZM1, Retsch GmbH, Haan, Germany) with a particle size of 0.5 mm, mixed with 
10 g of sea sand and first extracted with dichloromethane (DCM) (all solvents used were 
pure grade or purified by distillation prior to use) at 50°C in four cycles of five minutes each, 
using an “Accelerated Solvent Extractor” (ASE 100, Dionex GmbH, Idstein, Germany). The 
remaining plant material was then extracted with ethyl acetate (EtOAc) and finally with 
methanol (MeOH) under the same conditions (Fig. 14). The crude extracts were stored at 
-80°C. 
For the phytochemical investigation of Baccaurea stylaris MUELL. ARG. (voucher no. 
1786-6C), 750 g of the heat-dried drug material were processed and extracted as above, 
yielding 90.9 g crude extract from the extraction with DCM, 4.99 g from that with EtOAc, and 
further 79.32 g with MeOH/H2O (8:2). 
 
Fig. 14 Extraction scheme  
4. ISOLATION  
The separation of substances from a crude extract or from a fraction often is a long and 
expensive process. Like the proverbial needle in a haystack a lot of hay has to be removed 
to leave only the needle, without knowing what the needle looks like or where it is in the 
haystack.144 The nature of the separation problem varies considerably and most separation 
procedures require several steps. 
Thin layer chromatography (TLC) is a classic and simple planar chromatography method in 
which the mobile phase migrates through a stationary phase with a flat geometry by capillary 
action. Only a suitable vessel and a coated plate are required to carry out separation or 
qualitative and semiquantitative analyses. The broad choice of layers – modified or 
unmodified – developing solvents as well as detection reagents, lead to unsurpassed 
specificity in TLC and - being an off-line method - the various steps of procedure can also be 
carried out independently.145  
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In the present study NP (normal phase: silica gel) TLC was used in routine laboratory work 
for identifying and monitoring the behaviour of components during purification and at the final 
purification step, and it was also used to select and optimize the mobile phase for column 
chromatography conditions. It was performed on precoated silica gel 60 F254 plates (Merck 
KG a. A., Darmstadt, D), while detection was achieved at 254 nm by (Camag UV Cabinet, 
Berlin, D) and by spraying with anisaldehyde-sulphuric acid followed by heating. 
Although a variety of modern techniques are also available, conventional gravity-driven open 
column chromatography is still widely used in natural product research, since silica gel 
chromatography provides a mild and efficient technique for preliminary fractionation of crude 
extracts or fractions and may also yield pure compounds.146 
Vacuum-liquid chromatography (VLC) is a very convenient and simple open column method 
mostly used for crude fractionation of plant extracts. The reduced pressure utilised in this 
technique leads to an increase of the flow rate of the mobile phase through a short bed of 
stationary phase.146 The VLC column is a glass funnel, which is dry packed with TLC grade 
sorbents. Uniform and tight packing is achieved by initially tapping onto the funnel and by 
application of a vacuum from below it. The sample is applied to the top and eluted with 
appropriate solvent mixtures, starting with solvent of low polarity while working with NP. 
Advantages of the VLC include the simplicity of equipment, low costs, low solvent 
consumption as well as the speed of separation.146 
In the present work VLC was used as an initial separation procedure for the crude extracts. 
High performance liquid chromatography (HPLC) has developed in the recent years into one 
of the leading chromatographic techniques in natural product research, in both analytical and 
preparative scale. The combination of rapid analysis, high resolution, and separation power 
as well as elimination of a prior derivatization step, gives HPLC a marked advantage over 
other methods of separation.147 The use of microparticulate supports (7-18 µm) and high flow 
rates at pressures up to 300 – 400 bar, permits very high separation efficiency. However, 
detection is still one of the weakest points of practical HPLC, although a definite progress 
has been made in the design of sensitive and specific detectors in the recent years. 148 The 
complexity, high capital-, and maintenance costs are other disadvantages of this method. 
HPLC (Varian Pro Star, Darmstadt, Germany) was applied as final purification step. 
FRACTIONATION PROTOCOL 
Fractionation and isolation (Fig. 15) were carried out from the DCM-extract of Baccaurea 
stylaris MUELL. ARG. by various chromatographic methods as described previously. 
10 g of the extract were crudely fractionated via VLC using a column of 4.5 cm diameter and 
29 cm of the stationary phase in height (consisting of 250 g silica gel Geduran SI60 (Merck, 
Darmstadt, D) with a particle size of 0.063 – 0.2 mm), while the extract was eluted two times 
with 5,400 mL solvent each and with a step gradient (100%, 75/25%, 50/50%, 25/75%, 
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100%) of petrol ether (PE) with increasing concentrations of EtOAc and EtOAc and 
increasing concentrations of MeOH to give seven fractions (V1 – V7). 
0.35 g of the fraction V2 (eluted with PE/EtOAc 7.5:2.5) were processed by open column 
chromatography using a column of 2.5 cm diameter and 43.5 cm length of the stationary 
phase (silica gel; 70 g) with 1,515 mL PE/ EtOAc (10:1) as elution agent yielding in six 
fractions (I1 – I6).  
Fraction I4 (eluted between 555 and 690 mL) was further processed by HPLC using a 
RP18-Eurospher 100 column of 1.6 cm in diameter and 22 cm length; particle size 
C18 - 7 µm) using ACN/H2O (9:1) giving six fractions (I4G1 – 6), including 20 mg of the pure 
compound I4G5 (eluted between 7 and 22 min. with a flow rate of 4.6 mL/min.). 
Fraction I5 (eluted between 690 and 825 mL) was further processed by HPLC as described 
above yielding seven fractions (I5G1 – 7), including 12.1 mg of the pure compound I5G5 
(eluted between 9.5 and 13 min. with a flow rate of 4.6 mL/min.). 
0.88 g of the fraction V3 (eluted with PE/EtOAc 5:5) were processed by open column 
chromatography using a column of 4.5 cm diameter and 50 cm length of the stationary phase 
(silica gel; 300 g) with PE/ EtOAc (8:2) as elution agent yielding in 13 fractions (G1 - 13), with 
G7 (40 mg; eluted between 3,480 and 3,945 mL) already pure.  
0.2 g of the fraction G6 (eluted between 2,760 and 3,480 mL) were further processed by 
open column chromatography using a column of 3.5 cm diameter and 20.5 cm length of the 
stationary phase (silica gel; 60 g) with PE/ EtOAc (7.5:2.5) as elution agent yielding in seven 
fractions (D5G1 - 7) and giving 20.6 mg of the pure compound D5G2 (eluted between 465 
and 705 mL). 
0.23 g of the fraction G9 (eluted between 4,440 and 6,375 mL) were further processed by 
open column chromatography using a column of 2.0 cm diameter and 46 cm length of the 
stationary phase (silica gel; 70 g) with PE/ EtOAc (7.5:2.5) as elution agent yielding in five 
fractions (D6G1 - 5).  
25 mg of fraction D6G2 (eluted with 1,140 and 1,560 mL) were further processed by HPLC 
as described above yielding three fractions (D6.1G1 – 3) and giving 15 mg of the pure 
compound D6.1G2 (eluted between 6.2 and 8 min. with a flow rate of 4.6 mL/min.). 
0.2 g of the fraction V4 (eluted with PE/EtOAc 2.5:7.5) were further processed by open 
column chromatography using a column of 3.5 cm diameter and 19.8 cm length of the 
stationary phase (silica gel; 60 g) with PE/ EtOAc (1:1) as elution agent yielding in six 
fractions (E1 - 6). Fraction E6 (eluted between 1,965 and 2,115 mL) was further processed 
by HPLC as described above yielding three fractions (E6G1 – 3), including 10 mg of the pure 
compound E6G3 (eluted between 5.4 and 25 min. with a flow rate of 4.6 mL/min.). 
0.35 g of the fraction V5 (eluted with EtOAc 100%) were further processed by open column 
chromatography using a column of 3.5 cm diameter and 27.8 cm length of the stationary 
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phase (silica gel; 75 g) with PE/ EtOAc (2:1) as elution agent yielding in ten fractions 
(H1 - 10). Fraction H9 (eluted between 3,045 and 3,345 mL) was further processed by HPLC 
as described above yielding two fractions (H9G1 – 2), including 7 mg of the pure compound 
H9G1 (eluted between 0 and 5.6 min. with a flow rate of 4.6 mL/min.). 
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 Fig. 15 Isolation scheme of the DCM-extract of B. stylaris 
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5. STRUCTURE ELUCIDATION 
The process of structure elucidation is like a puzzle being pieced together to yield a chemical 
structure. It involves the accumulation of data obtained from numerous sources, each giving 
some structural information. Nowadays a wide range of spectroscopic, spectrometric, and 
physical methods are available and the methods used in this study will be briefly in the 
following. 
5.1 SPECTROSCOPIC METHODS 
UV/ VIS SPECTROSCOPY 
Organic molecules are able to absorb ultraviolet (UV) or visible (VIS) light, whereas different 
molecules absorb radiation of different wavelengths. UV/VIS spectroscopy deals with this 
interaction of electromagnetic radiation with the molecules in a wavelength range between 
200 and 800 nm (UV: 200-380 nm; VIS: 380-800 nm). The frequency of the absorbed 
radiation correlates with the structure of the molecule and therefore absorption spectra, in 
which the amount of absorbed light for each wavelength is shown, show a pattern of maxima 
characteristic for the chemical structure of the molecule.  
UV spectra were recorded on a Cary 50 Scan (Varian, Darmstadt, Germany), all compounds 
in CHCl3, purity > 99.9%. 
NMR-SPECTROSCOPY 
Atomic nuclei such as 1H or 13C can be visualised like tops, turning on their own axis (this 
feature is called “spin”, but this doesn’t mean that they actually turn on their own axis but 
describes a quantum mechanical property).149 Due to this fact and that nuclei are charged 
they behave like tiny bar magnets and when placed in a magnetic field, two things happen: 
they adopt one of two possible orientations, aligned with the external magnetic field or 
opposite to it and exhibit a characteristic rotational motion, known as “precession”. Its 
resonant frequency, the so called Larmor frequency, differs characteristically for each type of 
nucleus. All nuclei that contain a non-zero spin quantum number can be used for NMR 
spectroscopy, e.g. 1H, 2D, 13C, 15N, 17O, or 19F. Four isotopes appear to have the greatest 
potential for structure determination of natural organic molecules: 1H, 13C, 15N, and 17O.150 
In NMR spectroscopy the behaviour of certain nuclei in a magnetic field is observed. A 
method for obtaining an NMR spectrum is the pulse-Fourier-transformation technique. It 
involves irradiation of the sample with a single radiofrequency pulse of only a few 
microseconds duration and if the resonant frequency is chosen, all nuclei are excited and 
emit signals known as free induction decays (FID). Fourier transformation of this decay yields 
the NMR-spectrum.151 
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Of all modern methods used for structure elucidation, NMR spectroscopy provides the most 
complete information, either with or without prior structural knowledge. Not only number and 
type of nuclei present, but also their individual environment in a molecule can be determined. 
Disadvantages of this method are on the one hand high acquisition costs of the instrument 
and the deuterated solvents and on the other hand the difficulty of a valid interpretation, 
particularly of two-dimensional spectra, which usually requires considerably more than 
minimal experience.151 
One dimensional NMR techniques (1D-NMR) 
Most NMR studies begin with recording of 1D-NMR spectra, most notably 1H- and 
13C measurements.  
In the 1H NMR nuclei in a molecule are also influenced by their surrounding electrons. These 
produce a weak magnetic field which slightly shields the nucleus from the applied magnetic 
field. This causes differences in the Larmor-frequencies of the nuclei due to the chemical 
environment, an effect called chemical shift. Thus, 1H NMR supplies a convenient method for 
the determination of the chemical shift for each resonance as well as the relative number of 
protons responsible for each resonance calculated from their integrated intensities. If 
multiplicity and coupling pattern of each signal are also interpretable, the number and the 
stereochemical orientation of adjacent protons can be proposed as well.149 
The 13C NMR provides important chemical information since it directly arises from the nuclei 
forming the framework of an organic molecule. It also gives information on non-protonated 
carbon atoms such as carbonyl groups, which are not detectable in the 1H NMR. In the 
1H decoupled 13C spectrum - the most frequent type - all 13C signals appear as single lines. 
Altogether 13C-spectra provide important structural information such as the number of carbon 
atoms present in a molecule, their substitution, as well as presence and sometimes also 
position of sugar moieties. A disadvantage is the larger sample amount compared with 1H 
spectra.151 
All 1H and 13C NMR experiments were recorded on a Bruker Avance 300 (operating at 
300.13 MHz for 1H and 75.47 MHz for 13C) at 296.1 K. The spectra were recorded in CDCl3 
(Deutero GmbH, purity 99.8%, Kastellaun, Germany) and referenced against residual non 
deuterated solvent.  
Two dimensional NMR techniques (2D-NMR) 
The interpretation of a 1D spectrum for complex molecules is not possible due to signal 
overlapping, but if a new dimension is brought in, these overlaps can be solved. The 
resulting spectra show the frequency on both axes, while the signal intensities correspond to 
the third dimension. Thus the spectra are represented as contour plot, just as mountains on 
an ordinary map. The spectra are obtained by recording a series of 1D spectra differing only 
by a time increment.149 2D NMR techniques can be divided into two groups, homonuclear, 
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and heteronuclear methods, the homonuclear correlating couplings within the same type of 
atoms (COSY, NOESY) and the heteronuclear correlating 1H coupling with 13C atoms. 
(HMBC, HSQC). 
The correlation spectroscopy (COSY) correlates protons through homonuclear coupling and 
is thus the primary 2D technique utilised for structure elucidation. In a COSY spectrum only 
signals of protons which are coupled over only two or three bonds are visible. For aliphatic 
compounds this technique is very useful, but for highly substituted aromatic compounds 
heteronuclear experiments also have to be performed.152 
The nuclear Overhauser effect allows to determine the local neighbourhood of the nuclei 
within a molecule and to infer information about their distances. In the nuclear Overhauser 
enhancement spectroscopy (NOESY) information of all nuclei in a molecule is given in a 
single experiment, helping to identify protons close enough to interact, yielding the relative 
stereochemistry of the molecule.149 
Heteronuclear shift correlation NMR-spectroscopy is a 2D technique utilised to determine, 
which 1H of a molecule is bonded to which 13C atom (or another nucleus) in the molecule. 
The heteronuclear multiple bond correlation (HMBC) experiment performs the 
H-C correlation via 13C chemical shift evolution of double quantum coherence. It is extremely 
useful in determination of connectivity between 1H and 13C atoms separated by two or three 
bonds via their coupling constants. They provide the means to span heteroatoms and 
quaternary carbons, thus giving useful structural information.152 
The heteronuclear single quantum coherence (HSQC) experiment yields the same 
information as the HMBC, but only signals of directly bond atoms are shown and it is 
therefore sometimes superior in the case of crowded 13C spectra.149 
The 1H and 13C NMR, COSY, NOESY, HSQC, and HMBC experiments were recorded on a 
Bruker Avance 400 (operating at 400.X MHz for 1H and 100.X MHz for 13C) at 296.1 K. The 
spectra were recorded in CDCl3 (Deutero GmbH, purity 99.8%, Kastellaun, Germany) and 
referenced against residual non deuterated solvent.  
5.2 MASS SPECTROMETRY 
Mass spectrometry (MS) is a method in which an organic compound is degraded into 
fragments and the fragmentation pattern is recorded according to the mass. The sample 
vapour diffuses into a vacuum system of a mass spectrometer, where it is ionized to cause 
fragmentation of the chemical bonds. The resulting positively or negatively charged ions are 
accelerated in a magnetic field which disperses the fragments and permits the measurement 
of the relative abundance of ions with a given mass-to-charge ratio. Presented in a diagram 
as ion constituents versus mass it yields the mass spectral graph, consisting of a series of 
lines representing varying intensities at different mass units.153 This technique only requires a 
EXPERIMENTAL PART  
 60
microgram of the substance to provide an accurate molecular weight and it also yields a 
complex fragmentation pattern, often characteristic for a particular compound.154  
Electron Impact (EI) is the original mass spectrometry (MS) ionization method and is still 
probably the most widely used of all ionization methods. In the EI process, the sample of 
interest is bombarded with a stream of high energy electrons, in which an electron is 
removed from the molecule forming a positively charged ion. This electron removal leaves an 
unpaired electron in the molecule, making it to a highly reactive radical cation (molecular 
ion). The ionizing electrons carry an excess of energy, part of which is transferred to the 
newly produced ion as internal energy. This energy may cause the molecular ion to fragment 
into neutral pieces and smaller fragment ions.  
The fragmentation of molecular ions into an assortment of fragment ions is a mixed blessing. 
The nature of the fragments often provides a clue to the molecular structure, but if the 
molecular ion has a lifetime of less than a few microseconds it may decompose entirely and 
the most vital piece of data, the molecular mass is lost. In such cases softer ionization 
techniques should be preferred.155 
HR- and LREIMS (70 eV) was measured on a MAT 710A.  
5.3 PHYSICAL METHODS 
MELTING POINT 
The melting point is a characteristic physical constant of amorphous or crystalline 
compounds that does not provide structural information but is a measure for their purity. In a 
dirty compound or a mixture of compounds it is always lower than in the pure analogue. 
The melting points in this study were determined on a Melting Point B-545 apparatus (Buechi 
Labortechnik GmbH, Essen, Germany) (uncorrected). 
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RESULTS 
1. ETHNOBOTANY 
In Vanuatu most people do not assume Western hospitel meresin (hospital medicine) or 
meresin blong waetman (white man’s medicine) and traditional lif meresin (leaf medicine) or 
Kastom meresin (Kastom medicine) as contradictory systems, but regard them as 
complementary elements creating one comprehensive medicinal system. In Aneityum this 
medical pluralism slightly lost balance towards Western medicine because of a good 
disposability of Western medicinal care all over the island for about 60 years by now, leading 
to a loss of former traditional knowledge and lack of interest in its preservation. Besides the 
two major hospitals in Port Vila (Efate) and Luganville (Espiritu Santo) and two smaller ones 
in Malekula and Tanna, there are health centres, dispensaries, and small “aid posts” 
dispersed over the islands. Hospitals, health centres, and dispensaries are run by the 
government and differ only in the number of employees. Aid posts are community owned 
health stations with volunteer workers trained by the Ministry of Health, providing first aid and 
health education service.63 Building and volunteer workers are provided by the community, 
but medicines and medical equipment are supplied by the Ministry of Health.65  
In previous ethnobotanical studies in Vanuatu it was assumed, that indeed the general 
population is knowledgeable about local plants and everyone seems to know at least a few 
recipes, but that some individuals, especially experienced in plants and treating sicknesses 
are known in their communities as true therapists and some of them with an extra knowledge 
of the supernatural powers, are the so called klevas.67, 70, 71 This system could be proven in 
Aneityum and partly in Ambrym, but in Loh, Torres Islands every family had its special 
recipes for a variety of illnesses and preferably the elders of the own family of the same 
gender were consulted in case of a sickness. Indeed some elders were more experienced 
and knowledgeable, but no strict differentiation between ordinary and special healers was 
made. In Ambrym every member of a village was a specialist for a specific kind of illness and 
the adequate specialist was consulted by the patient no matter which family he belonged to. 
The knowledge on plants and traditional medicine is usually inherited from generation to 
generation. In Loh it is given from mother to daughter and father to son in a strict consexual 
manner and is most likely conserved in one family. In Ambrym and Aneityum this system has 
been eased. If a consexual heir is not at hand, these rules can be changed, and knowledge 
can be passed on inter-sexually from father to daughter or mother to son or even to third 
parties. In Ambrym also the transmission of knowledge of plant medicine with a “proven 
effect” to all community-members regardless of which family is common. Some especially 
gifted people in Ambrym, an island with strong magical beliefs, claimed to obtain their 
knowledge directly from spirits. Nowadays the traditional medicine is also partly influenced by 
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Christianity, which is very strong in Vanuatu. Not only maleficent magic implemented by an 
enemy, conjured magic “backfiring” to the initiator by careless use, or breaking an important 
taboo, but also sinful behaviour are regarded as possible sources of illnesses and former 
Christian rituals like exorcism mixed with herbal medicine and magic could be observed in 
treating a person with a diabetic foot in Ambrym. God is also sometimes named as creator of 
the “natural apothecary”, e.g. in an interview in Loh a healer told me, that every plant on the 
island has properties as a medicinal plant, that even plants against AIDS and cancer could 
be found there due to the reason that god does not create an illness without setting an 
antipole and this special knowledge can be obtained in a dialogue with god. 
1.1 SELECTION OF THE STUDY AREAS 
One of the first priorities was to select the study sites. Due to the huge linguistic diversity 
(see 1.3 Population and Languages), Vanuatu cannot be considered as a consistent cultural 
area, a region where the inhabitants share the same culture, defined by ideas, behaviour, 
techniques, and social organisation156. In addition, by reason of the comparatively large 
distances between the single islands, inter-cultural exchange was only possible in a small 
degree. Furthermore due to diverse ecosystems as a result of dissimilar climate zones and 
soils (see 1.1 Geography, Geology, and Climate) a diverse island biodiversity can be at least 
expected for distant islands. Traced back to these facts, different medicinal systems should 
have developed on each island and sometimes even more than one. Therefore, islands in 
three climate zones and with different ethnological background were chosen which also had 
never or only poorly been studied before: in Loh and Southwest Ambrym ethnobotanical 
studies had never been performed before and in Aneityum only an investigation 
concentrating on plants used in gynaecology had taken place.70, 71 The culture and mentality 
of the inhabitants of Loh is said to be related to that in the Solomon Islands and even though 
more Melanesian than Polynesian, the culture is located in a borderland sharing many values 
and practices that are idiosyncratic to both of these Oceanic regions.157 The climate is 
tropical and the soil of coral origin. Ambrym, located in the middle of Vanuatu with a climate 
settled between tropical and subtropical, is a mountainous volcanic Island with pure 
Melanesian background and strong beliefs in magic. Aneityum in the far South is a 
mountainous island with a floral composition and subtropical climate resembling New 
Caledonia’s and a pure Polynesian ethnological background.  
1.2 ETHNOTAXONOMY 
Taxonomy is regarded as one of the oldest fields of biological science, dating back at least to 
the time of Aristotle (381-323 B.C.E.) who under the patronage of Alexander the Great 
undertook a large-scale classification, arranging biological organisms into a hierarchical 
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pattern, whereas the term “taxonomy” was coined not before 1813 by the Swiss botanist 
Augustin de Candolle. The tendency of organising the biological world is not peculiar to the 
Western world, but common to all cultures studied so far158. These folk taxonomies have 
attracted the attention of ethnotaxonomists over the last 50 years. Discrepancies between 
Linnean and folk taxonomy are widespread159 and could be observed in this study, too. In the 
research areas visited medicinal as well as non-medicinal plants were classified by the 
healers exclusively by their leaves; flowers were never taken into account and it was even 
assumed, that some plants did not bear flowers at all. This situation sometimes posed a 
problem when identifying plants lacking flowers and the informant could give no information 
on their appearance. Another pitfall in plant taxonomy in the field is the use of vernacular 
names. Firstly it is essential to get a wordlist (see WORD LISTS) of the plant parts if the local 
language is not spoken, because local names of flower, fruit, or leaf or general categories as 
tree or shrub can be confused with the vernacular plant names. Secondly species can be 
under- or over-differentiated, a term used by anthropologists, viz. a single Linnean species 
can be split into two or more distinct species in the folk taxonomy system indicating different 
morphotypes, or vice versa. Scientific species of particular cultural significance are often 
over-differentiated. Under-differentiation may occur in cases where several taxa are used for 
the same purpose, e.g. as fuel wood158. Neither over- nor under-differentiation, but only 
one-to-one correspondence was observed in Vanuatu. 
1.3 DISEASES AND THEIR CURES  
The same problems have to be faced in the attempt to translate folk to Western medicinal 
terminology. Vanuatu’s ethnomedicine differs significantly from Western medicine in its 
descriptions of disease aetiology; so for some diseases the Western counterpart is not found, 
a dilemma often observed in traditional medicinal systems. 
A good example for this is the definition of cancer, a term adapted to the folk medicine, but 
used in another context: In the Western medicine cancer is not just one disease, but a class 
of diseases with three main characteristics: uncontrolled cell-growth, invasion (intrusion on 
and destruction of adjacent tissues) and in case of malignant tumours metastasis, the ability 
of these cells to migrate from the original site and spread other locations in the body via 
blood or lymph, characteristics that can not be observed without specialised scientific 
equipment. In Vanuatu the term “cancer” was used for severe illnesses with a slow healing 
process, which may indeed correspond with the Western cancer in some cases but should 
be viewed sceptically. The term was sometimes further specified in “cancer inside the body” 
and “skin cancer”. “Cancer inside the body” was described as a sickness with a burning pain 
behind the sternum, occurring after consumption of fatty food and therefore most likely to be 
heart-burn. “Skin cancer” on the other hand was described as a big, slowly healing sore; 
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maybe indeed corresponding with skin-cancer in some cases, but infected wounds or 
carbuncles are most likely to be assumed because of its comparative fast and easy 
curability.  
Another example for the adaptation of a Western term is “HIV”. To date only one case of 
HIV-infection or AIDS respectively has been confirmed in 1997, leading to a huge 
educational campaign63 dealing with risks and prevention of this disease. However, some 
informants were sure to have cured themselves from “HIV” several times, so this term must 
be used for another disease, which unfortunately could not be specified. 
Other illnesses mentioned in the interviews and not easily fitting into a Western illness 
category were blad i soa, jes i soa, pispis waet, and soa leva:  
Blad i soa (painful blood) is described as a severe illness with painful blood, maybe 
leukaemia or sepsis, whereas sepsis is more likely, because it is treatable with the leaves of 
Solenostemon scutellarioides L. (Lamiaceae), which have already shown antibacterial effects 
in biological tests.160  
Jes i soa (sore chest) is illustrated as a disease with pain and squeezing pressure behind the 
sternum, probably matching with angina pectoris in the Western terminology.  
Pispis waet (white coloured urine) is portrayed as a severe and usually deadly disease, 
characterised by foamy (white coloured) urine probably showing albuminuria, a symptom of 
nephropathy (see also “Diseases of the kidney”).  
Soa leva (painful liver) is pictured as an illness with pain in the upper part of the abdomen. A 
painful liver can be caused by several illnesses and it was not possible to translate this 
illness into a Western term. 
Not only terms but also Western medicine has been adapted and included in the traditional 
system. Panadol® (trade name of Paracetamol in Australia) is carelessly consumed on a 
daily basis in some islands. Plants are also subsequently included into the 
ethnopharmacopoeia. A case in Tongoa (Vanuatu) was described in 1999.65 During a severe 
dengue fever outbreak in 1989/1990 not only many Tongoans but also inhabitants of other 
islands in Vanuatu realised the existence of a sickness not even curable with Western 
medicine. The possibility of utilising plant medicine was discussed in a newspaper article 
published in Vanuatu Weekly. The Solanaceae Physalis angulata L., a traditional medicine 
for dengue fever in the Fijian pharmacopoeia, was described including a photo, vernacular 
and scientific names, characteristic features, and procedures of processing it for medicine by 
a Fijian botanist staying in Port Vila. In the same article a rather sceptical comment on the 
plant from the medical director of the main hospital in Port Vila who did not recommend the 
use of this plant since there was no scientific proof of its efficacy against the dengue virus 
was included. The sceptical comment was ignored by many islanders and the information on 
the wondrous herb, discovered by a saentist (scientist) rapidly spread to islands with good 
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access to newspapers, radio, and other mass media. The islanders diagnosed with dengue 
fever in health stations were treated with febrifuges and painkillers and additionally used the 
plant medicine if the symptoms remained. As soon as they had recovered, the plant was 
already an essential part of the Tongoan ethnopharmacopoeia and in this study it was also 
observed to be used in Ambrym for the same purpose and in the same mode of preparation 
and application (see “Multisystem Diseases”). 
Traditional medicine in the research areas is based on techniques including the use of 
plants, massage, magical spells, and ceremonies. In the following the most common 
techniques are briefly summarised: 
Cold digestion 
The plant part of choice, sometimes previously ground or macerated (crushed, chopped, 
rubbed between the hands, etc. to gain access to the cell structure) is squeezed in cold 
fresh- or saltwater, coconut water, or coconut milk and then filtered through a cloth. 
Infusion 
Boiling water is poured over the plant part used (occasionally previously ground or 
macerated), it is allowed to steep for a time and then filtered through a cloth. 
Decoction 
The plain or previously macerated or ground plant part of choice is boiled for a time and 
afterwards filtered through a cloth. 
Inhalation 
A decoction or (mostly) ingestion is prepared as described above and the steam is inhaled. 
Bath and Wash 
A cold digestion, infusion, or decoction is used to bathe the whole body or only a body part or 
it is chilled and used as a mouth- or head-wash. 
Fumigation 
The plant part is burnt in a fire to either fumigate the sick part of the body or to dispel evil 
spirits or poison (in food).  
Massage 
The sore body part is massaged with a maceration, infusion, or decoction of the plant used. 
Cataplasm 
The plant part used, mainly the leaf, maybe previously crushed, rubbed between the hands, 
or softened by heat over a fire is applied to the sore and sometimes fastened with a rope. 
Kastom ceremony 
In some cases the medicinal treatment is linked with a special ceremony or spells. Especially 
sicknesses caused by spirits or of unknown origin like pain disorders are treated this way and 
particularly male healers tended to combine plant medicine with several complicated rituals 
and spells. 
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1.4 RESULTS ETHNOBOTANY 
In previous ethnobotanical publications it was postulated, that the culturally important plants 
which are used for the same category of illnesses by a large number of healers are also the 
most effective ones in terms of bioactivity, while plants cited only once are considered to be 
less important in the indigenous community as well as in terms of bearing potentially 
bioactive compounds. To evaluate the variability of the use of medicinal plants and to 
determine whether plants from certain groups are of particular interest in the search of 
bioactive compounds, the so called informant consensus factor ICF can be calculated using 
the following formula.161 
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This allows the comparison of the total case number (number of use reports) for each ailment 
with the number of separate remedies for this disease. The ICF  ranks between 0 and 1, 
whereas a high value indicates that relatively few species are used by many healers and a 
low one indicates that the healers disagree on the species used for the treatment of the 
certain disease, due to two reasons: Plant selection thus may be more random as no plant is 
very effective or little intra-cultural exchange of medicinal plant knowledge is taking place. 
Using the ICF  to compare the ethnobotanical data in a cross-cultural basis and to determine 
whether plants from certain groups are of particular interest in the search for bioactive 
compounds was not reasonable in the present study due to the following reasons:  
As mentioned previously, the permission to collect ethnobotanical information was limited by 
the Cultural Centre to only well known and widely used plant species and preparations, 
because traditional knowledge in Vanuatu is subject to restrictions by reason of the 
Kastom-system. As a result of these restrictions or taboos a profound insight in the 
pharmacopoeia of the three ethnic groups could not be gained in this study. 
As also indicated before, this study focused on remedies in a very narrow therapeutical 
context to improve the chance of getting good interview results, because healers are often 
reluctant to give information on their secrets due to the reason that knowledge of plant 
medicines is a secret family bound property, which is usually inherited even between closely 
related family members of the same gender, only. As a researcher in Vanuatu a fieldworker 
of the Cultural Centre, who is part of the visited community, is appointed to supervise the 
research in order to on the one hand protect the indigenous people, assuring that the Kastom 
laws are observed and that the researcher stands to the contract with the Cultural Centre 
and on the other hand to introduce the researcher to the chiefs, assisting in promoting the 
study to the community and acting as an interpreter if necessary. For female researchers 
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extra safety precautions are taken, since several women complained about sexual assaults. 
They are more or less adopted by the family of a female fieldworker, sharing bed and board 
and therefore being under the family’s protection. This is on the one hand beneficial, 
because it gives a very good opportunity to gain insight into the family life and as being a 
family member, the new relatives are less reluctant in passing their knowledge to the 
researcher. On the other hand this situation also has disadvantageous effects. Members of 
other families are getting more reserved, even if they are willing to share their secrets with 
the researcher; they fear that the researcher’s family could get hold of them. This was 
particularly distinct when interviewing male healers in the field, where in most cases a child 
of the fieldworker’s family accompanied us due to the already mentioned extra safety 
precautions, although I must say, that I never had an unpleasant experience of that kind 
while staying in the research areas. Furthermore the strong patriarchal system in Vanuatu 
presented an obstacle while collecting ethnobotanical data as a woman. Sometimes male 
informants were much more communicative and it was possible to have very informative and 
cordial conversations when no other male community members were around, but some men, 
e.g. the priest in Loh were very supportive and showed much interest in the study and helped 
to persuade the more reluctant community members by discussing advantages and 
disadvantages of this study in a meeting with the researcher and the chiefs to find a consent 
of mutual benefit. In Aneityum, though the impact of the fieldworker constrained the project: 
by reason that the female fieldworker appointed by the Cultural Centre showed no interest to 
supervise the project and did not seem able to understand it either, the male fieldworker of 
the island was ordered to take charge instead. He made contacts and in preliminary talks 
with the interview partners in the vernacular language Indass Khermo he informed them 
about plants and remedies already mentioned in previous interviews advising them not to 
mention these plants again, because he could not understand, that the number of use 
reports on a single plant is also important in an ethnobotanical study. Due to the fact that the 
fieldworker commands respect in a community and due to his presence during the whole 
interview and participation on the conversation it was not possible to correct this mistake in 
some cases and people were also very reluctant in giving secret information when another 
community member was around. 
At last the relatively short time of only about one month in each research area did not allow 
making contact and inspiring confidence with every community member, so that only a short 
glimpse on the existing medicinal system could be obtained. It would have been better to visit 
the islands a second or third time to emphasise the interest of the researcher in traditional life 
and medicine and to stabilise the contacts with the indigenous people. This would certainly 
have resulted in more data. 
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But however, a database of ethnobotanical information collected during the fieldwork was 
generated, consisting of 420 use reports on 130 species of 54 plant families, contributed by 
27 informants, including 16 men and 11 women, aged between 25 and 79 years with four 
people interviewed at least twice. 
The use reports (UR) were then divided into 17 categories of use (Tab. 3), grouped 
according to their medicinal affiliation and/or sociocultural relevance. The ranking results 
agree with a report of Vanuatu’s Ministry of Health in the main lines, in which respiratory and 
skin diseases are the leading cause of morbidity in adults and diarrhoea plays an important 
role in the morbidity of children under four years (FAO, 2003). Vanuatu’s traditional medicine 
is called lif meresin (leaf medicine) – reflecting the fact, that leaves are part of the majority of 
traditional remedies (Tab. 3). 
Tab. 3 Quantitative ethnobotanical analysis of the 17 use groups
entity 
 
1nUR 
 
UR 
[%] 
2nSpecies 
 
Species 
[%] 
leaf 
[%] 
root/ rhizome 
[%] 
bark/ wood 
[%] 
flower/ fruit 
[%] 
skin 75 17.9 45 34.6 74.7 6.7 16.0 2.7 
gastrointestinal system 33 7.9 26 20.0 84.9  -  3.0 12.1 
respiratory system 31 7.4 22 16.9 67.7 3.2 29.0  -  
urogenital system 25 6.0 24 18.5 72.0  -  20.0 8.0 
multi-system diseases 25 6.0 18 13.9 56.0 24.0 16.0 4.0 
immune system 18 4.3 11 8.5 50.0 11.1 16.7 22.2 
cardiovascular and haematopoietic system 13 3.1 6 4.6 92.3  -  7.7  -  
nervous system/ pain disorders 10 2.4 9 6.9 50.0  -  50.0  -  
skeleto-muscular system 9 2.1 6 4.6 66.7  -  33.3  -  
dental system 9 2.1 9 6.9 33.3 11.1 44.4 11.1 
ears 7 1.7 6 4.6 100.0  -   -   -  
eyes 7 1.7 7 5.4 42.9  -  14.3 42.9 
kidney 3 0.7 3 2.3 33.3 33.3 33.3  -  
others: 182 43.3 45 34.6 23.6 6.6 26.9 42.9 
food & stimulants 93 22.1 21 16.2 9.7 12.9  -  77.4 
house & garden 65 15.5 15 11.5 23.1  -  72.3 4.6 
Kastom 23 5.5 18 13.9 73.9  -  13.0 13.0 
body care  2 0.5 2 1.5  -   -   -  100.01 
                                                
 
1 total 426 use reports, 2total 130 species; UR [%] = Percentage of UR contributed to the total amount of UR for an entity; Species [%] = 
Percentage of Species contributed to the total amount of Species reported for an entity; leaf [%] = Percentage of leaf medicines 
contributed to the total amount of plant parts used reported for an entity (same for root/ rhizome, bark/ wood and flower/ fruit) 
In the following the categories will be described regarding ethnobotanical importance, the 
illnesses their causes and their treatments and the most important plants will be described in 
detail including a literature survey.  
DISEASES OF THE SKIN 
About one third (34.6%) of all species are used to treat skin infections and nearly one fifth 
(17.9%) of all use reports falls into this group (Tab. 3). The ethnobotanical importance of 
dermatological disorders has already been shown for other indigenous groups, e.g. in Leonti 
et al.162 for the Popoluca in Mexico. Parasites, reduced access to antibiotics, poverty, 
                                                                             1.4 RESULTS ETHNOBOTANY 
 
 69
malnutrition, and a hot and humid climate contribute to a high incidence of soft tissue 
infections in the tropics. Wounds caused by accidents while working in the garden or cutting 
wood and infections of the skin, e.g. boils (furuncles), carbuncles, and abscesses commonly 
caused by Streptococcus pyogenes and other β-haemolytic streptococci or by Staph. 
aureus163 are particularly important (Tab. 4). Infestations with Scabies (Sarcoptes scabiei), 
transmitted by close personal contact and due to low quality of water are especially common 
in children. Scratching often results in second bacterial infection and pustule formation.163  
Tab. 4 Quantitative analysis of skin ailments 
skin ailment 1nUR UR [%] 
wounds 29 38.7 
boils/ carbuncles/ abscesses 13 17.3 
scabies 10 13.3 
bleeding 8 10.7 
2skin cancer (severe wounds) 4   5.3 
burns/ sunburns 3   4.0 
centipede bites 3   4.0 
insect bites 3   4.0 
stings of a stonefish 2   2.7 
hair loss 1   1.3 
lice 1   1.3 
neurodermatitis/ infantile eczema 1   1.3 
splinter 1   1.3 
sting of Dendrocnide moroides 1   1.3 
warts 1   1.32 
                                                
 
1total 75 use reports for skin ailments; UR [%] = Percentage of UR contributed to the total amount of UR reported for skin ailments; 2 see 
“Diseases and their cures” 
Dermatological complaints are most commonly treated topically with fresh sap squeezed 
from the plant part used (in most cases leaves, see Tab. 3) or cataplasms, but sometimes 
the plant parts are also boiled in water and the inflicted area is bathed in the chilled infusion. 
The most important plant in this category is Mikania micrantha KUNTH. (Asteraceae), followed 
by Macaranga dioica MUELL. ARG. and Macaranga tanarius (L.) MUELL. ARG. (both 
Euphorbiaceae), and further Tabernaemontana pandacaqui LAM. (Apocynaceae), 
Gyrocarpus americanus JACQ. (Hernandiaceae/Gyrocarpaceae), Macropiper latifolium (L.F.) 
(Piperaceae), Aidia racemosa (CAV.) D.D. TIRVENG (Rubiaceae), and Pipturus argenteus 
WEDD. (Urticaceae). Epipremnum variegatum (L.) ENGL. (Araceae), Scaevola taccada ROXB. 
(Goodeniaceae), and Capsicum frutescens L. (Solanaceae) play an important role in other 
categories and are therefore also briefly described in this section. 
Most frequently the fresh leaf sap of Mikania micrantha KUNTH. (Asteraceae) is used to treat 
various kinds of skin ailments (Tab. 5). It is also used in other places in Vanuatu, in the 
Banks Islands the sap is applied to cuts to stop bleeding as observed in Torres, Loh, 
Lungharigi, and North Ambrym (Tab. 5) and taken internally against fever (Tab. 22). The 
“American rope”, originally from tropical America, is an invasive species introduced by the 
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Americans during WWII to camouflage airfields. Disturbed habitats are rapidly overrun, as 
the English name mile-a-minute indicates. This vine is one of two major species threatening 
natural regeneration in logged or disturbed areas in Vanuatu and many programs have been 
established to eradicate this pest, in some islands there is even an obligation to inform the 
authorities if this plant is spotted. But however, it has been widely adapted as a medicinal 
plant, on the one hand certainly because of its wide distribution and good accessibility; but 
on the other hand, antibacterial activity of its methanolic and/or watery extracts against 
Escherichia coli, Bacillus subtilis, Staph. aureus, Proteus vulgaris, and Enterobacter 
aerogenes164, 165 has already been proven in biological tests, and sesquiterpene lactones with 
activity against Staph. aureus and Candida albicans have been isolated as well,166-169 some 
also showing cytotoxic activity.164 For further uses of this plant in Vanuatu’s pharmacopoeia 
see “Diseases of the gastrointestinal system” p. 75, “Diseases of the respiratory system” p. 
81, “Urogenital system” p. 84, “Multi-system diseases” p. 87, and “Diseases of the eye” p. 98. 
Second most commonly utilised plants for the treatment of skin ailments are Macaranga 
dioica MUELL. ARG. and Macaranga tanarius (L.) MUELL. ARG., both Euphorbiaceae. The sap 
of the leaves or the inner bark is usually freshly applied to wounds, sunburn, and to stop 
bleeding or the leaves are used to cover wounds as cataplasms (Tab. 5). Besides its uses in 
Vanuatu’s traditional medicine it plays a role in agriculture, too. In Maewo (Vanuatu) taro 
seeds are wrapped into its leaves to protect them against Papuana huebneri, a plant 
pathogenic beetle.59 M. dioica has not been studied yet but for M. tanarius 
radical-scavenging activities due to megastigmane glycosides isolated from the leaves,170 in 
vitro inhibition of DNA topoisomerase II, and cytotoxic activities (against the human lung 
cancer cell line A549) due to triterpenoids isolated from the bark171 have been demonstrated 
only recently (when the plant had already been collected) and allelopathic and 
anti-inflammatory active flavonoid derivatives have been isolated from the leaves.172-174 Other 
members of the genus have also revealed anti-inflammatory activities: M. adenanthera due 
to the coumarinolignoid cleomiscosin A and ellagic acid derivatives,175 M. conifera and M. 
triloba176 due to prenylated flavonoids.177 Antifungal activity was demonstrated for M. 
monandra due to the presence of a clerodane-type diterpenoid. Stilbenes with cytotoxic 
activity against human ovarian cancer cell lines SK-OV-3 and SKVLB-1 were isolated from 
M. mappa178 and M. schweinfurthii179 and antiproliferative prenylated stilbenes and flavonoids 
with antiproliferative impact from M. alnifolia.180 For further uses of Macaranga dioica MUELL. 
ARG. in Vanuatu’s ethnopharmacopoeia see “Diseases of the nervous system” p. 94, and 
“Diseases of the cardiovascular and haematopoietic system” p. 93, and for Macaranga 
tanarius (L.) MUELL. ARG. see “Diseases of the respiratory system” p. 81, and “Diseases of 
the teeth” p. 97. Both plants were chosen for the screening regimen performed in this study, 
due their ethnomedicinal use, their phytochemical composition, and the mentioned biological 
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activities already proven for other members of the genus. Leaves and bark of M. dioica and 
the leaves of M. tanarius were collected. 
Crushed Tabernaemontana pandacaqui LAM. (Apocynaceae) leaves are applied to wounds 
or “skin cancer” (see “1.3 Diseases and their cures) and the latex to centipede bites to relieve 
the pain (Tab. 5). In Banks Islands, Moto Lava T. pandacaqui is used to prepare a love 
potion,72 in Erromango the bark is used to stimulate the growth of banana plants, and in 
Gaua the leaves as a fertiliser for yam plants.59 Ethnobotanical use of T. pandacaqui has 
also been reported from Tonga, where an infusion of the leaves is made to treat mouth 
infections of infants, toothache, and infections of teeth or gums.181 In the Philippines the latex 
is applied to wounds182 and swellings,183 a decoction of the leaves is taken against 
snakebites and dysentery,184 and a decoction of bark and roots to cure disorders of the 
stomach and intestines, including gastro-enteritis.182 The leaves, mixed with powdered rice 
husks and fried, are rubbed over the body of a person suffering a relapse from any kind of 
illness and the pounded leaves are heated and placed on the navel and the small of the back 
to combat sudden sickness causing severe stomach-ache and cramps.185 In Columbia T. 
amygdalaefolia leaves186 and latex187 and in Tanzania the root bark of T. elegans are 
traditionally used to treat cancer.188 In biological assays ethanolic extracts obtained from 
stem, leaf, and flower of T. pandacaqui have already shown cardiovascular effects,189, 190 
extracts from stem, leaf, flower, and root caused sedation, decreased respiration, and 
skeletal muscle tone, showed analgesic effects and (except from the leaf extract) caused 
vasodilatation of ear vasculature in rats.191 The isolated Iboga-alkaloid congeners 
coronaridine192 and voacangine provoked analgesic and hypothermic effects in mice193 and a 
crude alkaloidal fraction from the stem possessed CNS depressant activity.194 Due to the 
alkaloidal components192, 195-197 significant anti-inflammatory, antipyretic, and antinociceptive 
activities were observed in mice.198 Other species of the genus showed good anti-leishmanial 
(T. sananho, root)199 or cytotoxic properties, T. holstii roots or T. arborea sap against the 
murine lymphoma cell line P-388, and T. calcarea against the human ovarian cancer cell line 
A2780. See ”Diseases of the respiratory system” p. 81 and “Diseases related to the 
urogenital system” p. 84 for further uses of this plant in the Vanuatu ethnopharmacopoeia. 
This plant has been chosen for the screening regimen mainly due to various biological 
activities already proven for other members of the genus and its membership to the 
Apocynaceae, a family rich in alkaloids. The leaves of this plant have been collected twice for 
the screening regimen, because one plant has been misidentified as a second species due 
to a lack of flowers and because no latex was present. A phylogenetic sequencing analysis, 
using the internal transcribed spacer 2 (ITS2) sequence-structure alignment, a sufficient 
condition to distinguish even closely related species 200 has been performed in the Institute of 
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Botany, Team C. Oberprieler, University of Regensburg, Germany resulting in >99% 
sequence similarity between the two probes (data not shown). 
The sap of freshly squeezed leaves of Gyrocarpus americanus JACQ. 
(Hernandiaceae/Gyrocarpaceae) is applied to wounds (Tab. 5), the inner bark is added the 
fodder to tame pigs and the wood is often used for carving (kenutri in Bislama, meaning 
canoe tree) in Vanuatu’s ethnopharmacopoeia (Tab. 22). Ethnobotanical uses of this plant 
are also illustrated for Fiji, where it is used to treat relapsed illness, swellings, stomach-ache, 
and intestinal filariasis and Tonga, where an infusion of the leaves is taken internally201 or 
applied to the skin in case of skin inflammations and wounds.181 An infusion of the bark is 
taken as a potion for the treatment of stomach-ache181 or skin infections201 and utilised 
against breast cancer.202 Alkaloids and flavonoids have been isolated from the bark and 
leaves,164, 203-205 whereas the alkaloid Gyrocarpine showed strong in vitro activity against the 
promastigote forms of L. braziliensis, L. amazonensis, and L. donovani.206 Hypotensive164 
and curare-like effects207 have also been demonstrated in previous studies. The leaves of 
this plant were collected for the screening regimen because of their wound-healing properties 
described in Vanuatu’s and other ethnopharmacopoeia(s) and the alkaloid- and flavonoid 
content expected for a member of the Hernandiaceae family. 
The Piperaceae Macropiper latifolium (L.F.), the wael (wild) kava, is a plant widely used in the 
ethnopharmacopoeia of Vanuatu. Its leaves are prepared as a cataplasm to draw out a 
splinter (Tab. 5) and it is also an important Kastom plant; its fruits are eaten to protect 
against black magic and its leaves are used in a ceremony in which a person is lifted from 
the ground without being touched (Tab. 22). For further uses of this plant see “Diseases 
related to the urogenital system” p. 84, “Multi-system diseases” p. 87, “Modulators of the 
immune system” p. 90, and “Diseases of the eye” p. 98. In Moto Lava , Banks Islands 
(Vanuatu) the flowers are ingested against stomach-ache and ulcers and the leaves are used 
to dispossess an ill person. Against cough the inner part of an internode of a young branch is 
scratched out, squeezed in water, and drunk and the leaves are used to protect against black 
magic (both in Mota, Banks Islands).72 In Ambae taro shoots are wrapped into the leaves 
after planting to protect them against Papuana huebneri, a plant pathogenic beetle.61 Outside 
Vanuatu it is also widely used. In the Cook Islands for herbal medicines of unknown effects208 
and a preparation made from the leaves is used against breast cancer.209 The essential oil 
component ß-asarone has been isolated from the roots.210 The stalks of M. latifolium have 
been collected for the screening regimen on the one hand because of its wide ethnobotanical 
uses and on the other hand because of its close relationship to Piper methysticum J.R. & G. 
FORST., the real Kava, a very popular stimulant.211 The roots have been proven useful for the 
treatment of stress disorders,212 as an analgesic, anti-convulsive, and centrally muscle 
relaxing drug due to kavalactones,213 and have shown many other effects on the CNS. The 
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maybe incorrectly attributed hepatotoxic effects of this plant have led to a slump of the kava 
trade in the global market with huge economic consequences for the major exporting 
countries in the Pacific, Fiji, and Vanuatu. 
A decoction of the Rubiaceae Aidia racemosa (CAV.) D.D. TIRVENG (synonym Randia 
racemosa) leaves is used to bathe skin areas inflicted with scabies. This species has not 
been studied yet, but some investigations of the genus Randia already took place. The fruit 
extract of R. echinocarpa, which is used to treat and prevent cancer in the 
Sinaloa-ethnopharmacopoeia in Mexico, has shown antioxidant effects in the β-carotene 
bleaching method as well as antimutagenic activities in the Salmonella micro-suspension 
assay.214 In addition diuretic and urolithiatic effects in rats were described.215 Crude extracts 
of R. siamensis, used in Thai folkloric medicine to induce abortion and control blood 
pressure, demonstrated antinociceptive216 as well as cardiovascular effects.217 Triterpene 
saponins isolated from the fruits of R. dumetorum displayed haemolytic, molluscidal, and 
immunostimulating activities as well as significantly enhanced the proliferation of human 
lymphocytes in vitro;218 crude extracts from the seeds induced infertility219 and were also 
shown to possess antimicrobial impact.220 Besides the already mentioned triterpene saponins 
flavonoids have been isolated from the leaves of R. formosa221 and iridoids from the stems of 
R. spinosa222 and R. ruiziana.223 The leaves of this plant have been collected for the 
screening regimen due to antimicrobial activities shown in other Randia species and because 
of its affiliation to the alkaloid-bearing family Rubiaceae.  
The bark of Pipturus argenteus WEDD. (Urticaceae) is used as a cataplasm, forming a 
protective occlusive layer to treat boils (Tab. 5). The same application has been reported 
from the Cook Islands ethnopharmacopoeia.208 The tiny and rather tasteless fruits are eaten 
by children and birds (Tab. 22). The application of the leaves to muscle pain and sprains is 
also practised in Vanuatu.66 P. argenteus has not been studied yet, but antiviral, against 
Herpes Simplex Virus (HSV) 1 and 2 and Vesicular Stomatitis Virus (VSV), antimicrobial, 
against Staph. aureus and S. pyogenes, antifungal against Microsporum canis, Trichophyton 
rubrum, and Epidermophyton floccosum, and anti-complement activities were shown for P. 
albidus, a plant used in Polynesian traditional medicine in Hawaii for the treatment of 
infectious diseases224 and three phenolic acids, (+)-catechins, chlorogenic acid, and rutin 
with antioxidant activity have been isolated from its leaves.225 For further uses of this plant in 
Vanuatu’s ethnopharmacopoeia see ”Diseases of the gastrointestinal system” p. 75, 
“Diseases related to the urogenital system” p. 84, and “Modulators of the immune system” p. 
90. The proven biological activities of P. albidus have initiated the collection of the bark of 
this plant for the screening regimen. 
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The juice squeezed from a stalk of Epipremnum variegatum (L.) ENGL. (Araceae) is applied 
to wounds to stop bleeding (Tab. 5). For detailed information on this plant see “Diseases 
related to the urogenital system p. 84”. 
A decoction of the leaves of Scaevola taccada ROXB. (Goodeniaceae) is used to bathe the 
whole body in case of itchy rashes caused by scabies (Tab. 5). A detailed description is 
found under “Modulators of the immune system” p. 90. 
A fresh fruit of Capsicum frutescens L. (Solanaceae) is applied to boils (Tab. 5). In Tonga, 
Samoa, Tahiti, and the Cook Islands the crushed leaves mixed with coconut oil are used to 
cover sores226 and boils.227 In Fiji the leaves are prepared to a remedy against boils, 
abscesses, and wounds.201 More information on this plant is found under “Diseases of the 
skeleto-muscular system” p. 96. 
Tab. 5 Plants used to treat diseases of the skin 
scientific name family 1UR 2POC 3PPU use 
Achyranthes aspera L.                                                 Amaranthaceae 1 APP L boils 
Crinum xanthophyllum HANNIBAL, 1972                                  Amaryllidaceae 1 SWA Lat (L) warts 
Annonaceae 1 TLL L scabies Annona muricata L.                                                      
 1 SWA L scabies 
Apocynaceae 1 TLL Lat (L) centipede bites 
 1 L wounds 
Tabernaemontana pandacaqui LAM.                    
 1 
AA 
L "skin cancer" (severe 
wounds?) 
Epipremnum pinnatum (L.) ENGL.                            Araceae 2 TLL/ TLT St stops bleeding 
Cocos nucifera L.                                                        Arecaceae 1 NA oB wounds 
Ageratum conyzoides L.                                             Asteraceae 1 AA L wounds 
Asteraceae 1 SWA sap (L) boils 
 2 L scabies 
 2 
TLL 
L insect bites 
 1 L wounds 
 1 L wounds 
 1 
BML 
L wounds 
Mikania micrantha KUNTH.                                          
 2 TLL/ NA wP stops bleeding 
Asteraceae 1 L boils Vernonia cinera (L.) LESS.                                          
 1 
AA 
L wounds 
Diplazium latifolium MOORE                                           Athyriaceae 1 SWA Fr wounds 
Ipomoea indica (BURM.F.) MERR.                                     Convolvulaceae 1 AA Lat 
(St) 
stops bleeding 
Ipomoea pes-caprae (L.) R. Br.                                     Convolvulaceae 1 TLL L boils 
Convolvulaceae 1 St "skin cancer" (severe 
wounds?) 
Stictocardia campanulata (HALLIER F.) MERR.            
 1 
NA 
St wounds 
Luffa sp.                                                                              Cucurbitaceae 1 NA L scabies 
Cycas seemannii A.BRAUN                                           Cycadaceae 1 TLT L sting of stonefish 
Cycas weinmannii                                                           Cycadaceae 1 TLL L centipede bites 
Dioscorea bulbifera L.                                                    Dioscoreaceae 1 NA L wounds 
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scientific name family 1UR 2POC 3PPU use 
Excoecaria agallocha L.                                             Euphorbiaceae 1 AA Lat (L) wounds 
Euphorbiaceae 1 AA yL wounds 
 1 iB wounds 
 1 L wounds 
Macaranga dioica MUELL. ARG.                                        
 1 
SWA 
L wounds 
Euphorbiaceae 1 yL sunburn 
 2 
SWA/ NA 
yL wounds 
Macaranga tanarius (L.) MUELL. ARG.                            
 1 SWA yL stops bleeding 
Euphorbiaceae 1 L boils 
 1 L sunburn 
scientific plant name not known 1                                           
# 0276-2 
 1 
TLL 
L various skin diseases 
scientific plant name not known 2                                            
# 1176-10 
Euphorbiaceae 1 TLL L boils (painful) 
Scaevola taccada ROXB.                                                   Goodeniaceae 1 TLL L scabies 
Gyrocarpus americanus JACQ.                                    Hernandiaceae/ 
Gyrocarpaceae 
2 TLL L wounds 
Hyptis pectinata (L.) POIT.                                          Lamiaceae 1 AA L circumcision wounds 
Lamiaceae 1 wP scabies 
 1 wP boils 
Salvia sp.                                                                             
 1 
TLL 
wP wounds 
Leguminosae – 
Papilionoideae 
1 L boils 
 1 L carbuncles  
Derris trifoliata LOUR.                                                  
 1 
TLL 
L  abscesses 
Mucuna gigantea (WILLD.) DC.                                 Leguminosae – 
Papilionoideae 
1 SWA sap (L) sting of Dendrocnide 
moroides 
Malvaceae 1 Sh stops bleeding Hibiscus tiliaceus L.                                                    
 1 
SWA 
Sh wounds 
Marattia smithii METT. EX KUHN                                Marattiaceae 1 AA Fr neurodermatitis, infantile 
eczema 
Artocarpus altilis (PARK.) FOSB.                             Moraceae 1 AA Lat (L) wounds 
Ficus sp.                                                                          Moraceae 1 NA iB burns 
Pandanus tectorius PARK.                                        Pandanaceae 1 TLL Rt lice 
Macropiper latifolium (L.F.)                                       Piperaceae 1 SWA St to draw a splinter 
Digitaria radicosa PRESL                                            Poaceae 1 BML sap (L) wounds 
Drynaria rigidula (SW.) BEDD.                                        Polypodiaceae 1 AA Fr hair loss 
Aidia racemosa (CAV.) D.D. TIRVENG.                    Rubiaceae 1 TLL L scabies 
Citrus aurantifolia CHRISTM.                                         Rutaceae 1 TLL Frt scabies 
Pometia pinnata J.R. FORST. & G. FORST.                  Sapindaceae 1 TLL iB boils 
Capsicum frutescens L.                                             Solanaceae 1 APP Frt boils 
Tectaria latifolia (FORST.) COPEL.                              Tectariaceae 1 SWA Fr wounds 
Pipturus argenteus WEDD.                                        Urticaceae 1 BML iB boils 
Lantana camara L.                                                        Verbenaceae 1 AA L wounds 
Stachytarpheta cayennensis (RICH.) VAHL  Verbenaceae 1 AA L wounds 
Vitaceae 1 sap 
(St) 
"skin cancer" (severe 
wounds?) 
Cayratia trifolia (L.) DOMIN.                                          
 1 
NA 
sap 
(St) 
wounds3 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; #: voucher number;  AA: Aneityum, Anelcauhat, APP: 
Aneityum, Port Patrick, BML: Banks Islands, Moto Lava, NA: North Ambrym, SWA: Southwest Ambrym, TLL: Torres, Loh, Lungharigi, 
TLT: Torres, Loh, Telaklak; Fr: frond, Frt: fruit, L: leaf, Lat: latex, iB: inner bark, oB: outer bark, Rt: root, Sh: shoot, St: stem, wP: whole 
plant, yL: young leaf 
DISEASES OF THE GASTROINTESTINAL SYSTEM 
A fifth (20%) of all species is used to treat gastrointestinal disorders and after skin diseases 
the second most use reports fall in this category (Tab. 3). The ethnobotanical importance of 
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gastrointestinal disorders has already been shown for other indigenous groups, e.g. in Leonti 
et al.162 for the Popoluca in Mexico. In Vanuatu diarrhoea, liver complaints, and indigestion, 
followed by mouth infections and constipation are the most common gastrointestinal 
complaints (Tab. 6). In most cases diarrhoea is caused by entero-viruses or entero-bacteria; 
if blood is involved and the patient complains of fever, more severe infections with Shigella 
sp., Campylobacter sp., Salmonella sp., Vibrio cholerae, or Yersinia sp. are also possible. 
Liver complaints are mostly caused by hepatitis viruses, indigestion and constipation are 
mainly a result of an unbalanced diet usually very rich in carbohydrates as consumed in most 
islands, and mouth infections are predominantly caused by Bacteroides sp., Fusobacterium 
sp., and Leptotricha sp. and triggered by bad water quality and malnutrition.163  
Tab. 6 Quantitative analysis of gastrointestinal disorders 
gastrointestinal disorder 1nUR UR [%] 
diarrhoea  6 18.18 
hepatitis and other liver disorders 5 15.15 
indigestion 5 15.15 
mouth infections 4 12.12 
constipation/ ileus 4 12.12 
abdominal pain 2   6.06 
gastritis/ stomach-ache/ ulcer 2   6.06 
severe illness with bloody faeces 2   6.06 
appendicitis 1   3.03 
2cancer (heart burn?) 1   3.03 
protein intoxication 1   3.034 
                                                
 
1total 33 use reports for gastrointestinal disorders; UR [%] = Percentage of UR contributed to the total amount of UR reported for 
gastrointestinal disorders; 2 see “Diseases and their cures” 
Gastrointestinal disorders are most commonly treated systemically with infusions or 
decoctions mainly of fruits or flowers, or they are ingested as a whole. Only mouth infections 
are treated topically (Tab. 7). 
The most important plant in this category is Crinum asiaticum L. (Amaryllidaceae), followed 
by Acalypha wilkesiana MUELL. ARG. (Euphorbiaceae), Hibiscus tiliaceus L. (Malvaceae), 
Psidium guajava L. (Myrtaceae), and Syzygium malaccense (L.) MERR. & L.M. PERRY 
(Myrtaceae). Furthermore Dracontomelon vitiense ENGL. (Anacardiaceae), Mikania 
micrantha KUNTH. (Asteraceae), Canarium vulgare LEENH. (Burseraceae), Carica papaya L. 
(Caricaceae), Morinda citrifolia L. (Rubiaceae), and Pipturus argenteus WEDD. (Urticaceae) 
are briefly summarised due to their importance in other disease entities. 
The leaves of Crinum asiaticum L. (Amaryllidaceae) are squeezed in water and the resulting 
solution is taken to treat indigestion or the latex is mixed with water and drunk as an emetic 
(Tab. 7). The use as an emetic (and poison antidote) is also described in the Micronesian 
ethnopharmacopoeia for the bulbs and the leaves, the leaves, however, are used to relieve 
backaches and to prepare a treatment for permanent retraction of the testes.164 In Malekula 
(Vanuatu) the latex in water or coconut milk is also used as an emetic with a view to cure 
                                                                             1.4 RESULTS ETHNOBOTANY 
 
 77
ciguatera.64 In Fiji the leaves are used for wound healing and to reduce swellings and a 
preparation of the bulbs is utilised to facilitate childbirth and for the treatment of postpartum 
haemorrhage.164 In Samoa inflammations are treated with the leaves228 and in New 
Caledonia emetic and laxative, as well as diaphoretic and diuretic remedies are prepared 
from this plant.229 In Vanua Lava (Vanuatu) and Loh C. asiaticum is planted near trees to 
protect them against the plant pathogenic fungus Phellinus noxius59 and in Gaua (Vanuatu) 
the fruits are added as a fertiliser when taro is planted.59 In biological tests cytotoxic activities 
due to alkaloids230, 231 as well as antibacterial activities have already been demonstrated.232 
For further uses of this plant in Vanuatu’s ethnopharmacopoeia see “Diseases of the teeth” 
p. 97 and “Diseases of the ear” p. 97. 
The fresh leaves of Acalypha wilkesiana MUELL. ARG. (Euphorbiaceae) are either chewed or 
the sap is applied topically to treat mouth infections (Tab. 7). This activity may be due to the 
richness of tannins in the leaves,233 which have already shown antimicrobial activities,234 e.g. 
against Staph. aureus235 and even against a methicillin-resistant Staph. aureus (MRSA) 
strain.236 Antifungal activities234 have also been demonstrated, e.g. against Trichophyton 
rubrum, T. mentagrophytes, Candida albicans, and Aspergillus flavus235 and against Tinea 
pedis, Pityriasis versicolor, and Candida intetrigo.237 The leaves reveal modulation of multiple 
cytokines238 and the seeds, an essential component of a complex plant mixture used 
empirically by traditional healers in Southwest Nigeria to treat breast tumours and 
inflammation, displayed cytotoxic and immunomodulatory properties in biological tests.239 For 
further uses in the Vanuatu ethnopharmacopoeia see “Diseases of the eye” p. 98.  
The mucilaginous shoots of Hibiscus tiliaceus L. (Malvaceae) are both freshly eaten to treat 
gastritis, stomach-ache, and ulcers or ground and chewed for constipation or ileus. The 
shoots are squeezed in water and the slimy mash is put onto wounds to stop bleeding and 
accelerate the healing process (Tab. 6). Its multicoloured wood is often used for house 
construction, as fuel wood, and for carving (Tab. 22). In Gaua and Malekula the sap 
squeezed from the bark is taken to facilitate childbirth and in Erromango the sap collected 
from a trunk is drunk for the same reason.70 In Moto Lava and Mota in the Banks Islands the 
excorticated stem is used like a needle to penetrate wounds, with the leaves pus is removed 
from inflamed skin areas, and a cataplasm to relieve pain caused by stings or bites is also 
prepared from the leaves.72 The bark of a subspecies in Aneityum is cooked and eaten.34 H. 
tiliaceus is also widely used in ethnopharmacopoeias outside Vanuatu. In Tonga and 
Samoa228 the slimy sap from the bark (in Samoa the root) is dripped onto eye ailments or an 
infusion of the bark is taken in case of stomach-ache,181 in Tahiti the flowers are used to treat 
sores240 and in the Cook Islands they are mashed and put onto boils, carbuncles, and cuts,226 
whereas fractures and sprains are soaked with the sap226 and in Samoa the bark is part of a 
remedy for appendicitis.228 In the past the inner bark fibres were fashioned into grass skirts – 
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now unfortunately replaced by gorgeous pink coloured plastic fibres imported from China and 
sold as traditional grass skirts to cruise ship tourists - and many other artefacts, the leaves 
were used to wrap food, as baby nappies, and as serving platters.34 Substances with 
cytotoxic activity against P-388 cells and human colon carcinoma HT-29 cells have been 
isolated from the wood241 and methanolic extracts of the leaves have shown strong 
tyrosinase inhibitory activity.242 In vivo antioxidant and antimutagenic properties of methanolic 
flower extracts have also been demonstrated243, 244 and triterpenes have recently been 
isolated from stem and bark.245 For further uses see “Multi-system diseases” p. 87. 
The leaves of Psidium guajava L. are freshly chewed against diarrhoea or the leaf sap, 
squeezed in water, is taken to treat a severe illness with bloody faeces (Tab. 7), maybe 
caused by Shigella sp., Campylobacter sp., Salmonella sp., Vibrio cholerae (does not occur 
anymore in Vanuatu), or Yersinia sp. (in Fiji a decoction of the leaves is used to treat 
Cholera246). The fruits are edible (Tab. 22) and a good source of vitamins B and C. An 
infusion of the leaves is used in many parts of the Pacific to treat diarrhoea.228, 247 In the Cook 
Islands it is utilised to treat abdominal pain208 and in Tonga for stomach-ache.227 In Fiji the 
juice pressed from the young leaves is ingested for dysentery and upset stomach, an 
infusion of the roots or leaves for diarrhoea and indigestion, the unripe fruits are eaten as a 
laxative246 and in Kerala (South India) they are eaten to prevent gastrointestinal complaints 
due to antimicrobial activities.248 In the Cook Islands the leaves, chewed with or without 
coconut oil, are applied to cuts and boils and an extract of the young leaves is given as a 
bath to women who have just given birth, in order to speed recovery and relieve pain.208 
Many studies on P. guajava have already been achieved and antimicrobial activities,249 even 
against Vibrio cholerae250 have been proven, maybe due to their high content in tannins251 
and many other secondary plant metabolites.252-255 
In Vanuatu the leaves of Syzygium malaccense (L.) MERR. & L.M. PERRY, another 
Myrtaceae, are chewed to treat mouth-infections and abdominal pain (Tab. 7) (the same is 
known from Tonga and other parts of Polynesia,181 where the bark is also used for the same 
application and - together with that of other tree species - it is boiled and taken as a potion 
against stomach-ache and abdominal ailments).181 In previous studies ethnobotanical uses of 
the bark as a remedy for Ciguatera256 and rheumatism229 were also described. In the Cook 
Islands and Western Polynesia, a solution of the leaves or bark is used to treat thrush,226 or 
the bark is utilised to prepare an emetic.208 In New Caledonia a laxative is made from the 
bark.56 In Samoa the leaf galls are used to treat inflammations.228 The fruits are eaten in 
Vanuatu as well as in other parts of the Pacific. The wood is very hard and durable and often 
utilised for house ground posts and as fuel wood (Tab. 22). Extracts of S. malaccense have 
shown abilities as xanthine oxidase inhibitors (used in the treatment of gout) in an in vitro 
assay and were able to prevent cataractogenesis in diabetic rats.257 They have also 
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demonstrated inhibitory effects on cyclooxigenase-1 (COX-1) and 2 (COX-2), due to flavanol 
derivatives present in the extracts.258 Antiviral activities against VSV and HSV-1 and 2, 
antimicrobial activities against Staph. aureus and Streptococcus pyogenes as well as 
complement inhibition were shown.224 Extracts of other species of the genus Syzygium 
(synonym Eugenia) have demonstrated antiviral259 and antifungal properties on the 
dermatophytes Trichophyton mentagrophytes, T. rubrum, and Microsporum gypseum.260 A 
triterpenoid, isolated from the stems of Eugenia sandwicensis, revealed potential as a cancer 
chemoprevention agent261 and E. caryophyllus demonstrated antioxidant activity.262 For 
further uses in Vanuatu’s ethnopharmacopoeia see “Multi-system diseases” p. 87. The 
leaves of this plant have been collected for the screening regimen due to its use in Vanuatu’s 
ethnopharmacopoeia and proven biological activities of other members of the genus. 
The inner bark of Dracontomelon vitiense ENGL., wrapped in a leaf of any plant, toasted and 
squeezed in water is a remedy for a severe illness with bloody faeces (Tab. 7), maybe 
caused by Shigella sp., Campylobacter sp., Salmonella sp., Vibrio cholerae (does not occur 
anymore in Vanuatu), or Yersinia sp.. The tasteless fruits of this plant are edible and very 
popular (Tab. 22). A cold digestion of the bark is applied to the woman’s navel to facilitate 
childbirth in Malekula.70 D. vitiense ENGL. has not been studied, but crude methanolic 
extracts of leaves, bark, or root of Dracontomelon dao have shown significant antibacterial 
activities, and the leaf extract has also shown antifungal effects.263 The caries-free Kammu 
women in Vietnam and Laos use a stain composed of an extract of D. dao nuts and the wood 
of two other plants to blacken their teeth. An extract of D. dao nuts has shown significant 
growth inhibition of salivary mutans streptococci in vitro and therefore a caries preventing 
effect of this extract is assumed.264 The antibacterial activity shown for D. dao and 
antimalarial activities shown for other members of the family265 have initiated the collection of 
the bark for the screening regimen performed in this study. 
The leaf juice of Mikania micrantha KUNTH. (Asteraceae) mixed with water is used as a 
treatment of diarrhoea. See “Diseases of the skin” p. 68 for detailed information on this plant.  
The leaves of Canarium vulgare LEENH. (Burseraceae) are prepared to a remedy against 
diarrhoea (Tab. 7). For a detailed description of this plant see “Multi-system diseases” p. 87. 
A decoction of the flowers of Carica papaya L. (Caricaceae) is drunk as a potion for hepatitis 
(Tab. 7). The seeds are eaten to treat infestations with intestinal worms, as also reported 
from Samoa, Tahiti, and the West Indies.226 In Tonga they are eaten in case of diarrhoea.227 
In Fiji the ripe fruit pulp is taken for ingestion, diarrhoea, and dysentery and as an 
appetizer246 and in India as a stomachic and carminative. The latex is utilised for bleeding 
haemorrhoids, ulcers, and dyspepsia.246 In the Caribbean an emetic is made from the 
leaves266. In biological tests effects on the contraction of the jejunum were shown.267 See 
“Multi-system Diseases” p. 87 for a detailed description of this plant.  
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The fruits of Morinda citrifolia L. (Rubiaceae) are freshly eaten to treat constipation. In 
Malekula the leaves are ground, smelled, and rubbed on the stomach to treat constipation.64 
In the Cook Islands the fruit is used as a remedy for diaphragmatic hernia and other 
abdominal swellings.226 In Tonga an infusion of bark or leaves is taken as a potion for 
stomach-ache, and the juice from a squeezed fruit is applied to mouth infections.227 These 
effects have been proven in vivo in rats.268 See “Modulators of the immune system” p. 90 for 
a more detailed description of this plant. 
An infusion of the leaves of Pipturus argenteus WEDD. (Urticaceae) is taken to treat hepatitis 
(Tab. 7). See “Diseases of the skin” p. 68 for further information on this plant.  
Tab. 7 Plants used to treat diseases of the gastrointestinal system  
scientific name family 1UR 2POC 3PPU use 
Cordyline fruticosa (L.) A. CHEV.                Agavaceae 1 AA L leprosy in the mouth 
Amaryllidaceae 1 SWA/NA L indigestion Crinum asiaticum L.                               
 2 SWA Lat (L) to cause emesis 
Dracontomelon vitiense ENGL.               Anacardiaceae 1 NA iB severe illness with bloody faeces 
Mikania micrantha KUNTH.                     Asteraceae 1 SWA L diarrhoea 
Canarium vulgare LEENH.                       Burseraceae 1 AA L diarrhoea 
Carica papaya L.                                    Caricaceae 1 SWA Fl hepatitis 
Ipomoea indica (BURM.F.) MERR.           Convolvulaceae 1 SWA Lat (St) laxative 
Operculina turphetum (L.) SILVA 
MANSO                     
Convolvulaceae 1 TLT Sh abdominal pain 
Euphorbiaceae 1 TLL L aphthous ulcers Acalypha wilkesiana MUELL. ARG.          
 1 AA L aphthous ulcers 
Euphorbia cyathophora L., MURR.           Euphorbiaceae 1 AA Frt diarrhoea 
Garcinia sp.                                            Guttiferae 1 AA L liver pain 
Lamiaceae 1 wP indigestion Salvia sp.                                               
 1 
TLL 
wP gastritis, stomach-ache, ulcers 
Desmodium incanum (SW.) DC.             Leguminosae – 
Papilionoideae 
1 AA L diarrhoea 
Inocarpus fagifer PARK.                          Leguminosae – 
Papilionoideae 
1 TLL Sd protein intoxication after consumption of too 
much seafood (flatulence + pain) 
Pueraria lobata (WILLD.) OHWI                Leguminosae – 
Papilionoideae 
1 SWA L hepatitis 
Vigna luteola (JACQ.) BENTH.                  Leguminosae – 
Papilionoideae 
1 SWA L hepatitis 
Malvaceae 1 BML Sh gastritis, stomach-ache, ulcers Hibiscus tiliaceus L.                               
 1 TLL Sh constipation/ ileus 
Sida rhombifolia L.                                 Malvaceae 1 AA L diarrhoea 
Myrtaceae 1 BML L diarrhoea Psidium guajava L.                                
 1 NA L severe illness with bloody faeces 
Myrtaceae 1 TLL L mouth infections Syzygium malaccense  (L.) MERR. & 
L.M. PERRY  1 SWA L abdominal pain (to cause emesis) 
Piper methysticum J. R. & G. FORST.     Piperaceae 1 SWA L appendicitis 
Gardenia tannaensis GUILL.                   Rubiaceae 1 TLT L constipation 
Morinda citrifolia L.                                 Rubiaceae 1 AA Frt constipation 
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scientific name family 1UR 2POC 3PPU use 
Pipturus argenteus WEDD.                     Urticaceae 1 SWA L hepatitis 
Cayratia trifolia (L.) DOMIN.                     Vitaceae 1 NA L „cancer“ (heart burn?)5 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, BML: Banks Islands, Moto 
Lava, NA: North Ambrym, SWA: Southwest Ambrym, TLL: Torres, Loh, Lungharigi, TLT: Torres, Loh, Telaklak; Fl: flower, Frt: fruit, iB: 
inner bark, L: leaf, Lat:: latex, Sd: seed, Sh: shoot, St: stem, wP: whole plant 
DISEASES OF THE RESPIRATORY SYSTEM 
Respiratory complaints rank directly behind gastrointestinal disorders in Vanuatu’s traditional 
medicine (Tab. 3). Cough is the most important disorder in this entity (Tab. 8) and is mainly 
of viral origin; second infestations with Haemophilus influenzae, Streptococcus pneumoniae, 
or Pneumococcus sp. are possible and common.63 Close personal contact and an 
unbalanced diet lacking vitamins leads to a high incidence of cough in the outer islands. If 
fever is involved, cough can also be a symptom of a more severe illness like bronchitis or 
tuberculosis. 
Tab. 8 Quantitative analysis of respiratory complaints 
respiratory disease 1nUR UR [%] 
2cough 14 42.42 
asthma 12 36.36 
3chest pain (angina pectoris?) 2   6.06 
bronchitis 1   3.03 
cold 1   3.03 
sore throat 1   3.03 
tuberculosis 1   3.036 
                                                
 
1total 31 use reports for respiratory disorders; UR [%] = Percentage of UR contributed to the total amount of UR reported for respiratory 
disorders; 2 “simple” cough, lacking fever , 3see “Diseases and their cures” 
Diseases of the respiratory system are most commonly treated systemically with cold 
digestions prepared mainly from the leaves (Tab. 3). 
The most important plants in this category are Erythrina variegata L. (Leguminosae – 
Papilionoideae) and Baccaurea stylaris MUELL. ARG. (Phyllanthaceae), followed by Mikania 
micrantha KUNTH. (Asteraceae), Bidens pilosa L. (Asteraceae), and Acalypha grandis BENTH. 
(Euphorbiaceae), but Intsia bijuga (COLEBR.) O. KTZE. (Leguminosae – Caesalpinioideae), 
Euodia latifolia DC. (Rutaceae), Tabernaemontana pandacaqui LAM. (Apocynaceae), 
Macaranga tanarius (L.) MUELL. ARG. (Euphorbiaceae), and Ficus septica BURM.F. 
(Moraceae) are also briefly described, because of their importance in other disease entities. 
A cold digestion of the leaves of Erythrina variegata L. (Leguminosae – Papilionoideae) is 
utilised to treat cough, a cold digestion of the inner bark for chest pain, maybe angina 
pectoris (for definition of “chest pain” see “1.3 Diseases and their cures”) and a cold digestion 
of the bark (toasted beforehand) for asthma (Tab. 9), which is also used as a laxative229 and 
a potion against ciguatera is produced by adding bark of Pterocarpus indicus WILLD..269 In 
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Samoa a remedy for inflammation and with anti-viral properties is prepared from the bark228 
and in Tonga an infusion to treat stomach-ache is made from the bark of this plant and that 
of Cananga odorata (LAM.) HOOK.F. & THOMSON (Annonaceae).181 Throughout Vanuatu, E. 
variegata is planted as an ornamental or as a living fence due to its showy red flowers and 
variegated leaves. In central Pentecost (Vanuatu) the onset of flowering at the end of the dry 
season is an indication sign for the planting season,34 in the Cook Islands it marked the 
beginning of the whaling season in former times.208 The light wood is utilised as fuel wood or 
for fishing floats.240 E. variegata has already extensively been studied in the last years. 
Antibacterial,270, 271 antiinflammatory,228 cytotoxic,272 and other biological properties228 due to 
flavonoids273, 274, alkaloids,275-277 and other secondary plant metabolites have been 
determined. 
A decoction of the leaves and/or inner bark of Baccaurea stylaris MUELL. ARG. is used to 
bathe the whole body when suffering from asthma or cough (Tab. 9). Not much is known 
about this genus so far; only one study has been carried out81 in which ten compounds, 
comprising among others a prenylated flavonol, a flavonoid and a lignan, isolated from the 
leaves of Baccauera ramiflora LOUR. showed significant antioxidant activities. Other 
members of this genus are often planted for their edible fruits.278 Bark and leaves of this plant 
have been collected for the screening regimen due to biological activities demonstrated for 
the tribe Antidesmateae (see “2.6 Phytochemistry and Pharmacology of Baccaurea LOUR. 
and other Phyllanthaceae”) and the lack of studies of the genus and the bark has also been 
chosen for the phytochemical purification procedure described later in this study.  
The fresh leaf juice of Mikania micrantha KUNTH. (Asteraceae) mixed with water is taken as a 
remedy for cough or the leaves are boiled in water and the steam is inhaled to treat the 
symptoms of a cold (Tab. 9). See “Diseases of the skin” p. 68 for detailed information on this 
plant. 
In Vanuatu a cold digestion of the shoots of Bidens pilosa L. (Asteraceae) is drunk as a 
remedy for cough (Tab. 9). In the Cook Islands the chewed or pounded leaves are put on 
cuts,208 in Tonga they are utilised for the same purpose and are also applied to eye ailments, 
particularly those caused by evil spirits.227 Many studies have been done before, dealing with 
its biological activities and spectrum of constituents, revealing antimalarial,279 antibacterial,280 
cytotoxic,281, 282 anti-inflammatory,283-286 and other properties. This plant has been collected 
for the screening regimen by mistake, because it had been misidentified in the field. 
The leaves of Acalypha grandis BENTH. (Euphorbiaceae) are freshly chewed to treat sore 
throat (Tab. 9). Decoctions of the leaves or flowers in saltwater can also be used as 
mouthwash or gargle to treat mouth infections or sore throat as done in Moto Lava.72 In 
Erromango (Vanuatu) a remedy to induce temporary sterility is prepared from the leaves, 
mixed with fronds of a fern and the bark of another plant.70 Until now no studies on A. grandis 
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have been achieved, but other members of the genus Acalypha have already shown several 
biological activities. For example A. australis,287 A. communis,288 A. guatemalensis ,289, 290 A. 
hederacea,291 A. hispida,233 A. siamensis,292 and A. wilkesiana233-236 demonstrated 
antimicrobial, A. australis287 antiviral, A. fruticosa,293 and A. wilkesiana237 antifungal, A. 
guatemalensis294 antiprotozoal and A. australis287 and A. siamensis295 cytotoxic properties 
(see also A. wilkesiana in section “Diseases of the gastrointestinal system” p. 75). Further 
uses of A. grandis are described in the section “Diseases related to the urogenital system” p. 
84. The leaves of this plant have been collected for the screening regimen due to the great 
variety of biological activities already demonstrated for other members of the genus in 
previous studies.  
The inner bark of Intsia bijuga (COLEBR.) O. KTZE. (Leguminosae – Caesalpinioideae), 
squeezed in coconut water, is taken as a remedy for asthma (Tab. 9). The hard wood is used 
for carving (Tab. 22), ground posts, and house construction.34 No studies have been carried 
out on this genus, but other members of the Leguminosae – Caesalpinioideae have already 
shown cytotoxic or antimicrobial activities, e.g. Caesalpinia sappan which exhibits both.296-298 
See also “Multi-system Diseases” p. 87 and “Modulators of the immune system” p. 90. The 
leaves of I. bijuga have been collected for the screening regimen due to cytotoxic activities 
already shown for other members of the family.  
A remedy for cough is prepared from the leaves of Euodia latifolia DC. (Rutaceae) (Tab. 9). 
No studies have been performed on this species yet, but other members of the genus have 
already shown significant cytotoxic activities against various cancer cell lines,299-301 and also 
anti-inflammatory,302 303 antibacterial,304-306 antifungal,306 and antimalarial307 activities due to a 
high content of alkaloids,303, 304 flavonoids,303 lignans,303 and other secondary plant 
metabolites.303 The leaves of this plant have been collected for the screening regimen due to 
their ethnomedicinal use, activities of other Euodia sp. in various biological tests, and 
phytochemical composition of the genus.  
The latex escaping from a broken leaf of Tabernaemontana pandacaqui LAM. (Apocynaceae) 
is mixed with water and the solution is taken as a treatment for tuberculosis (Tab. 9). See 
“Diseases of the skin” p. 68 for detailed information on this plant. 
The leaves of Macaranga tanarius (L.) MUELL. ARG. (Euphorbiaceae) are rubbed between the 
hands, squeezed in water and the solution is given to babies suffering from asthma (Tab. 9). 
See “Diseases of the skin” p. 68 for a more detailed description of this plant. 
The leaves of Ficus septica BURM.F. (Moraceae) are squeezed in water and the milky 
solution is ingested to treat asthma (Tab. 9). See “Diseases of the nervous system” p. 94 for 
more information on this plant. 
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Tab. 9 Plants used to treat diseases of the respiratory system 
scientific name family 1UR 2POC 3PPU use 
Achyranthes aspera L.                                 Amaranthaceae 1 AA L asthma 
Crinum xanthophyllum HANNIBAL, 1972        Amaryllidaceae 1 AA L asthma 
Kopsia flavida BL.                                         Apocynaceae 1 TLL yL cough 
Tabernaemontana pandacaqui LAM.            Apocynaceae 1 SWA Lat (L) tuberculosis 
Bidens pilosa L.                                            Asteraceae 1 AA Sh cough 
Asteraceae 1 L cold Mikania micrantha KUNTH.                            
 1 
AA 
L cough 
Ipomoea indica (BURM.F.) MERR.                  Convolvulaceae 1 TLL wP cough 
Convolvulaceae 1 L cough Ipomoea littoralis (L.) BL.                               
 1 
TLL 
L bronchitis 
Zehneria sp.                                                 Cucurbitaceae 1 SWA L cough 
Acalypha grandis BENTH.                             Euphorbiaceae 1 BML L sore throat 
Chamaesyce hirta L.                                    Euphorbiaceae 1 AA L asthma 
Macaranga tanarius (L.) MUELL. ARG.           Euphorbiaceae 1 TLL L asthma (babies) 
Barringtonia edulis SEEM.                             Lecythidaceae 1 SWA iB cough 
Intsia bijuga (COLEBR.) O. KTZE.                   Leguminosae - Caesalpinioideae 1 SWA iB asthma 
Leguminosae – Papilionoideae 1 SWA L cough 
 1 iB chest pain (angina pectoris?) 
Erythrina variegata L.                                   
 2 
TLL 
iB asthma 
Pueraria lobata (WILLD.) OHWI                      Leguminosae – Papilionoideae 1 TLL L asthma 
Ficus septica BURM.F.                                  Moraceae 1 SWA L asthma 
Phyllanthaceae 1 L asthma 
 1 iB asthma 
 1 L cough 
Baccaurea stylaris MUELL. ARG.                  
 1 
AA 
iB cough 
Piperaceae 1 L cough Piper methysticum J. R. & G. FORST.             
 1 
AA 
Rt cough 
Oplismenus hirtellus (L.) P.BEAUV.                  Poaceae 1 AA Sh cough 
Euodia latifolia DC.                                       Rutaceae 1 TLL L cough 
Pometia pinnata J.R. FORST. & G. FORST.     Sapindaceae 1 SWA iB asthma 
Alpinia novae-pommeraniae K. SCHUM.         Zingiberaceae 1 SWA St chest pain (angina pectoris?)7 
                                                
 
1UR: number of use reports, 2 OPC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, SWA: Southwest Ambrym, 
TLL: Torres, Loh, Lungharigi; iB: inner bark, L: leaf, Lat: latex, Rt: root, Sh: shoot, wP: whole plant, yL: young leaf 
DISEASES RELATED TO THE UROGENITAL SYSTEM 
Remedies to treat postpartum pain and to expulse the placenta are leading in this category, 
followed by potions that are said to be able to influence the sex of the embryo during 
pregnancy (this kind of medicine is considered as inefficient by the author, as it lacks a 
scientific basis, but is considered as very useful and effective in Vanuatu’s 
ethnopharmacopoeia) medicine to treat all kinds of disorders concerning menstruation, and 
remedies to facilitate childbirth (Tab. 10). 
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Tab. 10 Quantitative analysis of diseases related to the urogenital system 
Diseases related to the urogenital system 1nUR UR [%] 
postpartum pain/ expulse placenta 8 25.81 
influence sex of embryo during pregnancy 4 12.90 
emmenagogue 3   9.68 
facilitation of childbirth 3   9.68 
abortive 2   6.45 
urogenital tract infection 2   6.45 
contraceptive 1   3.23 
fertility drug 1   3.23 
gonorrhoea 1   3.238 
                                                
 
1total 25 use reports for diseases related to the urogenital system; UR [%] = Percentage of UR contributed to the total amount of UR 
reported for diseases related to the urogenital system 
Diseases related to the urogenital system are most commonly treated systemically with cold 
digestions prepared primarily from the leaves (Tab. 3). 
The most important plant in this category is Epipremnum pinnatum (L.) ENGL. (Araceae), 
followed by Tabernaemontana pandacaqui LAM. (Apocynaceae), Acalypha grandis BENTH. 
(Euphorbiaceae), Erythrina variegata L. (Leguminosae – Caesalpinioideae), Macropiper 
latifolium (L.F.), and Pipturus argenteus WEDD. (Urticaceae). 
The leaf juice of Epipremnum pinnatum (L.) ENGL. (Araceae) - mixed with water - is taken in 
case of amenorrhoea and the leaves are chewed as an abortifacient (Tab. 11). In Gaua 
(Vanuatu) the root tips are eaten to facilitate childbirth,70 in Singapore the leaves are used as 
a folk remedy to treat cancer.308 Growth inhibition of breast cancer cells while treated with 
crude extract of E. pinnatum has been demonstrated.309 For a more information on this plant 
see “Diseases of the skin” p. 68. 
A fresh stalk of Tabernaemontana pandacaqui LAM. (Apocynaceae) is chewed to influence 
the sex of an embryo during pregnancy in favour of a girl (Tab. 11). In the Philippines the 
leaves are placed on the abdomen as a cataplasm to induce menstruation or to hasten 
parturition310 and women have a bath of a decoction of the leaves after or a decoction of bark 
or roots as a drink during childbirth.183 For a detailed description of this plant see “Diseases 
of the skin” p. 68. 
The sap of the leaves of Acalypha grandis BENTH. (Euphorbiaceae) mixed with water is 
utilised as a remedy for gonorrhoea (Tab. 11). See “Diseases of the respiratory system” p. 81 
for more information on this plant. 
The young leaves of Erythrina variegata L. (Leguminosae – Caesalpinioideae) are freshly 
chewed to treat postpartum abdominal pain and to expulse the placenta (Tab. 11). For a 
detailed description of this plant see “Diseases of the respiratory system” p. 81. 
The leaf galls of Macropiper latifolium (L.F.) are ingested to influence the sex of an embryo 
during pregnancy (Tab. 11). In Gaua (Vanuatu) the fresh leaves are eaten to expulse the 
placenta and the leaf galls to facilitate childbirth70 or in Pentecost the leaves are combined 
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with the leaves of another (undetermined) species, squeezed in water, and the solution is 
taken to facilitate childbirth.311 A detailed description of M. latifolium is found in “Diseases of 
the skin” p. 68. 
The sap of Pipturus argenteus WEDD. (Urticaceae), squeezed from the inner bark and mixed 
with water, is drunk as an abortifacient (Tab. 11). The same is known from Epi (Vanuatu), 
where the inner bark, mixed with coconut, is ingested to induce sterility and as a 
contraceptive70 and the sap or bark to facilitate childbirth.312 For further information on this 
plant see “Diseases of the skin” p. 68. 
Tab. 11 Plants used to treat disorders related to the urogenital system 
scientific name family 1UR 2POC 3PPU use 
Achyranthes aspera L. (red variety)   Amaranthaceae 1 AA L increases fertility in woman 
Cananga odorata (LAM.) HOOK.F. & 
THOMSON  
Annonaceae 1 TLL iB postpartum abdominal pain (to expulse 
placenta) 
Alstonia vitiensis SEEM.                      Apocynaceae 1 AA L contraceptive 
Tabernaemontana pandacaqui 
LAM.                    
Apocynaceae 1 AA St influences sex of embryo during pregnancy  in 
favour of girl (magic) 
Araceae 1 SWA L amenorrhoea Epipremnum pinnatum (L.) ENGL.      
 1 TLL Sh abortive 
Polyscias cumingiana (C.PRESL) 
FERN.-VILL.         
Araliaceae 1 SWA L influences sex of embryo during pregnancy in 
favour of girl (magic) 
Polyscias scutellaria (BURM.F.) 
FOSB.                   
Araliaceae 1 SWA L influences sex of embryo during pregnancy  in 
favour of girl (magic) 
Hoya vanuatensis                              Asclepiadaceae 1 SWA L facilitates childbirth 
Ipomoea indica (BURM.F.) MERR.        Convolvulaceae 1 SWA Fl facilitates childbirth 
Ipomoea pes-caprae (L.) R. BR.        Convolvulaceae 1 AA St severe abdominal pain during pregnancy 
caused by spirits 
Stictocardia campanulata (HALLIER 
F.) MERR.            
Convolvulaceae 1 NA St inflammation in the urogenital system 
Zehneria sp.                                       Cucurbitaceae 1 SWA L facilitates childbirth 
Acalypha grandis BENTH.                   Euphorbiaceae 1 TLT L gonorrhoea 
Salvia sp.                                           Lamiaceae 1 TLL wP menses pain 
Cassytha filiformis L.                          Lauraceae 1 TLL wP postpartum abdominal pain (to expulse 
placenta) 
Entada pursaetha DC.                        Leguminosae – 
Mimosoideae 
1 AA L severe pain during pregnancy 
Erythrina variegata L.                         Leguminosae – 
Papilionoideae 
1 TLL yL postpartum abdominal pain (to expulse 
placenta) 
Ficus sp.                                             Moraceae 1 SWA Lat 
(L) 
postpartum abdominal pain (to expulse 
placenta) 
Maesa ambrymensis GUILL.               Myrsinaceae 1 SWA Frt to initiate the menopause 
Macropiper latifolium (L.F.)                 Piperaceae 1 NA LG influences sex of embryo during pregnancy (girl 
or boy) (magic) 
Pometia pinnata J.R. FORST. & G. 
FORST.                  
Sapindaceae 1 TLL yL bloody urine + pain 
Pipturus argenteus WEDD.                 Urticaceae 1 SWA iB abortive 
not known 3 
# 2286-1.4.1                                       
plant family not known 1 AA L severe abdominal pain during pregnancy 
caused by spirits (magic) 
not known 4 
# 2286-1.4.2                                      
plant family not known 1 AA L severe abdominal pain during pregnancy 
caused by spirits9 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; #: voucher number; AA: Aneityum, Anelcauhat, NA: North 
Ambrym, SWA: Southwest Ambrym, TLL: Torres, Loh, Lungharigi, TLT: Torres, Loh, Telaklak; Fl: flower, Frt: fruit, iB: inner bark, L: leaf, 
Lat: latex, LG: leaf gall, Sh: shoot, St: stem, wP: whole plant, yL: young leaf 
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MULTI-SYSTEM DISEASES 
Medicines to treat ciguatera, “cancer” (see “1.3 Diseases and their cures”), diabetes, dengue 
fever, malaria and AIDS (see “1.3 Diseases and their cures”) build the category “Multi-system 
diseases” (Tab. 12). 
Most remedies are used to treat Ciguatera (Tab. 12), a foodborne disease transmitted by 
consumption of sea fish, contaminated with the heat-resistant ciguatoxin which is present in 
many microorganisms (particularly the micro-algae Gambierdiscus toxicus) living in tropical 
waters. It bioaccumulates in lower-level organisms, resulting in higher concentration of the 
toxin at the end of the food chain.313 Hallmark symptoms of ciguatera include gastrointestinal 
and neurological effects, such as nausea, paresthesia, numbness, ataxia, and 
hallucinations.313 Severe cases of ciguatera can also result in cold allodynia, which is a 
burning sensation on contact with cold.314 There is no effective treatment or antidote for 
ciguatera poisoning yet. 
In the last years an increasing prevalence of obesity, type II diabetes, and cardiovascular 
diseases has been assessed in Vanuatu. While the rural population follows a predominantly 
subsistence lifestyle, the urban population or the population with good transport connection 
to urban areas has adopted a more westernised lifestyle with decreasing consumption of 
traditional foods like root crops, such as yam and taro or starchy fruits such as plantain and 
breadfruit and increasing consumption of imports namely rice, fat/oils, canned meat/fish, 
refined sugar, bread, and ready meals. The rise in non-communicable diseases has been 
attributed, in part, to this transition away from traditional in favour of imported food.315, 316 
Dengue fever is an illness caused by arboviruses transmitted by day-biting Aedes aegypti 
mosquitoes. An estimated 40–80 million people are infected each year with highest incidence 
in Southeast Asia. Dengue symptoms range from benign febrile illness to severe, 
life-threatening, haemorrhagic fever.163 Only symptomatic treatment is possible yet due to 
lack of a suitable medicine. 
Tab. 12 Quantitative analysis for multi-system diseases 
Multi-system diseases 1nUR UR [%] 
ciguatera 13 52.00 
2cancer   5 20.00 
diabetes   4 16.00 
dengue fever   2   8.00 
malaria   1   4.00 
2AIDS   1   4.0010 
                                                
 
1total 25 use reports for multi-system diseases; UR [%] = Percentage of UR contributed to the total amount of UR reported for multi-
system diseases; 2 see “Diseases and their cures” 
Multi-system diseases are most commonly treated systemically with cold digestions prepared 
predominantly from the leaves (Tab. 3). 
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The leaf juice of Canarium vulgare LEENH. (Burseraceae) mixed with coconut water is taken 
in case of ciguatera (Tab. 13). In Malekula (Vanuatu) the juice pressed from leaves or bark is 
ingested to facilitate childbirth70 and in ancient times the resin was used for light or as canoe 
caulk.34 The tasty seeds are eaten in Vanuatu (Tab. 22) as well as in other parts of the 
Pacific. The nut oil is part of tanning lotions and other cosmetics.278 In previous studies of 
other members of the genus Canarium, tannins with antioxidant activity,317 flavonoids and 
triterpenoids with hepatoprotective effects318-320 were isolated and crude extracts have shown 
anti-diabetic properties.321 See “Diseases of the gastrointestinal system” p. 75 for further 
uses of this plant. 
The flowers of Carica papaya L. (Caricaceae) are chewed to treat ciguatera; the roots are 
chewed with coconut milk in case of “AIDS” in the first stage (see also “Diseases and their 
cures”) (Tab. 13), and the ripe fruits are edible and very popular (Tab. 22). A decoction of the 
flowers269 or the leaves, which have shown cardiac actions and activities as laxative229 56 are 
also utilised in the treatment of ciguatera in Vanuatu and New Caledonia. In Polynesia the 
unripe fruits are cooked and eaten and the cooking water is drunk for the same purpose.322 A 
remedy to induce abortion is also reported from Vanuatu: the green fruits are swallowed with 
lime juice and four tablets of Nivaquine® (a malaria medication that should be avoided by 
pregnant women as it may cause abortion)70 and in India the seeds are used as an 
emmenagogue and abortifacient.246 In the Cook Islands the grated green fruit is mixed with 
coconut oil and rubbed onto boils and carbuncles, cuts and sores.226 In Fiji the latex is 
applied to ringworm (Tinea, a superficial fungal infection of the skin) and in India the latex of 
an unripe fruit is used as a cosmetic for freckles or a medicine for ringworm and psoriasis 
and the ripe fruit is said to have diuretic properties 246. In Tonga an infusion of the sap from a 
green fruit is taken for asthma and shortness of breath 227 and in Fiji the leaves are ground 
and taken with salt for coughs.246 Many studies have been carried out on C. papaya, 
revealing e.g. antibacterial,323-327 antioxidant,328, 329 anti-diabetic,330 diuretic,330 liver-
protective,331 and abortifacient323, 332-334 activities. For further uses of this plant see “Diseases 
of the gastrointestinal system” p. 75. 
A cold digestion of the rhizome of Zingiber zerumbet (L.) SM. (Zingiberaceae) is taken in 
case of “cancer” (see also “1.3 Diseases and their cures”) (Tab. 13). In Banks Islands, Moto 
Lava (Vanuatu) the leaf juice is applied to conjunctivitis.72 In Fiji the juice squeezed from a 
rhizome is taken in case of ciguatera poisoning201 and is also used for diabetes, coughs, and 
colds. In India the rhizome has multiple uses: as a stimulant and tonic, as a carminative for 
stomach troubles, dyspepsia, and flatulent colic, for fever or as a flavouring agent.246 In 
Samoa it is used to treat inflammation,228 in Tonga for peptic ulcers, stomach-ache, and 
mouth infections.227 In the Cook Islands the copious fluid that accumulates in the bracts is 
said to elongate and soften the hair and a solution of the grated rhizome is applied to 
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haemorrhoids and prolapsed rectum.208 Compounds isolated from the rhizomes such as 
flavonoids335, 336 or the sesquiterpenoid zerumbone337 have already shown cytotoxic activities 
against P-388 cells and the human promyelocytic leukaemia cell line HL-60,338 human breast 
cancer MCF-7 cells,335 and human liver cancer HepG2 cells.339 Extracts also revealed cancer 
chemopreventive,340-342 anti-allergic343 as well as immunomodulatory336, 342, 344-349 activities. 
Zerumbone and its derivatives have shown significant antibacterial activities,350 and the 
extracts have demonstrated effects on Giardia intestinalis351 and Entamoeba histolytica strain 
HTH-56:MUTM and strain HM1:IMSS.352 The rhizomes of this plant have been collected for 
the screening regimen, because it has been misidentified as an Alpinia due to the lack of 
flowers. A phylogenetic sequencing analysis, utilising the internal transcribed spacer 2 (ITS2) 
sequence-structure alignment, a sufficient condition to distinguish even closely related 
species200 has been performed in the Institute of Botany, Team C. Oberprieler, University of 
Regensburg, Germany resulting in 99% sequence similarity with Z. zerumbet (data not 
shown). 
The leaf juice of Mikania micrantha KUNTH. (Asteraceae) in water is taken as a remedy for 
fever and dengue fever. For a more detailed description of this plant see “Diseases of the 
skin” p. 68. 
The leaves or inner bark of Intsia bijuga (COLEBR.) O. KTZE. (Leguminosae – 
Caesalpinioideae) are squeezed in saltwater and the solution is ingested as a remedy for 
diabetes (Tab. 13). For more information on this plant see “Diseases of the respiratory 
system” p. 81. 
A remedy for “cancer” (see “1.3 Diseases and their cures”) is prepared from inner bark or 
leaves of Hibiscus tiliaceus L. (Malvaceae). A detailed description of this plant is found under 
the section “Diseases of the gastrointestinal system” p. 75. 
The juice squeezed from the inner bark of Syzygium malaccense (L.) MERR. & L.M. PERRY 
(Myrtaceae) mixed with water is taken as a remedy for ciguatera (Tab. 13). For more 
information on this plant see “Diseases of the gastrointestinal system” p. 75. 
The roots of Macropiper latifolium (L.F.) (Piperaceae) - prepared like kava - are used as a 
remedy for ciguatera (Tab. 13). The use of this plant against ciguatera has previously been 
reported.256 More information on M. latifolium is found under the section “Diseases of the 
skin” p. 68. 
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Tab. 13 Plants used to treat multi-system diseases 
scientific name family 1UR 2POC 3PPU use 
Crinum xanthophyllum HANNIBAL, 1972                              Amaryllidaceae 1 AA sap 
(L) 
ciguatera 
Polyscias samoensis (A.GRAY) HARMS                Araliaceae 1 AA L ciguatera 
Mikania micrantha KUNTH.                                          Asteraceae 1 SWA L dengue fever 
Burseraceae 1 AA L ciguatera Canarium vulgare LEENH.                                             
 1 APP L ciguatera 
Garuga floribunda DECNE.                                          Burseraceae 1 TLL L ciguatera 
Caricaceae 1 BML Rt "HIV" 1st stage Carica papaya L.                                                            
 1 AA Fl ciguatera 
Stictocardia campanulata (HALLIER F.) MERR.            Convolvulaceae 1 SWA L pain of the spleen 
(malaria?) 
Luffa cylindrica (LOUR.) ROEM.                                      Cucurbitaceae 1 SWA L "cancer" 
Dracaena angustifolia ROXB.                                      Dracaenaceae 1 AA L ciguatera (to stimulate 
emesis)  
Leguminosae – 
Caesalpinioideae 
1 L diabetes Intsia bijuga (COLEBR.) O. KTZE.                                      
 1 
SWA 
iB diabetes 
Malvaceae 1 iB "cancer" Hibiscus tiliaceus L. 
  1 
SWA 
L "cancer" 
Syzygium malaccense (L.) MERR. & L.M. PERRY  Myrtaceae 1 AA iB ciguatera 
Macropiper latifolium (L.F.)                                       Piperaceae 1 TLL Rt ciguatera 
Saccharum robustum BRAND. & JESW. EX GRASSL F.  Poaceae 1 SWA St ciguatera 
Physalis angulata L.                                                    Solanaceae 1 SWA L dengue fever 
Vittaria lineata (L.) JE. SMITH                                      Vittariaceae 1 AA Fr ciguatera 
Alpinia sp.                                                                       Zingiberaceae 1 SWA Rh diabetes 
Zingiber zerumbet (L.) SM.     Zingiberaceae 1 TLL Rh "cancer" 
Zingiberaceae 1 Rh diabetes Hornstedtia sp.                                                               
 1 
APP 
Rh "cancer" 
plant family not known 1 L ciguatera not known 5                                                                    
# 1886-5.2 
 1 
AA 
L ciguatera11 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; #: voucher number; AA: Aneityum, Anelcauhat, APP: 
Aneityum, Port Patrick, BML: Banks Moto Lava, SWA: Southwest Ambrym, TLL: Torres, Loh, Lungharigi; Fl. flower, Fr: frond, iB: inner 
bark, L: leaf, Rh: rhizome, Rt: root, St: stem 
MODULATORS OF THE IMMUNE SYSTEM 
In this category tonics and panaceas are found. Information on the panaceas were given by 
only one healer from Ambrym who pretended to have cured himself several times from 
“cancer” and “AIDS” (see also “1.3 Diseases and their cures”) and who otherwise as well did 
not seem credible. Modulators of the immune system are mostly cold digestions prepared 
from the leaves (Tab. 3). 
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The most important plant used in Vanuatu as a modulator of the immune system is Morinda 
citrifolia L. (Rubiaceae), followed by the red variety of Strobilanthes reptans ENGL. 
(Acanthaceae), Scaevola taccada ROXB. (Goodeniaceae), Intsia bijuga (COLEBR.), and 
Pipturus argenteus WEDD. (Urticaceae). Ficus septica BURM. F. (Moraceae) and Macropiper 
latifolium (L.F.) (Piperaceae) are also briefly described, because of their importance in other 
disease entities. 
The liquid that leaks from ripe fruits of Morinda citrifolia L. (Rubiaceae) is taken as a panacea 
and a decoction of the leaves as a tonic (Tab. 14), same as in India.246 In Western countries 
an antioxidant remedy prepared from the fruits is already widely used due to its 
immunomodulatory activities and to aid digestion,278 the effects being proven in biological 
test systems.353-355 In Moto Lava, Banks Islands (Vanuatu), the leaves are rubbed between 
the hands and the smell is inhaled to protect from magic.72 In Aneityum the leaves are used 
to stimulate the growth of sugarcane.59 In Malekula the leaves are wrapped together with a 
string, the bundle is warmed over a fire and pressed onto an enlarged and sore spleen 
(maybe caused by malaria?) for 30 seconds to one minute.64 A red or yellow dye is prepared 
from the root bark, the fruits are edible but have an unpleasant cheese-like smell, and the 
wood is occasionally used for house construction.34 In Polynesia the juice squeezed from 
unripe and ripe fruits is mixed with coconut milk and taken as a remedy for ciguatera.322 In 
the Cook Islands the leaves are applied to wounds,208 the roots are used to treat external 
cancerous lesions,209 an infusion of the fruits mixed with these of Thespesia populnea (L.) 
SOL. (Malvaceae) - occasionally combined with the leaves of Cordia subcordata LAM. 
(Boraginaceae) or the roots of Piper methysticum FORST. F. (Piperaceae) - is taken in case of 
painful urination, a solution of the grated root is put on the top of the head in treating stings of 
a stonefish, in Tahiti it is applied directly to the sting226 and the leaves are put onto 
wounds.208 In Fiji an infusion of powdered root- or stem bark is used to treat urinary tract 
infections and the warmed leaves covered with oil are utilised as a poultice for sprains and 
broken bones.246 In Tonga an infusion of the leaves is taken internally to cure a variety of 
ailments caused by evil spirits. The leaves, heated over a fire, are applied to boils and in 
Samoa the flower is used for the same purpose.227 In India an infusion of the leaves is taken 
for fever or put onto wounds and ulcers, unripe fruits mixed with salt are applied to gingivitis, 
and the leaf juice is rubbed on painful joints caused by gout.246 In Hawaii a foetid insecticidal 
hair oil278 and a treatment of breast cancer308 are prepared from the fruits. Many studies on 
“noni” have already been performed;356, 357 anthrachinones, lignans, flavonoids, and iridoids 
have been isolated,358, 359 revealing e.g. anti-inflammatory and cancer-chemopreventive 
properties,360-365 cytotoxic,366-369, antibacterial,370 and wound-healing,371 anti-diabetes,372 
anxiolytic,373 and analgesic374 activities. See also “Diseases of the gastrointestinal system” p. 
75 for further uses of this plant. 
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A cold digestion of the leaves of the red variety of Strobilanthes reptans ENGL. 
(Acanthaceae) is taken as a tonic (Tab. 14). In Pentecost the roots or leaves are eaten to 
facilitate childbirth70 or the leaf juice is claimed to reverse sterility induced by Asplenium 
nidus L. (Aspleniaceae)71. This plant has not been studied yet, but other members of this 
genus have shown significant antiviral,375-377 antimicrobial,378 antioxidant,379 antifungal,380 
antiinflammatory, and further biological activities378, 381-383 due to triterpenoids, alkaloids, 
lignans, and other secondary plant metabolites.379, 384-386 See also “Diseases of the 
cardiovascular and haematopoietic system” p. 93 for detailed information on this plant. 
A decoction of the leaves or inner bark of Scaevola taccada ROXB. (Goodeniaceae) serves 
as a tonic (Tab. 14). The fruit - mixed with coconut milk - is used to treat ciguatera.322 In Moto 
Lava, Banks Islands, the leaves are applied to swellings of the axillary or inguinal lymph 
nodes72 and elsewhere in Vanuatu a remedy to induce sterility is prepared from the leaf 
buds.70 In Aneityum the leaves are added as fertiliser when taro is planted.61 In Samoa the 
bark is used for menstruation problems,228 in several Polynesian archipelagos the leaves are 
constituents of herbal remedies, in Tokelau the pith of the stem is stung into leis, and in the 
Cook Islands in dancing skirts.240 In Fiji, liquid from the leaves is used to treat weakness after 
childbirth which leads to pneumonia, the roots are used for stomach-ache, and a decoction of 
the bark and leaves as a tonic.164 In Tonga, the sap squeezed from the bark is used in 
treating ringworm and the roots for beriberi, syphilis, and dysentery.164 In the Solomon 
Islands, parts of the plant are utilised to treat cough, tuberculosis, and stings of the sting 
ray.201 Many compounds have already been isolated from S. taccada387, 388 and extracts have 
shown anti-inflammatory, antipyretic,389 antibacterial,390 and antiviral (HSV-1 and 2 and 
VSV)224 effects. S. balansae extracts revealed activities against Leishmania donovani and 
Trichomonas vaginalis,391 S. spinescens antiviral activity against human cytomegalovirus 
(HCMV).392 Cytotoxic triterpenoids have also been isolated393 and at last iridoids have been 
discovered in S. racemigera 394 and S. montana.395 See also “Diseases of the skin” p. 68 for 
further uses of this plant. 
The leaves or the inner bark of Intsia bijuga (COLEBR.) O. KTZE. (Leguminosae – 
Caesalpinioideae) are squeezed in saltwater and the solution is taken internally to defeat 
infections (Tab. 14). For more information on this plant see “Diseases of the respiratory 
system” p. 81. 
The sap of Pipturus argenteus WEDD. (Urticaceae) collected from a cut root during nighttimes 
is ingested as a panacea and the sap squeezed from the shoots and mixed with water is 
given to children as a tonic (Tab. 14). 
The dewdrops that have accumulated on a fruit of Ficus septica BURM. F. (Moraceae) during 
the night are collected as a tonic for children (Tab. 14). In “Diseases of the nervous system” 
p. 94 detailed information on this plant is found. 
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The juice of squeezed from a stalk of Macropiper latifolium (L.F.) (Piperaceae) mixed with 
water is drunk as a panacea (Tab. 14). More information on this plant is found in “Diseases 
of the skin” p. 68. 
Tab. 14 Plants used as modulators of the immune system 
scientific name family 1UR 2POC 3PPU use 
Strobilanthes reptans ENGL. red variety        Acanthaceae 2 TLL L tonic for children 
Stictocardia campanulata (HALLIER F.) 
MERR.            
Convolvulaceae 1 SWA L tonic for babies 
Goodeniaceae 1 L tonic Scaevola taccada ROXB.                               
 1 
AA 
iB tonic 
Calophyllum inophyllum L.                            Guttiferae 1 TLL Frt Tamanu oil (anti-inflammatory 
properties) 
Leguminosae – 
Caesalpinioideae 
1 L to defeat infections Intsia bijuga (COLEBR.) O. KTZE.                   
 1 
SWA 
iB to defeat infections 
Ficus septica BURM.F.                                   Moraceae 1 SWA dd/rw 
(Frt) 
tonic for children 
Macropiper latifolium (L.F.)                            Piperaceae 1 SWA St panacea 
Rubiaceae 1 L panacea 
 1 Frt panacea 
 1 L tonic 
Morinda citrifolia L.                                        
 1 
SWA 
Frt tonic 
Urticaceae 1 sap (Rt) panacea Pipturus argenteus WEDD.                            
 1 
SWA 
Sh tonic for children 
Hornstedtia lycostoma (LAUTERB. & K. 
SCH.) K. SCH.  
Zingiberaceae 1 TLL L tonic 
Hornstedtia sp.                                              Zingiberaceae 1 APP Rh tonic12 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, APP: Aneityum, Port Patrick, 
SWA: Southwest Ambrym, TLL: Torres, Loh, Lungharigi; dd/rw: dewdrops/ rainwater, Frt: fruit, iB: inner bark, L: leaf, Rh: rhizome, Rt: 
root, Sh: shoot, St: stem 
DISEASES OF THE CARDIOVASCULAR AND HAEMATOPOIETIC SYSTEM  
In this category mostly remedies for anaemia or with influence on the blood pressure are 
found. Hypertension is very frequent in Vanuatu, and it is estimated, that it is mostly 
originating from post-streptococcal glomerulonephritis, very often indicating threatening renal 
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failure.63 They are almost always cold digestions of the leaves that are taken internally (Tab. 
3). In this category exclusively red coloured plant parts or plant parts containing a red 
coloured sap were used, indicating plant selection based on the dictum similia similibus 
curantur. The most important plants in this category are Graptophyllum pictum (L.) GRIFF. 
(Acanthaceae), Macaranga dioica MUELL. ARG. (Euphorbiaceae), and Solenostemon 
scutellarioides L. (Lamiaceae), followed by the red variety of Strobilanthes reptans ENGL. 
(Acanthaceae). 
The leaf sap of Graptophyllum pictum (L.) GRIFF. (Acanthaceae) - mixed with water - is drunk 
to treat hypotension or anaemia (Tab. 15). Planted near the house it is said to protect the 
residents from black magic (Tab. 22). Extracts of the red leaves, also used in the Indonesian 
folk medicine, have shown anti-inflammatory activities due to flavonoids.396 
The leaf juice of Solenostemon scutellarioides L. mixed with water is drunk in case of 
anaemia, “leukaemia” (see “1.3 Diseases and their cures”), and sepsis (Tab. 15). See 
“Diseases of the skeleto-muscular system” p. 96 for a detailed description of this plant.  
A remedy for hypertension is prepared from young red leaves of Macaranga dioica MUELL. 
ARG. (Euphorbiaceae) (Tab. 15). See “Diseases of the skin” p. 68 for a detailed description of 
this plant. 
A cold digestion of the leaves of the red variety of Strobilanthes reptans ENGL. 
(Acanthaceae) is taken internally to treat anaemia (Tab. 15). For a detailed description of this 
plant see “Modulators of the immune system” p. 90. 
Tab. 15 Plants used to treat diseases of the cardiovascular and haematopoietic system 
scientific name family 1UR 2POC 3PPU use 
2 L hypotension Graptophyllum pictum (L.) GRIFF.                                       Acanthaceae 
1 
SWA 
sap 
(L) 
anaemia 
Strobilanthes reptans ENGL.                                                                    
red variety                                                                             
Acanthaceae 2 NA L anaemia 
Euphorbiaceae 2 SWA yL hypertension Macaranga dioica MUELL. ARG.                                        
 1 NA yL hypertension 
Lamiaceae 2 L anaemia Solenostemon scutellarioides L.                                
 1 
TLL 
L leukaemia and 
sepsis 
Pterocarpus indicus WILLD.                                          Leguminosae – 
Papilionoideae 
1 AA iB anaemia13 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, NA: North Ambrym, SWA: 
Southwest Ambrym, TLL: Torres, Loh, Lungharigi; iB: inner bark, L: leaf, yL: young leaf 
DISEASES OF THE NERVOUS SYSTEM 
Remedies to treat headache and other pain disorders are summarised in this category and 
the most important plants in this section are Ficus septica BURM. F. (Moraceae), Macaranga 
dioica MUELL. ARG. (Euphorbiaceae), and Grewia inmac GUILL. (Sparrmanniaceae).  
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The stalk of Ficus septica BURM. F. (Moraceae) can either be chewed or the healer chews the 
young leaves and spits them into the patients face to treat headache (Tab. 16). The leaves 
are prepared to a remedy for children’s diseases caused by spirits (Tab. 22). In Malekula the 
fruits are eaten to expulse the placenta,70 in Gaua to increase the fertility of the garden soil.61 
Alkaloids with cytotoxic activity against the human nasopharyngeal carcinoma cell line 
HONE-1 and the human stomach cancer cell line NUGC have been isolated from the 
stems.397 See “Diseases of the respiratory system” p. 81, “Modulators of the immune system” 
p. 90, and “Diseases of the eye” p. 98 for further information on this plant.  
The inner bark of Macaranga dioica MUELL. ARG. (Euphorbiaceae) is used in a special 
Kastom ceremony to relieve migraine headache (Tab. 16). A detailed description of this plant 
is found in the section “Diseases of the skin” p. 68. 
A decoction of the leaves of Grewia inmac GUILL. (Sparrmanniaceae) is taken internally to 
treat pain. The plant is called “aelan Panadol®” (island paracetamol) due to its use as a 
painkiller (Tab. 16). Nothing is known about G. inmac yet, but other members of the genus 
have already shown activity in biological assays: G. bilamellata demonstrated cytotoxic and 
antimalarial – due to triterpenoids and lignans,398 G. bicolor, G. erythraea, and G. 
occidentalis antibacterial,399-401 G. bicolor,400 G. elyseoi,402 403 and G. occidentalis 404 oxytocic, 
and G. asiatica radioprotective405 activities. Triterpenoids and alkaloids with oxytocic and 
antimicrobial properties have been isolated from G. bicolor400, 406 and G. tiliaefolia407 and 
flavonoids from G. damine408 The leaves of this plant have been collected for the screening 
regimen due to activities of other members of the genus Grewia in various test systems and 
phytochemical composition. 
Tab. 16 Plants used to treat diseases of the nervous system 
scientific name family 1UR 2POC 3PPU use 
Crinum xanthophyllum HANNIBAL, 1972             Amaryllidaceae 1 TLL St headache 
Codiaeum variegatum (L.) BL.                            Euphorbiaceae 1 AA L migraine headache 
Macaranga dioica MUELL. ARG.                        Euphorbiaceae 1 AA iB migraine headache 
Pterocarpus indicus WILLD.                               Leguminosae – Papilionoideae 1 SWA yL pain 
Artocarpus altilis (PARK.) FOSB.                        Moraceae 1 AA Sh migraine headache 
Ficus adenosperma MIQ.                                  Moraceae 1 AA St headache 
Moraceae 1 SWA yL headache Ficus septica BURM.F.                                       
 1 AA St headache 
Pandanus tectorius PARK.                                Pandanaceae 1 TLL L headache 
Grewia inmac GUILL.                                         Sparrmanniaceae 1 AA L pain "aelan panadol”"414 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used, 4 “aelan panadol” means island paracetamol; AA: 
Aneityum, Anelcauhat, SWA: Southwest Ambrym, TLL: Torres, Loh, Lungharigi; iB: inner bark, L: leaf, Sh: shoot, St: stem, yL: young 
leaf 
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DISEASES OF THE SKELETO-MUSCULAR SYSTEM 
Diseases of the skeleto-muscular system include fractures, muscle- and back pain (which is 
not caused by kidney diseases), as well as disorders in the rheumatic sphere. The most 
important plants in this group are Solenostemon scutellarioides L. (Lamiaceae) and 
Capsicum frutescens L. (Solanaceae). 
The leaves of Solenostemon scutellarioides L. (Lamiaceae) are utilised as a cataplasm for 
fractures (Tab. 17). S. scutellarioides is also planted as an ornamental (Tab. 22). In 
Pentecost (Vanuatu) the leaves - together with those of an undetermined species - are 
prepared to an abortifacient remedy, the sap is used as a contraceptive409 and the whole 
plant or leaves respectively are prepared to an emmenagogue.229, 410 In many parts of 
Vanuatu it is planted to protect trees from the plant pathogenic fungus Phellinus noxius and 
the plant pathogenic beetle Papuana huebneri.61 Diterpenoids isolated from the leaves have 
shown antibacterial and antifungal effects.160 For further information on this plant see 
“Diseases of the cardiovascular and haematopoietic system” p. 93. 
The fresh leaves of Capsicum frutescens L. (Solanaceae) are rubbed onto painful muscles 
and rheumatism (Tab. 17). In Samoa the leaves are also used to treat maternity 
complications and the fruits are chewed to cure internal illnesses.228 In New Caledonia a 
handful of the fruits are swallowed in case of ciguatera.56 In Fiji remedies against 
tuberculosis, mild conjunctivitis, and jaundice and in Samoa a medicine for cough are 
prepared from C. frutescens.201 This plant has also demonstrated several effects in biological 
tests: antibacterial,411, 412 antifungal due to saponins,413-415 or lectins,416 anti-diabetic,417-419 
analgesic,420-422 anti-inflammatory, and cytotoxic421-423 effects. Capsaicin - the main 
compound - is able to neutralise the haemorrhagic effect of Bothrox atrox venom, a snake 
poison.424 For further uses of this plant see “Diseases of the skin” p. 68. 
Tab. 17 Plants used to treat diseases of the skeleto-muscular system 
scientific name family 1UR 2POC 3PPU use 
Crinum xanthophyllum HANNIBAL, 1972                                  Amaryllidaceae 1 SWA St fractures 
Cocos nucifera L.                                                        Arecaceae 1 SWA iB back pain 
Solenostemon scutellarioides L.                                Lamiaceae 3 TLL L fractures 
Freycinetia tannaensis MARTINELLI                             Pandanaceae 1 AA L fractures 
Solanaceae 1 L muscle pain Capsicum frutescens L.                                             
 1 
AA 
L rheumatism 
Trema orientalis (L.) BL.                                                    Ulmaceae 1 NA iB fractures15 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, NA: North Ambrym, SWA: 
Southwest Ambrym, TLL: Torres, Loh, Lungharigi; iB: inner bark, L: leaf, St: stem 
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DISEASES OF THE TEETH 
Toothache is mostly treated with decoctions of the bark (Tab. 3) used as a mouthwash to 
relieve the pain. The most important plants in this section are Crinum asiaticum L. 
(Amaryllidaceae) and Macaranga tanarius (L.) MUELL. ARG (Euphorbiaceae). 
A decoction of the bulbs of Crinum asiaticum L. (Amaryllidaceae) is used as a mouthwash for 
toothache (Tab. 18). A detailed description of this plant is found under “Diseases of the 
gastrointestinal system” p. 75. 
A decoction of the inner bark of Macaranga tanarius (L.) MUELL. ARG (Euphorbiaceae) is 
utilised as a mouthwash for toothache (Tab. 18). For a detailed description of this plant see 
“Diseases of the skin” p. 68. 
Tab. 18 Plants used to treat diseases of the teeth 
scientific name family 1UR 2POC 3PPU use 
Crinum asiaticum L.                                                      Amaryllidaceae 1 AA Rt toothache 
Synedrella nodiflora (L.) GAERTN.                                    Asteraceae 1 AA L toothache 
Terminalia catappa L.                                                      Combretaceae 1 TLL L toothache 
Macaranga tanarius (L.) MUELL. ARG.                            Euphorbiaceae 1 AA iB toothache 
Barringtonia asiatica (L.) KURZ                                      Lecythidaceae 1 AA iB toothache 
Barringtonia edulis SEEM.                                           Lecythidaceae 1 SWA iB toothache 
Pyrrosia confluens (R.BR.) CHING                          Polypodiaceae 1 TLT Fr toothache 
Micromelon minutum (FORST.F.) WIGHT & ARN.    Rutaceae 1 TLT L toothache 
Alpinia novae-pommeraniae K. Schum.                  Zingiberaceae 1 SWA St   toothache16 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, SWA: Southwest Ambrym, 
TLL: Torres, Loh, Lungharigi, TLT: Torres, Loh, Telaklak; Fr: frond, iB: inner bark, Rt: root, L: leaf, St: stem 
DISEASES OF THE EAR 
Ear infections are mainly caused by Staph. aureus, Streptococcus sp. Pneumococcus sp., or 
Haemophilus influenzae and treated topically (Tab. 3). The most important plant in this 
section is Cucurbita pepo L. (Cucurbitaceae), but Crinum asiaticum L. (Amaryllidaceae) is 
also briefly described due to its importance in another category. 
The leaf juice of Cucurbita pepo L. (Cucurbitaceae) is applied to the ear or a stalk is warmed 
over a fire and the healer spits into the infected ear using the stalk like a straw (Tab. 19). In 
the Cook Islands the leaves are occasionally used in herbal medicine.208 In Germany the 
seeds are utilised as a treatment for irritable bladder and benign prostatic hyperplasia 425,426, 
427. The seed oil showed antioxidant activities in biological tests428, 429 and triterpenoids with 
cytotoxic activity against human cervix carcinoma HeLa cells have been isolated.430 
The latex of Crinum asiaticum L. (Amaryllidaceae) leaves is applied topically to aching ears 
(Tab. 19). See “Diseases of the gastrointestinal system” p. 75 for further uses of this plant.  
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Tab. 19 Plants used to treat diseases of the ear 
scientific name family 1UR 2POC 3PPU use 
Crinum asiaticum L.                                                      Amaryllidaceae 1 SWA Lat (L) ear ailments 
Crinum xanthophyllum HANNIBAL, 1972                              Amaryllidaceae 1 TLL L ear ailments 
Hippeastrum puniceum (LAM.) URBAN                                Amaryllidaceae 1 TLL L ear ailments 
Cucurbitaceae 1 L ear ailments Cucurbita pepo L.                                                           
 1 
BML 
St ear ailments 
Dioscorea bulbifera L.                                                     Dioscoreaceae 1 TLT St ear ailments 
Sansevieria trifasciata PRAIN                                     Dracaenaceae 1 AA L ear ailments17 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, BML: Banks Islands, Moto 
Lava:, SWA: Southwest Ambrym, TLL: Torres Islands, Loh, Lungharigi, TLT: Torres Loh, Telaklak; L: leaf; Lat: latex, St: stem 
DISEASES OF THE EYE 
Conjunctivitis, as presented in this study, is of bacterial origin, because it is described as an 
illness of the eye with a purulent discharge, typical for bacterial infections. It is treated 
topically. Plants used to treat conjunctivitis and briefly summarised here are Mikania 
micrantha KUNTH (Asteraceae), Ficus septica BURM. F. (Moraceae), Macropiper latifolium 
(L.F.) (Piperaceae), and Acalypha wilkesiana MUELL. ARG. (Euphorbiaceae). 
Mikania micrantha KUNTH (Asteraceae) leaf juice is applied to the eye in case of 
conjunctivitis (Tab. 20). A detailed description of this plant is found under the section 
“Diseases of the skin” p. 68. 
The dewdrops that have accumulated on a fruit of Ficus septica BURM. F. (Moraceae) during 
the night are applied to sore eyes (Tab. 20). In “Diseases of the nervous system” p. 94 a 
detailed description of this plant is found. 
The juice squeezed from a stalk of Macropiper latifolium (L.F.) (Piperaceae) is applied to 
conjunctivitis. A detailed description of this plant is found in “Diseases of the skin” p. 68. 
The juice pressed from the leaves of Acalypha wilkesiana MUELL. ARG. (Euphorbiaceae) is 
applied to sore eyes (Tab. 20). For more information on this plant see “Diseases of the 
gastrointestinal system” p. 75. 
Tab. 20 Plants used to treat diseases of the eye 
scientific name family 1UR 2POC 3PPU use 
Mikania micrantha KUNTH.                                          Asteraceae 1 SWA L conjunctivitis 
Acalypha wilkesiana MUELL. ARG.                              Euphorbiaceae 1 BML L conjunctivitis 
Hibiscus rosa-sinensis L.                                         Malvaceae 1 TLL Fl conjunctivitis 
Ficus aspera FORST.                                                     Moraceae 1 AA L conjunctivitis 
Ficus septica BURM.F.                                                  Moraceae 1 SWA dd/rw (Frt) conjunctivitis 
Macropiper latifolium (L.F.)                                       Piperaceae 1 SWA St conjunctivitis 
Sphaerostephanos invisus (FORST. F.) HOLTTUM Thelypteridaceae 1 BML Fr conjunctivitis18 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used; AA: Aneityum, Anelcauhat, BML: Banks Islands, Moto 
Lava:, SWA: Southwest Ambrym, TLL: Torres Islands, Loh, Lungharigi; dd/rw: dewdrop/rainwater, Fl: flower, Fr: frond, Frt: fruit, L: leaf, 
St: stem 
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DISEASES OF THE KIDNEY 
Diseases of the kidney comprise kidney pain (maybe caused by pyelitis or renal colic) and 
pispis waet, described as a severe and almost always deadly illness with foamy (white) urine, 
probably albuminuria, a symptom of post-streptococcal glomerulonephritis, a common 
sickness in Vanuatu (see also “Diseases of the cardiovascular and haematopoietic system” 
p. 93). Kidney problems are treated internally. In this section the information on Dysoxylum 
arborescens (BL.) MIQ. (Meliaceae), and Allophylus timoriensis DC. BL. (Sapindaceae) is 
summarised. 
A remedy prepared from the inner bark of Dysoxylum arborescens (BL.) MIQ. (Meliaceae) is 
taken for kidney pain (Tab. 21) and the wood is used for construction.34 Nothing is known 
about this species yet, but other members of this genus, also partly used in traditional 
medicine, have shown activities in biological tests. In Erromango (Vanuatu) D. 
gaudichaudianum leaf juice in water is taken to facilitate childbirth, in Efate a decoction of the 
leaves is drunk as an abortifacient,70 and an emmenagogue is prepared from the bark in the 
Philippines.310 A remedy prepared from the bark together with that of D. bijugum, and 
Pandanus sp. (Pandanaceae) and the twigs of Terminalia catappa (Combretaceae) is 
ingested to treat ciguatera,256 but oxytocic activity could not yet be proven in vitro.71 
Triterpenoids from D. gaudichaudianum have demonstrated antiviral activity against 
respiratory syncytial virus (RSV).431 In Espiritu Santo (Vanuatu) the bark of D. aneityense is 
burned in reach of the vagina to facilitate childbirth.70 In Samoa a tonic is prepared from the 
bark of D. maota.228 Alkaloids with contraceptive activity in rats432 or anti-inflammatory and 
immunomodulatory activities433 have been isolated from D. binectariferum and its crude 
extracts were significantly active against Leishmania donovani in vitro as well as in vivo 
(hamster), with lower effects of the pure alkaloids isolated from D. binectariferum in vivo 
(hamster).434 Di- and triterpenoids have been isolated from D. hainanense,435, 436 triterpenoids 
from D. beddomei437 and D. malabaricum,438 and diterpenoids and acetophenone from D. 
lenticellare.439 Alkaloids isolated from D. lenticellare have shown cardioactivity in vivo in 
rats.440 The triterpenoids from D. malabaricum and D. beddomei showed insecticidal 
activities against Anopheles stephensi, a malaria vector.441 Cytotoxic effects have also been 
demonstrated: diterpenoids isolated from D. kuskusense were active against HL-60 cells, the 
human chronic myelogenous leukaemia (CML) cell line K-562, the human non-small cell lung 
carcinoma cell line NCI-H522,442 and P-388 cells, the human colorectal adenocarcinoma cell 
line HT-29 and the human epithelial cell lung carcinoma cell line A549,443 triterpenoids from 
D. variabile against the human HeLa contaminant KB cells,444 di- and sesquiterpenoids from 
D. cauliflorum against the human non-small bronchiopulmonary carcinoma cell line 
NSCLC-N6445 and crude extracts of D. cumingianum against the human renal cancer cell line 
UO-31, the human stomach cancer cell line NCI-H522,446 and several leukaemia- and 
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melanoma cell lines.447 The leaves of this plant have been collected for the screening 
regimen because of promising activities as cytotoxic agents proven for other members of the 
genus. 
The leaves of Allophylus timoriensis DC. BL. (Sapindaceae) are prepared to a medicine to 
relieve kidney pain (Tab. 21). In Banks Islands, Moto Lava a tonic for children is prepared 
from the leaves72 and elsewhere in Vanuatu the leaves are applied to swellings and 
inflammations66. No studies on this species have been performed yet, but other members of 
the genus have already shown activities in biological assays: A. serratus has shown 
anti-ulcerogenic activity in an in vivo rat ulcer model,448 extracts of A. cobbe, in New Ireland 
used to stun fish,278 demonstrated antifeedant activity against the larvae of the Mexican bean 
beetle, Epilachna varivestis MULS. (Coccinellidae),449 and A. comina extracts anti-diabetic 
activities, maybe due to phenolic compounds, tannins, saponins, triterpenoids, and steroids 
isolated from this plant.450 In addition flavones and sesquiterpenoids have been discovered in 
the fruits of A. laevigatus451 and cyanolipids in the seeds of A. natalensis and A. 
dregeanus.452 The leaves of this plant have been collected for the screening regimen due to 
its use in Vanuatu’s ethnopharmacopoeia. 
Tab. 21 Plants used to treat diseases of the kidney 
scientific name family 1UR 2POC 3PPU use 
Dysoxylum arborescens (BL.) MIQ.                      Meliaceae 1 TLL iB kidney pain 
Ficus adenosperma MIQ.                                     Moraceae 1 SWA sap (Rt) albuminuria 
Allophylus timoriensis DC. BL.                              Sapindaceae 1 TLL L kidney pain19 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used, SWA: Southwest Ambrym, TLL: Torres Islands, Loh, 
Lungharigi; iB: inner bark, L: leaf, Rt: root 
OTHER ETHNOBOTANICAL USES OF PLANTS IN VANUATU 
In the following table non-medicinal uses of the plants are summarised, including uses in 
cosmetics, as food and stimulants, in house and garden, and for Kastom (mostly magical) 
purposes. 
Tab. 22 Other ethnobotanical uses of plants in Vanuatu 
scientific name family 1UR 2POC 3PPU use sociocultural 
relevance 
Cananga odorata 
(LAM.) HOOK.F. & 
THOMSON  
Annonaceae 1 TLL Fl scents coconut 
oil 
body care 
Calophyllum 
inophyllum L.                 
Guttiferae 1 TLL Fl scents coconut 
oil 
body care 
Dracontomelon 
vitiense ENGL.                
Anacardiaceae 1 NA Frt edible food & stimulants 
Annona muricata L.       Annonaceae 1 TLL Frt edible food & stimulants 
Polyscias cumingiana 
(C.PRESL) FERN.-VILL.    
Araliaceae 1 SWA L edible food & stimulants 
Polyscias scutellaria 
(BURM.F.) FOSB.             
Araliaceae 1 SWA L edible food & stimulants 
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scientific name family 1UR 2POC 3PPU use sociocultural 
relevance 
Cocos nucifera L.          Arecaceae 6 TLL/TLT/SWA/NA/AA/APP Sd edible food & stimulants 
  6  Frt edible food & stimulants 
Canarium vulgare 
LEENH.                           
Burseraceae 6 TLL/TLT/SWA/NA/AA/APP Sd edible food & stimulants 
Carica papaya L.           Caricaceae 1 BML Frt edible food & stimulants 
Terminalia catappa L.   Combretaceae 1 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Sd edible food & stimulants 
Cucurbita pepo L.          Cucurbitaceae 1 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt edible food & stimulants 
Dioscorea bulbifera L.   Dioscoreaceae 1 NA L edible food & stimulants 
  6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Rh edible food & stimulants 
Barringtonia edulis 
SEEM.                            
Lecythidaceae 1 SWA Frt edible food & stimulants 
Entada pursaetha DC.  Leguminosae - 
Mimosoideae 
1 AA Frt edible food & stimulants 
Inocarpus fagifer 
PARK.                             
Leguminosae – 
Papilionoideae 
6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Sd edible food & stimulants 
Vigna luteola (JACQ.) 
BENTH.                           
Leguminosae – 
Papilionoideae 
1 SWA Sd edible food & stimulants 
Artocarpus altilis 
(PARK.) FOSB.                 
Moraceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt edible food & stimulants 
  6  Sd edible food & stimulants 
Psidium guajava L.        Myrtaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt edible food & stimulants 
Syzygium malaccense  
(L.) MERR. & L.M. 
PERRY  
Myrtaceae 4 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt edible food & stimulants 
Pandanus tectorius 
PARK.                             
Pandanaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt edible food & stimulants 
  6  L weaving food & stimulants 
Piper methysticum J. 
R. & G. FORST.               
Piperaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Rt folk drug food & stimulants 
Pometia pinnata J.R. 
FORST. & G. FORST.        
Sapindaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt edible food & stimulants 
Pipturus argenteus 
WEDD.                            
Urticaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt edible food & stimulants 
Polyscias cumingiana 
(C.PRESL) FERN.-VILL.   
Araliaceae 1 SWA wP hedge plant house & garden 
Polyscias scutellaria 
(BURM.F.) FOSB.             
Araliaceae 1 SWA wP hedge plant house & garden 
  1 SWA L to stimulate 
fruiting of a 
banana plant 
house & garden 
Cocos nucifera L.          Arecaceae 6 TLL/TLT/SWA/NA/AA/APP W carving house & garden 
Merremia peltata (L.) 
MERR.                            
Convolvulaceae 1 TLL St fish poison house & garden 
Calophyllum 
inophyllum L.                 
Guttiferae 1 TLL Sd toxic for chicken house & garden 
Gyrocarpus 
americanus JACQ.          
Hernandiaceae/ 
Gyrocarpaceae 
6 TLL/TLT/SWA/NA/AA/APP W carving house & garden 
Solenostemon 
scutellarioides L.           
Lamiaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
wP ornamental 
plant 
house & garden 
Barringtonia asiatica 
(L.) KURZ                        
Lecythidaceae 1 TLL/AA Sd fish poison house & garden 
  1 AA Frt fish poison house & garden 
Intsia bijuga 
(COLEBR.) O. KTZE.        
Leguminosae – 
Caesalpinioideae 
6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W carving house & garden 
Derris trifoliata LOUR.    Leguminosae – 
Papilionoideae 
9 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
St rope for 
firewood 
house & garden 
Pterocarpus indicus 
WILLD.                            
Leguminosae – 
Papilionoideae 
6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W carving house & garden 
Hibiscus rosa-sinensis 
L.                                   
Malvaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
wP ornamental 
plant 
house & garden 
Hibiscus tiliaceus L.      Malvaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W carving house & garden 
Ficus wassa ROXB.        Moraceae 1 TLT St to stimulate 
fruiting of a 
watermelon 
plant 
house & garden 
Vitex trifolia L. ssp. 
trifolia                            
Verbenaceae 6 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W outrigger 
canoes 
house & garden 
Graptophyllum pictum 
(L.) GRIFF.                      
Acanthaceae 1 SWA wP protection 
against black 
magic 
Kastom 
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scientific name family 1UR 2POC 3PPU use sociocultural 
relevance 
Cordyline fruticosa 
(L.) A. CHEV.                  
Agavaceae 1 TLL L Kastom plant 
(dye for hair 
when gaining 
rank) 
Kastom 
  3 TLL/SWA/AA wP several Kastom 
purposes 
Kastom 
Polyscias scutellaria 
(BURM.F.) FOSB.             
Araliaceae 1 SWA L poisoned food Kastom 
Garuga floribunda 
DECNE.                          
Burseraceae 1 TLL L ciguatera Kastom 
Ipomoea indica 
(BURM.F.) MERR.            
Convolvulaceae 1 SWA Lat/St poisoned food Kastom 
Luffa cylindrica 
(LOUR.) ROEM.               
Cucurbitaceae 1 SWA iB lovesickness Kastom 
Dracaena fragrans 
(L.) KER - GAWL.             
Dracaenaceae 1 SWA yL poisonous plant 
used to commit 
suicide 
Kastom 
Codiaeum variegatum 
(L.) BL.                           
Euphorbiaceae 1 AA/ APP/ NA/ SWA/ TLL/ 
TLT 
wP Kastom plant Kastom 
Calophyllum 
inophyllum L.                 
Guttiferae 1 TLL Frt game "sut 'em" Kastom 
Gyrocarpus 
americanus JACQ.         
Hernandiaceae/ 
Gyrocarpaceae 
1 TLL iB used to tame 
pigs 
Kastom 
Hibiscus rosa-sinensis 
L.                                   
Malvaceae 1 TLL Fl children, that 
don't speak 
Kastom 
Donax cannaeformis 
(G. FORST.) K. SCHUM.   
Marantaceae 1 NA dd/rw/L children, that 
don't speak 
Kastom 
Ficus septica BURM.F.    Moraceae 1 SWA L children's' 
diseases 
caused by 
spirits 
Kastom 
Maesa ambrymensis 
GUILL.                             
Myrsinaceae 1 NA L infant crying 
caused by 
magic 
Kastom 
Macropiper latifolium 
(L.F.)                              
Piperaceae 1 SWA Frt black magic Kastom 
 Piperaceae 1 NA L Kastom plant Kastom 
Pometia pinnata J.R. 
FORST. & G. FORST.       
Sapindaceae 1 SWA yL pain caused by 
magic 
Kastom 
  1 TLL L jealousy (of 
women) 
Kastom 
Vitex trifolia L. ssp. 
trifolia                            
Verbenaceae 1 SWA L infant crying Kastom 
Hornstedtia sp.              Zingiberaceae 1 APP L grass skirts Kastom20 
                                                
 
1UR: number of use reports, 2 POC: place of collection; 3 PPU: plant part used, AA: Aneityum, Anelcauhat, APP: Aneityum, Port Patrick, 
BML: Banks Islands, Moto Lava, NA: North Ambrym, SWA: Southwest Ambrym, TLL: Torres Islands, Loh, Lungharigi; TLT: Torres 
Islands, Loh, Telaklak; dd/rw: dewdrop/rainwater, Fl: flower, Frt: fruit, iB: inner bark, L: leaf, Lat: latex, Rh: rhizome, Sd: seed, St: stem, 
W: wood, wP: whole plant, yL: young leaf 
1.5 SELECTION OF PLANTS FOR THE SCREENING REGIMEN 
There are four basic approaches to select a plant for a pharmacological study: the 
ethnomedicinal, the phytochemical, the taxonomic, the random approach, or a combination 
of several criteria 453. In the ethnomedicinal tactic credibility is given to the traditional use, in 
the phytochemical particular compound types are regarded to be interesting in a given 
biological context and plants likely to contain this sort of compounds are collected, and finally 
in the taxonomic approach plants of a given genus or family are selected. In the random 
approach all available species are collected irrespective prior knowledge and experience.454 
A retrospective analysis of the NCI program showed that the percentage of active leads 
based on ethnomedicine was above that based on taxonomy and random.455 
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In this study a combination of the mentioned criteria was used to select plants for the 
intended screening regimen:  
(1) Ethnomedicinal method: In the interviews it has been chosen to target plant species 
which have been claimed by the healers to be pharmacologically active in a clearly defined 
therapeutical context (in this study we focused on remedies with immunomodulatory 
properties). This improved the chance to obtain good interview results, because as in many 
parts of the world healers are often reluctant to give information on their secrets as a whole. 
Furthermore the permission to collect information for this study was limited by the Vanuatu 
Cultural Centre to well known and widely used plant species and preparations, because 
traditional knowledge in this place is a very touchy issue and subject to restrictions due to the 
cultural Kastom system. Knowledge is usually inherited from generation to generation, given 
from mother to daughter and father to son and most likely staying in one family. Sometimes, 
if a consexual heir is not at hand, namely that there simply is no male descendant in a family 
or there is one, who does not intend to follow in his father’s footsteps, these rules can be 
changed and knowledge can be passed on inter-sexually from father to daughter or mother 
to son or even to third parties. When visiting Espiritu Santo I was told a story about a unique 
case in which wisdom of a male healer from Northern Ambrym was given to a female 
American scientist. She had to undergo several procedures, including the ingestion of a 
highly hallucinatic secret drug while staying alone in the jungle for several days This was 
called kakae (eat) tambu-faea (taboo fire; restricted for the use of men of a very high status), 
regrettably yielding in only very little information about secret plants and special healing 
procedures hardly worth mentioning. 
(2) Phytochemical and taxonomic methods: Plants bearing interesting compounds such as 
alkaloids, sesquiterpene lactones, or lignans were chosen by former literature study of 
genera and families. Detailed information on each plant is found in “Results Ethnobotany” 
and in Tab. 23 all plants collected for the screening regimen are listed with the reason(s) for 
their selection.  
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Tab. 23 Plants collected for the screening regimen and reasons for their selection 
scientific name PPU/C1 reason for collection  
ANACARDIACEAE  
Dracontomelon vitiense ENGL.  iB 
The antibacterial activity shown for D. dao and antimalarial 
activities shown for other members of the family265 (taxonomic 
affiliation).  
APOCYNACEAE  
Tabernaemontana pandacaqui LAM. I L 
Tabernaemontana pandacaqui LAM. II L 
Use against “skin cancer” and wounds, biological activities have 
already been demonstrated for other members of the genus and 
membership to the Apocynaceae, a family rich in alkaloids 
(ethnobotanical use, taxonomic affiliation, and phytochemical 
composition). 
Collected twice (I + II) because one plant has been misidentified 
in the filed as a second species due to a lack of flowers and 
because no latex was present in the second species. 
ASTERACEAE  
Bidens pilosa L. wP 
Ethnobotanical use (against cough) and misidentification in the 
field as another not yet investigated Asteraceae (ethnobotanical 
use). 
EUPHORBIACEAE  
Acalypha grandis BENTH. L 
Ethnobotanical use (against sore throat, gonorrhoea) and 
biological activities already demonstrated for other members of 
the genus (ethnobotanical use and taxonomic affiliation).  
Macaranga dioica MUELL. ARG. iB 
 L 
Ethnomedicinal use (wounds), phytochemical composition, and 
the mentioned biological activities already proven for other 
members of the genus (ethnobotanical use, taxonomic affiliation, 
and phytochemical composition). 
Macaranga tanarius (L.) MUELL. ARG. L Ethnomedicinal use (several dermatological complaints), 
phytochemical composition, and the mentioned biological 
activities already proven for other members of the genus 
(ethnobotanical use, taxonomic affiliation, and phytochemical 
composition). 
GYROCARPACEAE/ HERNANDIACEAE  
Gyrocarpus americanus JACQ. L 
Wound-healing properties described in Vanuatu’s and other 
ethnopharmacopoeia(s) and alkaloid- and flavonoid content 
expected for a member of the Hernandiaceae family 
(ethnobotanical use, taxonomic affiliation, and phytochemical 
composition). 
LEGUMINOSAE – CAESALPINIOIDEAE  
Intsia bijuga (COLEBR.) O. KTZE. L 
Cytotoxic activities shown for other members of the family 
(taxonomic affiliation).  
MELIACEAE  
Dysoxylum arborescens (BL.) MIQ.  L 
Promising activities as cytotoxic agents proven for other members 
of the genus and expected alkaloid content (taxonomic affiliation 
and phytochemical composition). 
MYRTACEAE  
Syzygium malaccense (L.) MERR. & L.M. 
PERRY 
L 
Use in Vanuatu’s ethnopharmacopoeia (mouth infections) and 
proven biological activities of other members of the genus 
(ethnobotanical use and taxonomic affiliation). 
PHYLLANTHACEAE  
Baccaurea stylaris MUELL. ARG. iB 
 L 
Ethnobotanical use (against cold), biological activities 
demonstrated for the tribe Antidesmateae (ethnobotanical use 
and taxonomic affiliation).  
PIPERACEAE  
Macropiper latifolium (L.F.) St 
Ethnobotanical use as an antibacterial agent against 
conjunctivitis, and close relationship to Piper methysticum J.R. & 
G. FORST., a popular stimulant211 whose roots have shown 
several biological activities (ethnobotanical use and taxonomic 
affiliation). 
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scientific name PPU/C1 reason for collection  
RUBIACEAE  
Aidia racemosa (CAV.) D.D. TIRVENG. L 
Antimicrobial activities shown for other Aidia species and 
because of its affiliation to the alkaloid-bearing family Rubiaceae 
(taxonomic affiliation and phytochemical composition). 
RUTACEAE  
Euodia latifolia DC. L 
Ethnomedicinal use (against cough), activities of other Euodia sp. 
in various biological tests, and phytochemical composition of the 
genus (ethnobotanical use, taxonomic affiliation, and 
phytochemical composition).  
SAPINDACEAE 
Allophylus timoriensis DC. BL. 
 
L 
 
Ethnobotanical use against kidney pain. 
SPARRMANNIACEAE  
Grewia inmac GUILL. L 
Use as “aelan panadol®” in Vanuatu’s ethnopharmacopoeia, 
activities of other members of the genus Grewia in various test 
systems and phytochemical composition expected for a member 
of this genus (ethnobotanical use, taxonomic affiliation, and 
phytochemical composition). 
URTICACEAE  
Pipturus argenteus WEDD. iB 
Ethnobotanical use against boils and biological activities of P. 
albidus (ethnobotanical use and taxonomic affiliation). 
ZINGIBERACEAE  
Zingiber zerumbet (L.) SM. Rh 
This plant was misidentified in the field as an Alpinia sp. and was 
therefore collected due to a broad spectrum of biological activities 
demonstrated for other Alpinia sp. and the phytochemical 
composition expected for a member of this genus (taxonomic 
affiliation and phytochemical composition). 21 
                                                
 
1PPU/C: plant part used and collected; iB: inner bark, L: leaves, Rh: rhizome, St: stem; wP: whole plant 
2. BIOLOGICAL TESTS 
2.1 CYTOTOXICITY ASSAY 
SELECTION OF INOCULATION DENSITIES 
Prior to inclusion of cell lines in the screening panel their growth and compatibility with the 
screening model had to be determined, including the comparison of the linearity of the 
MTT-generated optical density signal with the cell number in the assay. Cell growth was 
characterized over three days and from these data the specific inoculation density selected 
for each cell line was that which produced an optical density signal above the noise level of 
the assay and within the linear range of the MTT-signal and which was closest to cell 
densities used in the NCI60 in vitro screen (see EXPERIMENTAL PART) (data not shown).  
DETERMINATION OF THE SUITABLE DRUG-INCUBATION TIME 
The cytotoxic activities of the plant extracts were both tested after incubation periods of 48 h 
(data not shown) and 72 h. An incubation time of 72 h was finally chosen due to less 
variation of the optical density either within or between the experiments and the resulting 
better reproducibility of the data.  
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INTERACTION OF EXTRACTS AND MTT IN CELL-FREE SYSTEM 
The secondary plant metabolites present in the extracts tested in this study did not show any 
interaction with the MTT assay in a cell-free system (data not shown). 
POSITIVE CONTROL FOR THE CYTOTOXICITY ASSAY 
A positive control had to be established for the screening to confirm, that the basic conditions 
of the experiment were able to produce a positive result, even if none of the samples actually 
did. For each cell line the IC50 of podophyllotoxin or parthenolide, respectively has been 
determined as described in the EXPERIMENTAL PART - section. Parthenolide was used in 
two cases, because no reasonable value could be achieved with podophyllotoxin. A 
corresponding dose response analysis with DMSO was also included to make sure, that the 
DMSO-dose used to solubilise the positive control had no influence.  
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Fig. 16 Dose response curve for 786-0-cells 
incubated with (?) podophyllotoxin in DMSO 
for 72 h and corresponding curve for (▲) 
DMSO. Data shown as means ± SD (n=3)  
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Fig. 17 Dose response curve for A549-cells 
incubated with (?) podophyllotoxin in DMSO 
for 72 h and corresponding curve for (▲) 
DMSO. Data shown as means ± SD (n=3) 
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Fig. 18 Dose response curve for HT 29-cells 
incubated with (?) podophyllotoxin in DMSO 
for 72 h and corresponding curve for (▲) 
DMSO. Data shown as means ± SD (n=3) 
-6 -5 -4 -3 -2 -1 0 1 2 3
0
20
40
60
80
100
120
log10 c[µg/mL]
vi
ab
ili
ty
 [%
]
 
Fig. 19 Dose response curve for MCF7-cells 
incubated with (?) podophyllotoxin in DMSO 
for 72 h and corresponding curve for (▲) 
DMSO. Data shown as means ± SD (n=3)
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Fig. 20 Dose response curve for OVCAR-
3:NIH-cells incubated with (?) podophyllotoxin 
in DMSO for 72 h and corresponding curve for 
(▲) DMSO. Data shown as means ± SD (n=3) 
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Fig. 21 Dose response curve for PC-3-cells 
incubated with (?) podophyllotoxin in DMSO 
for 72 h and corresponding curve for (▲) 
DMSO. Data shown as means ± SD (n=3)
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Fig. 22 Dose response curve for SK-MEL-28-
cells incubated with (?) parthenolide in DMSO 
for 72 h and corresponding curve for (▲) 
DMSO. Data shown as means ± SD (n=3) 
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Fig. 23 Dose response curve for SNB-19-cells 
incubated with (?) parthenolide in DMSO for 
72 h and corresponding curve for (▲) DMSO. 
Data shown as means ± SD (n=3) 
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RESULTS OF THE SCREENING FOR CYTOTOXICITY 
In the following the results of the viability assays are presented. 
Altogether about 7% of the extracts showed good, 30% moderate, and 62% no cytotoxic 
activity at all, whereas 85% of the methanolic extracts and 58% of ethyl acetate extracts, but 
only 45% of the dichloromethane extracts were inactive. 
Renal cancer cell line 786-0  
19% of the dichloromethane (DCM)-, 11% of the ethyl acetate (EtOAc)-, and 13% of the 
methanolic (MeOH)-extracts showed growth inhibition of more than 50% at a concentration 
of 50 µg/mL (data not shown), at 25 µg/mL only 10% of the DCM-, one EtOAc-extract, and 
none of the MeOH-extracts remained active (Fig. 24).  
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Fig. 24 Results of the cytotoxicity Assay for 786-0. Incubation with 25 µg/mL plant extract for 72 h. 
Data as means ± SD (n=4); passage 5 - 15; **p<0.01 in comparison with DMSO-control (Dunnett's 
multiple comparison test). Ctrl.: positive control podophyllotoxin [0.005 ± 0.0005 µM]. 
The leaf extracts of Tabernaemontana pandacaqui LAM. II, Macaranga dioica MUELL. ARG., 
Gyrocarpus americanus JACQ., Aidia racemosa (CAV.) DD. TIRVENG., and Baccaurea stylaris 
MUELL. ARG. and the rhizome extract of Zingiber zerumbet (L.) SM. showed good cytotoxic 
effects with IC50-values ranging between 0.2 and 6.8 µg/mL (Fig. 25, Tab. 24), whereas 
selective activity against this cell line could be shown for T. pandacaqui, G. americanus, and 
A. racemosa. 
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Fig. 25 Dose response curves for 786-0-cells, incubated with extracts for 72 h. Data shown as means 
± SD (n=4). (?) A. racemosa CAV. DD. TIRVENG.. DCM-extract (leaves), (▲) G. americanus JACQ. 
DCM-extract (leaves), (▼) M. dioica MUELL. ARG. DCM-extract (leaves), (?) T. pandacaqui LAM. II 
DCM-extract (leaves), (?) Z. zerumbet (L.) SM DCM-extract (rhizome), (▲) Z. zerumbet (L.) SM 
EtOAc-extract (rhizome), (▼) B. stylaris MUELL. ARG. DCM-extract (leaves)  
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Lung cancer cell line A549  
While 22% of the DCM-, 10% of the EtOAc-, and 3% of the MeOH-extracts still displayed a 
decrease of viability greater than 50% at 50 µg/mL (data not shown), only 8% of the DCM-
extracts and two of the EtOAc- or none of the MeOH-extracts, respectively showed the same 
effects at a lower concentration (Fig. 26). 
Fig. 26 Results of the cytotoxicity Assay for A549. Incubation with 25 µg/mL plant extract for 72 h. 
Data as means ± SD (n=4); passage 5 - 15; **p<0.01 in comparison with DMSO-control (Dunnett's 
multiple comparison test). Ctrl.: positive control podophyllotoxin [0.038 ± 0.005 µM].  
The leaf extracts of Tabernaemontana pandacaqui LAM. I, Macaranga dioica MUELL. ARG., 
Baccaurea stylaris MUELL. ARG., and Euodia latifolia DC, the extract of the inner bark of 
Macaranga dioica MUELL. ARG., and the rhizome extract of Zingiber zerumbet (L.) SM. 
ranged between 1.4 and 14.2 µg/mL ( 
Fig. 27, Tab. 24), while T. pandacaqui and E. latifolia also demonstrated selective activity 
against this cell line. 
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Fig. 27 Dose response curves for A549-cells, incubated with extracts for 72 h. Data shown as means ± 
SD (n=4). (?) E. latifolia DC. DCM-extract (leaves), (▲) M. dioica MUELL. ARG. DCM-extract (inner 
bark), (▼) M. dioica MUELL. ARG. DCM-extract (leaves), (?) M. dioica MUELL. ARG. EtOAc-extract 
(leaves), (?) Z. zerumbet (L.) SM. DCM-extract (rhizome), (▲) B. stylaris MUELL. ARG. DCM-extract 
(leaves), (▼) T. pandacaqui LAM. I DCM-extract (leaves) 
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Colon cancer cell line HT-29  
24% of the DCM-, 16% of the EtOAc-, and 8% of the MeOH-extracts showed good cytotoxic 
effects at a drug concentration of 50 µg/mL (data not shown), whereas only 8% of the DCM-
extracts, and one EtOAc-extract remained active at a lower concentration (Fig. 28). 
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Fig. 28 Results of the cytotoxicity Assay for HT-29. Incubation with 25 µg/mL plant extract for 72 h. 
Data as means ± SD (n=4); passage 5 - 15; **p<0.01 and* p<0.1 in comparison with DMSO-control 
(Dunnett's multiple comparison test). Ctrl.: positive control podophyllotoxin [0.624 ± 0.017 µM]. 
The leaf extracts of Macaranga dioica MUELL. ARG., Dysoxylum arborescens (BL.) MIQ., 
Allophylus timoriensis DC. BL., and Grewia inmac GUILL., and the rhizome extract of Zingiber 
zerumbet (L.) SM. possessed an IC50 between 3.3 and 15 µg/mL, see Fig. 29 and Tab. 24, 
with D. arborescens, A. timoriensis, and G. inmac showing activities only on this cell line. 
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Fig. 29 Dose response curves for HT 29-cells, incubated with extracts for 72 h. Data shown as means 
± SD (n=4). (?) A. timoriensis DC. BL. DCM-extract (leaves), (▲) Z. zerumbet (L.) SM. DCM-extract 
(rhizome), (▼) G. inmac GUILL. DCM-extract (leaves), (?) M. dioica MUELL. ARG DCM-extract (leaves), 
(▲) M. dioica MUELL. ARG. EtOAc-extract (leaves), (▼) D. arborescens (BL.) MIQ. EtOAc-extract 
(leaves) 
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Breast cancer cell line MCF7  
While 13% of the DCM-, 21% of the EtOAc-extracts, and one MeOH-extract still showed a 
good decrease of viability at 50 µg/mL (data not shown), only 3% of the DCM-, 6% of the 
EtOAc-, and none of the MeOH-extracts remained active at a lower concentration (Fig. 30). 
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Fig. 30 Results of the cytotoxicity Assay for MCF7. Incubation with 25 µg/mL plant extract for 72 h. 
Data as means ± SD (n=4); passage 5 - 15; **p<0.01 and *p<0.1 in comparison with DMSO-control 
(Dunnett's multiple comparison test). Ctrl. positive control podophyllotoxin [0.961 ± 0.041 µM]. 
The leaf extract of Allophylus timoriensis DC. BL., the extract of the inner bark of Pipturus 
argenteus WEDD., and the rhizome extract of Zingiber zerumbet (L.) SM. showed good 
cytotoxic effects with an IC50 ranging between 1.4 and 13.7 µg/mL (Fig. 31 and Tab. 24), 
whereas the extracts of Acalypha grandis BENTH., Allophylus timoriensis DC. BL., and the 
extract of the inner bark of Pipturus argenteus WEDD. also displayed selective activity against 
this cell line. The effect of Z. zerumbet has previously been described for this cell line.335 
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Fig. 31 Dose response curves for MCF7-cells, incubated with extracts for 72 h. Data shown as means 
± SD (n=4). (?) A. grandis BENTH. DCM-extract, (▲) A. grandis BENTH. EtOAc-extract, (▼) A. 
timoriensis DC. BL. EtOAc-extract, (?) P. argenteus WEDD. EtOAc-extract, (▲) Z. zerumbet (L.) SM. 
DCM-extract, (?) Z. zerumbet (L.) SM EtOAc-extract 
RESULTS  
 112
Ovarian cancer cell line OVCAR-3:NIH  
14% of the DCM-, 11% of the EtOAc-, and only one MeOH-extract(s) displayed cytotoxic 
effects at 50 µg/mL (data not shown), but only 3% of the DCM- and none of the other 
extracts kept this effect at a lower drug concentration (Fig. 32). 
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Fig. 32 Results of the cytotoxicity Assay for OVCAR-3:NIH. Incubation with 25 µg/mL plant extract for 
72 h. Data shown as means ± SD (n=4); passage 5 - 15; **p<0.01 in comparison with DMSO-control 
(Dunnett's multiple comparison test). Ctrl.: positive control podophyllotoxin [0.778 ± 0.021 µM]. 
Only three extracts showed strong cytotoxic impact with an IC50 between 5.0 and 
14.1 µg/mL, namely the extracts of inner bark and leaves, respectively of Macaranga dioica 
MUELL. ARG., and the rhizome extract of Zingiber zerumbet (L.) SM., whereas no selective 
activities could be observed (Fig. 33 and Tab. 24). 
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Fig. 33 Dose response curves for OVCAR-3:NIH-cells, incubated with extracts for 72 h. Data shown as 
means ± SD (n=4). () M. dioica MUELL. ARG. DCM-extract (inner bark), (▲) M. dioica MUELL. 
ARG. DCM-extract (leaves), (▼) Z. zerumbet (L.) SM. DCM-extract (rhizome) 
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Prostate cancer cell line PC-3  
While 24% of the DCM-, 13% of the EtOAc- and 6% of the MeOH-extracts still strongly 
lowered the viability of this cell line PC-3 (data not shown), this effect could only be shown for 
2% of the DCM- and 5% of the EtOAc-extracts at 25 µg/mL (Fig. 34).  
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Fig. 34 Results of the cytotoxicity Assay for PC-3. Incubation with 25 µg/mL plant extract for 72 h. 
Data as means ± SD (n=4); passage 5 - 15; **p<0.01 in comparison with DMSO-control (Dunnett's 
multiple comparison test). Ctrl.: positive control podophyllotoxin [0.455 ± 0.024 µM]. 
The leaf extracts of Macaranga dioica MUELL. ARG. and Baccaurea stylaris MUELL. ARG., the 
extract of the inner bark of Baccaurea stylaris MUELL. ARG., and the rhizome extract of 
Zingiber zerumbet (L.) SM. demonstrated good cytotoxic effects with an IC50 ranging between 
0.4 and 12.6 µg/mL, with the leaf extracts and the extract of the inner bark of Baccaurea 
stylaris MUELL. ARG. demonstrating effects only on this cell-line (Fig. 35 and Tab. 24). 
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Fig. 35 Dose response curves for PC-3-cells, incubated with extracts for 72 h. Data shown as means ± 
SD (n=4). (?) M. dioica MUELL. ARG. DCM-extract (leaves), (▲) M. dioica MUELL. ARG. EtOAc-extract 
(leaves), (▼) Z. zerumbet (L.) SM. DCM-extract (rhizome), (?) B. stylaris MUELL. ARG. EtOAc-extract 
(inner bark), (▲) B. stylaris MUELL. ARG. EtOAc-extract (leaves) 
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Melanoma cell line SK-Mel-28  
10% of the DCM-, 14% of the EtOAc-, and 5% of the MeOH-extracts were shown to strongly 
inhibit cell growth at a drug concentration of 50 µg/mL (data not shown), whereas this effect 
only remained for one DCM-, EtOAc- or MeOH-extract, respectively at a lower drug 
concentration of 25 µg/mL (Fig. 36). 
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Fig. 36 Results of the cytotoxicity Assay for SK-Mel-28. Incubation with 25 µg/mL plant extract for 
72 h. Data as means ± SD (n=4); passage 5 - 15; **p<0.01 in comparison with DMSO-control 
(Dunnett's multiple comparison test). Ctrl.: positive control parthenolide [0.427 ± 0.035 µM]. 
The leaf extracts of Tabernaemontana pandacaqui LAM. II and Macaranga dioica MUELL. 
ARG. displayed IC50-values between 0.1 and 14.5 µg/mL and the only active MeOH-extract in 
the whole study, namely that of Tabernaemontana pandacaqui LAM. II was selective for this 
cell line (Fig. 37 and Tab. 24). 
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Fig. 37 Dose response curves for SK Mel 28-cells, incubated with extracts for 72 h. Data shown as 
means ± SD (n=4). (?) M. dioica MUELL. ARG. DCM-extract (leaves), (▲) M. dioica MUELL. ARG. 
EtOAc-extract (leaves), (▼) T. pandacaqui LAM. II MeOH-extract (leaves) 
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Glioblastoma cell line SNB-19  
Whereas still 17% of the DCM-, 13% of the EtOAc-, and 3% of the MeOH-extracts were able 
to reduce the cell viability more than 50% at 50 µg/mL, none of the extracts kept the same 
effect at a lower concentration of 25 µg/mL (Fig. 38). 
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Fig. 38 Results of the cytotoxicity Assay for SNB-19. Incubation with 25 µg/mL plant extract for 72 h. 
Data as means ± SD (n=4); passage 5 - 15; **p<0.01 in comparison with DMSO-control (Dunnett's 
multiple comparison test). Ctrl.: positive control parthenolide [0.780 ± 0.063 µM]. 
In Fig. 39 the results of the viability assay are summarised. The colour coding indicates the 
IC50-range, whereas extracts with an IC50 >50 µg/mL, which are considered as inactive in this 
study are marked light grey, extracts with an IC50 between 25 and 50 µg/mL, considered as 
moderately active, in medium grey, and extracts with an IC50 < 25 µg/mL, considered as 
active, in dark grey. The exact IC50 values were determined for the active extracts and are 
displayed in Tab. 24.  
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Fig. 39 Activity pattern for the plant extracts 
tested on eight cell-lines. 
 
 
Tab. 24 In vitro cytotoxicity of the active plant 
extracts (IC50 in µg/mL; means ± SD; n=4) 
786-0 IC50±SD 
Aidia racemosa (CAV.) DD. TIRVENG. 
DCM 
3.540 ± 0.522 
Baccaurea stylaris MUELL.ARG. 
DCM (leaves) 
3.993 ± 0.379 
Gyrocarpus americanus JACQ. 
DCM 
4.544 ± 0.462 
Macaranga dioica MUELL. ARG. 
DCM (leaves) 
0.226 ± 0.024 
Tabernaemontana pandacaqui LAM. II 
DCM 
4.616 ± 0.656 
Zingiber zerumbet (L.) SM. 
DCM 
3.635 ± 0.371 
EtOAc 6.792 ± 0.874 
A549  
Baccaurea stylaris MUELL.ARG. 
DCM (leaves) 
6.630 ± 0.931 
Macaranga dioica MUELL. ARG. 
DCM (inner bark) 
13.54 ± 1.036 
Macaranga dioica MUELL. ARG. 
DCM (leaves) 
1.443 ± 0.160 
Macaranga dioica MUELL. ARG. 
EtOAc (leaves) 
12.92 ± 1.290 
Tabernaemontana pandacaqui LAM. I 
EtOAc 
13.46 ± 0.983 
Euodia latifolia DC. 
DCM 
14.21 ± 0.890 
Zingiber zerumbet (L.) SM. 
DCM 
2.805 ± 0.389 
HT-29  
Allophylus timoriensis DC. BL. 
DCM 
10.93 ± 1.168 
Dysoxylum arborescens (BL.) MIQ. 
EtOAc (leaves) 
14.99 ± 2.308 
Grewia inmac GUILL.  
DCM 
4.570 ± 0.408 
Macaranga dioica MUELL. ARG. 
DCM (leaves) 
3.173 ± 0.455 
Macaranga dioica MUELL. ARG. 
EtOAc (leaves) 
14.99 ± 2.308 
Zingiber zerumbet (L.) SM. 
DCM 
3.332 ± 0.312 
MCF7  
Acalypha grandis BENTH. 
DCM 
13.72 ± 1.383 
Acalypha grandis BENTH. 
EtOAc 
9.960 ± 1.146 
Allophylus timoriensis DC. BL. 
EtOAc 
4.863 ± 0.563 
Pipturus argenteus WEDD.  
EtOAc 
1.630 ± 0.221 
Zingiber zerumbet (L.) SM. 
DCM 
4.128 ± 0.565 
EtOAc 1.373 ± 0.176 
OVCAR-3:NIH  
Macaranga dioica MUELL. ARG. 
DCM (inner bark) 
14.06 ± 1.547 
Macaranga dioica MUELL. ARG. 
DCM (leaves) 
10.14 ± 1.412 
Zingiber zerumbet (L.) SM. 
DCM 
5.003 ± 0.402 
PC-3  
Baccaurea stylaris MUELL.ARG. 
EtOAc (inner bark) 
5.043 ± 0.337 
Baccaurea stylaris MUELL.ARG. 
EtOAc (leaves) 
12.61 ± 1.789 
Macaranga dioica MUELL. ARG. 
DCM (leaves) 
0.435 ± 0.062 
Macaranga dioica MUELL. ARG. 
EtOAc (leaves) 
3.288 ± 0.0438
Zingiber zerumbet (L.) SM. 
DCM 
3.275 ± 0.445 
SK-Mel-28  
Macaranga dioica MUELL. ARG. 
DCM (leaves) 
0.088 ± 0.01 
Macaranga dioica MUELL. ARG. 
EtOAc (leaves) 
1.510 ± 0.082 
Tabernaemontana pandacaqui LAM. II 
MeOH 
14.52 ± 0.296 
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2.2 ANTIBACTERIAL AND ANTIFUNGAL ASSAYS 
None of the extracts has shown significant antibacterial activities, neither against the 
Gram-positive Staph. aureus nor the Gram-negative E. coli, only the DCM-extract of the 
inner bark of D. vitiense has displayed moderate activity against Staph. aureus in a 
pre-screening, which did not qualify it for a second screen. Furthermore none of the extracts 
was able to significantly inhibit the growth of Aspergillus fumigatus, Candida albicans, and 
Microsporum canis, only the methanolic extract of the inner bark of M. dioica has shown 
moderate activity against C. albicans, but did also not qualify for a second screen. The DCM 
extract of the inner bark and the EtOAc-extracts of both, the inner bark and the leaves of B. 
stylaris have shown moderate activities against Trichophyton rubrum but did not qualify for a 
re-screen either. 
Tab. 25 In vitro activities against selected bacteria and fungi (IC50 in µg/mL; n=1) 
                            IC50 [µg/mL]  
 
scientific name PPU SOE Sa Ca Tr 
ANACARDIACEAE      
Dracontomelon vitiense ENGL. iB DCM 5.78  -   -  
EUPHORBIACEAE      
Macaranga dioica MUELL.ARG. iB MeOH  -  8.24  -  
PHYLLANTHACEAE      
Baccaurea stylaris MUELL.ARG. iB DCM  -   -  9.39 
  EtOAc  -   -  5.51 
 L EtOAc  -   -  8.81 
Ampicillin   0.179   
Flucytosine    0.293  
Econazole     0.025 
Doxycyclin (E. coli): 0.671 µg/mL 
Terbinafine (A. fumigatus): 0.803 µg/mL 
Terbinafine (M. canis): 0.102 µg/mL22 
                                                
 
PPU: plant part used; iB: inner bark, L: leaf; SOE: solvent of extraction; DCM: dichloromethane, 
EtOAc: ethyl acetate, MeOH: methanol; Sa: Staph. aureus, Ca: Candida albicans, Tr: Trichophyton 
rubrum 
2.3 ANTIPROTOZOAL ASSAYS  
Eleven of 63 extracts tested have shown strong (IC50<5 µg/mL) or moderate (IC50 
5-15 µg/mL) activity against one or two of the protozoa tested. Five of 63 extracts have 
demonstrated moderate activity against Trypanosoma brucei brucei, 15 extracts have shown 
effects on Trypanosoma cruzi, with eight extracts exhibiting strong and three moderate 
activities, and finally eleven extracts displayed activity against Plasmodium falciparum, three 
of them strong and eight moderate. None of the extracts tested was effective against 
Leishmania infantum.  
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The extracts showing the best effects which may serve as candidates for further investigation 
are highlighted in grey. 
Tab. 26 In vitro activity against selected protozoal organisms (IC50 in µg/mL; means ± SD; n=3-4) 
 
scientific name 
 
PPU 
 
solvent of extraction 
Tbb 
IC50±SD [µg/mL] 
MRC-5SV2 
 IC50±SD [µg/mL] 
Macaranga dioica MUELL. ARG. L EtOAc 7.88 ± 0.17 6.96 ± 0.64 
Gyrocarpus americanus JACQ. L MeOH 6.46 ± 0.55  -  
Dysoxylum arborescens (BL.) MIQ. L DCM 8.23 ± 0.24 7.77 ± 0.74 
  EtOAc 8.30 ± 1.04  -  
Euodia latifolia DC. L DCM 8.28 ± 0.62 8.29 ± 0.43 
Tamoxifen    11.1 ± 0.14 
Suramin   0.06 ± 0.002  
 
 
 
PPU 
 
solvent of extraction 
Tc 
IC50±SD [µg/mL] 
MRC-5SV2 
 IC50±SD [µg/mL] 
Tabernaemontana pandacaqui LAM. I L DCM 7.30 ± 1.55 6.82 ± 0.25 
  EtOAc 7.27 ± 1.21  -  
Tabernaemontana pandacaqui LAM. II L DCM 1.53 ± 0.21 7.99 ± 0.67 
Macaranga dioica MUELL. ARG. L EtOAc 2.22 ± 0.38 6.96 ± 0.64 
Gyrocarpus americanus JACQ. L MeOH 6.69 ± 1.28  -  
Intsia bijuga (COLEBR.) O. KTZE. L EtOAc 2.45 ± 0.60 9.71 ± 2.29 
Dysoxylum arborescens (BL.) MIQ. L DCM 6.86 ± 1.35 7.77 ± 0.74 
  EtOAc 2.23 ± 0.05  -  
Baccaurea stylaris MUELL. ARG. iB DCM 3.15 ± 0.33  -  
  EtOAc 1.72 ± 0.50 9.20 ± 1.70 
Macropiper latifolium (L.F.) St EtOAc 6.61 ± 0.40  -  
  MeOH 4.87 ± 0.67  -  
Euodia latifolia DC. L DCM 6.55 ± 0.79 8.29 ± 0.43 
  EtOAc 7.64 ± 0.62 8.41 ± 0.80 
Zingiber zerumbet (L.) SM. Rh DCM 2.52 ± 0.87 8.03 ± 0.15 
Benznidazol   1.96 ± 0.14  
 
 
 
PPU 
 
solvent of extraction 
Pf 
IC50±SD [µg/mL] 
MRC-5SV2 
 IC50±SD [µg/mL] 
Dracontomelon vitiense ENGL. iB DCM 8.18 ± 1.03 6.82 ± 0.25 
Acalypha grandis BENTH. L MeOH 11.80 ± 2.04  -  
Macaranga dioica MUELL. ARG. L EtOAc 11.48 ± 1.20 6.96 ± 0.64 
Gyrocarpus americanus JACQ. L MeOH 1.59 ± 0.38  -  
Dysoxylum arborescens (BL.) MIQ. L DCM 8.85 ± 0.25 7.77 ± 0.74 
  EtOAc 2.58 ± 0.78  -  
Baccaurea stylaris MUELL. ARG. iB DCM 8.94 ± 0.76  -  
  EtOAc 4.30 ± 0.43 9.20 ± 1.70 
Euodia latifolia DC. L DCM 8.30 ± 1.43 8.29 ± 0.43 
  EtOAc 14.94 ± 2.72 8.41 ± 0.80 
Zingiber zerumbet (L.) SM. Rh DCM 6.85 ± 0.93 8.03 ± 0.1523 
Chloroquine   0.04 ± 0.002  
                                                
 
231PPU: plant part used; iB: inner bark, L: leaves, St: stem, Rh: rhizome; DCM: dichloromethane, 
EtOAc: ethyl acetate, MeOH: methanol; Tbb: Trypanosoma brucei brucei, Tc: Trypanosoma cruzi, Pf: 
Plasmodium falciparum 
All five extracts being moderately effective against Trypanosoma brucei brucei have only 
shown very low selectivity as they exhibited moderate or good activities against 
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Trypanosoma cruzi and Plasmodium falciparum as well. The best value was gained by the 
MeOH-extract of Gyrocarpus americanus JACQ. with an IC50 of 6.46 ± 0.55 µg/mL and no 
cytotoxic activity. Three extracts have shown good and specific activities against 
Trypanosoma cruzi, the DCM-extract of Tabernaemontana pandacaqui LAM. II (most 
effective/ 1.53 ± 0.21 µg/mL), the EtOAc-extract of Intsia bijuga (COLEBR.) O. KTZE. 
(2.45 ± 0.6 µg/mL), and the MeOH-extract of Macropiper latifolium (L.F.) (4.87 ± 0.67 µg/mL). 
The high cytotoxicity of the extracts of T. pandacaqui and I. bijuga suggest that the observed 
activity is maybe due to their cytotoxicity. Only the last extract showed no cytotoxic activity 
and is therefore a good candidate for further studies. Three extracts have demonstrated 
moderate and specific activity against the same parasite, namely the DCM- and the EtOAc-
extract of Tabernaemontana pandacaqui LAM. I (7.3 ± 1.55 µg/mL or 7.27 ± 1.21 µg/mL, 
respectively), and the EtOAc-extract of Macropiper latifolium (L.F.) (6.61 ± 0.40 µg/mL). Both 
are good candidates for further investigation, as their activity is not caused by cytotoxicity 
against the MRC5-SV2 host cells. Five have shown good but aspecific effects against T. 
cruzi, namely the EtOAc-extracts of Dysoxylum arborescens (BL.) MIQ. (2.23 ± 0.05 µg/mL), 
Macaranga dioica MUELL. ARG. (leaves) (2.22 ± 0.38 µg/mL), the DCM- and EtOAc-extract of 
Baccaurea stylaris MUELL. ARG. (3.15 ± 0.33 µg/mL and 1.72 ± 0.50 µg/mL, respectively), 
and the DCM-extract of Z. zerumbet (L.) SM. (2.52 ± 0.87 µg/mL), with the EtOAc-extract of 
D. arborescens and the DCM-extract of B. stylaris being non cytotoxic. 
Three extracts namely the MeOH-extract of Gyrocarpus americanus JACQ. and the EtOAc-
extracts of Dysoxylum arborescens (BL.) MIQ. and Baccaurea stylaris MUELL. ARG. were able 
to significantly kill Plasmodium falciparum with IC50s of 1.59 ± 0.38 µg/mL, 2.58 ± 0.78 µg/mL, 
or 4.30 ± 0.43 µg/mL, respectively, with the extracts of G. americanus and D. arborescens 
showing no cytotoxic effects. The extract of G. americanus, which only showed moderate 
effects on the two Trypanosoma species, could be a promising candidate for further 
investigation. The MeOH-extract of Dracontomelon vitiense ENGL. (8.18 ± 1.03 µg/mL) and 
DCM-extract of Acalypha grandis BENTH. (11.80 ± 2.04 µg/mL) were only moderately active, 
but at least displayed specific activity against only one protozoal test organism and the 
extract of A. grandis, which in addition did not display any cytotoxic activity, could be a 
possible candidate for further investigation.  
2.4 INFLICTIONS OF THE CENTRAL NERVOUS SYSTEM – 
PRELIMINARY RESULTS 
TESTING FOR NEW ACHE- AND BCHE-INHIBITORS  
In this pre-test five extracts have shown more than 70% inhibition of the activity of 
acetylcholinesterase and six extracts have shown similar effects on the activity of 
butyrylcholinesterase and could therefore be candidates for further investigation in order to 
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discover new lead molecules for the development of new drugs. As this assay has been 
performed only once yet, the results first have to be confirmed before a final statement can 
be made, but they were included in the thesis to roughly outline some further possibilities of 
the plants tested.  
Tab. 27 Activity of the extracts as AChE- and BChE-inhibitors (n=1) (preliminary results) 
scientific name PPU solvent inhibition of AChE [%] inhibition of BChE [%] 
ANACARDIACEAE     
Dracontomelon vitiense ENGL.  iB MeOH 60.0 91.8 
ASTERACEAE     
Bidens pilosa L. wP MeOH 36.5 99.7 
EUPHORBIACEAE     
Macaranga dioica MUELL. ARG. iB MeOH 69.1 92.5 
 L MeOH 62.8 -45.4 
MELIACEAE     
Dysoxylum arborescens (BL.) MIQ.  L MeOH 68.1 37.8 
MYRTACEAE     
Syzygium malaccense (L.) MERR. & L.M. 
PERRY 
L MeOH 57.9 87.7 
PIPERACEAE     
Macropiper latifolium (L.F.) St MeOH 64.2 -39.5 
RUTACEAE     
Euodia latifolia DC. L MeOH 14.9 69.5 
URTICACEAE     
Pipturus argenteus WEDD. iB MeOH 82.9 80.524 
                                                
 
PPU: plant part used/ iB: inner bark, L: leaves, St: stem, wP: whole plant; MeOH: methanol; AChE: 
acetylcholinesterase, BChE: butyrylcholinesterase 
Although the preliminary data look promising, the results shown here should be viewed as 
work in progress data only, since there is no sufficient statistical basis to them yet. However, 
some alkaloids have been isolated as natural AChE- and BChE inhibitors. Their incidence 
and their contribution to the effects observed for some of the extracts tested could be 
assumed, as alkaloids were actually isolated from one species (Bidens pilosa456), or are most 
likely to be present in the plants tested due to their occurrence in other members of the same 
genus: e.g. Dracontomelon mangiferum457, Dysoxylum lenticellare440, Syzygium jambos458, 
Piper methysticum459, and Euodia rutaecarpa301, 304, which already provided the potent AChE 
inhibitor dehydroevodiamine. Although no alkaloids have been isolated from members of the 
genera Macaranga and Pipturus yet, when performing a TLC and spraying the plates with 
Dragendorff’s reagent, alkaloids could be detected in the methanolic extracts of both plants 
(not shown).  
PRELIMINARY RESULTS OF THE NMDA-ASSAY 
Five extracts have shown effects as possible NMDA-receptor antagonists in a pre-screening. 
As the SD values are still much too high in some cases, the results were only included to 
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carefully point out some additional options of these plants, but these values have to be 
verified before a final statement on their usefulness in the given context can be made.
Tab. 28 Activity of the extracts as NMDA-receptor antagonists (n=2) (prelimiinary results) 
scientific name PPU solvent excitotoxicity  
    at 50 µg/mL [%] 
excitotoxicity 
    at 10 µg/mL [%] 
ANACARDIACEAE     
Dracontomelon vitiense ENGL.  iB MeOH 32.2 ± 13.1* 70.1 ± 17.9* 
LEGUMINOSAE CAESALPINIOIDEAE     
Intsia bijuga (COLEBR.) O. KTZE. L MeOH 28.7 ± 4.9 77.8 ± 23.4* 
MYRTACEAE     
Syzygium malaccense (L.) MERR. & L.M. 
PERRY 
 
L 
 
MeOH 
 
49.6 ± 18.0* 
 
103.7 ± 7.4 
PHYLLANTHACEAE     
Baccaurea stylaris MUELL. ARG. iB DCM 43.2 ± 17.1* 99.0 ± 8.1 
URTICACEAE     
Pipturus argenteus WEDD. iB MeOH 27.8 ± 6.7* 83.9 ± 10.325 
                                                
 
*SD value >20% (has to be repeated); PPU: plant part used/ iB: inner bark, L: leaves/ DCM 
dichloromethane, MeOH: methanol 
Only a few natural or naturally derived products with properties as NMDA receptor 
antagonists are known to date, therefore the identification of the bioactive compounds in the 
extracts tested would maybe open up new vistas in the development of new drugs for 
inflictions of the CNS such as Morbus Alzheimer or Morbus Parkinson. 
3. ISOLATION PROCEDURE 
When the chemical composition of a plant is unknown, the isolation procedure can be based 
on how the plant is used in folk medicine, or several extraction procedures with solvents of 
increasing polarity can be performed. 453 In Vanuatu plants are generally used freshly and 
this state was not convenient for the collected material due to transport issues and so the 
latter was chosen. 
Usually a good way to isolate a biologically active compound from an extract is the so called 
bioactivity-guided fractionation, in which every fraction obtained during the extraction process 
is submitted to a chosen bioassay in order to follow the activity. This method was not applied 
to the present survey, because Baccaurea stylaris MUELL. ARG., the plant chosen for 
phytochemical purification was not investigated due to a promising activity in a bioassay, but 
due to the fact, that the genus is only poorly studied and though we were interested in novel 
compounds. As some interesting compounds have already been isolated from other 
members of the tribe Antidesmateae, e.g. alkaloids, a lupeolactone, and triterpenoids87 this 
plant was considered as a perfect match in this context. 
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4. STRUCTURE ELUCIDATION 
Compound D5G2 was the dominating secondary metabolite in the DCM-extract of B. stylaris 
and was obtained as yellow, glassy oil with aromatic smell, UV: λmax 240 nm. Its 13C-NMR 
spectrum exhibited 20 carbon signals, which were sorted by an 1H,13C-HSQC experiment 
into three CH3, six CH2, six CH and five quaternary carbons. The low resolution EI-MS 
showed a molecular ion at m/z 316 indicating together with the 13C data a molecular formula 
of C20H28O3.  
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Fig. 40 D5G2, hardwickiic acid 
The 13C NMR and 1H spectra exhibited the presence of a 3-substituted furan moiety with 
characteristic carbon signals at δc 111.0 (C-14, d), 125.6 (C-13, s), 138.4 (C-16, d) and 142.7 
(C-15, d) and the respective proton signals at δH (H-14), (H-16) and H-(H-15), see Tab. 29 
and Tab. 30. Other NMR signals were in agreement with the presence of a diterpene with 
neoclerodane skeleton bearing a carboxyl group (C-18, 172.8) at position C-4. Comparison 
of the spectroscopic data with literature values revealed that compound D5G2 is identical 
with hardwickiic acid first isolated from Hardwickia pinnata (Leguminosae - 
Caesalpinioideae)460, This was confirmed by extensive use of 2D NMR especially 1H,1H-
COSY, 1H,13C-HSQC, 1H,13C-HMBC, and 1H,1H-ROESY. Up to now (-)-hardwickiic acid was 
also isolated from or detected in several other plants like Salvia divinorum (Lamiaceae)461, 
Solidago rugosa (Asteraceae),462 and Echinodorus grandiflorus (Alismataceae).463 Besides 
the more common (-)-hardwickiic acid, also the (+)-hardwickiic acid has been isolated from 
natural sources like copaiba oil (Copaifera officinalis, Leguminosae – Caesalpinioideae),464 
the optical rotation has to be determined before exact identification can be performed. 
Interestingly some biological investigation on (-)-hardwickiic acid has been done and 
revealed potent antibacterial activity against Bacillus subtilis and Mycobacterium 
smegmatis465, which which was not observed against Staph. aureus and E. coli used in this 
study (2.2 Antibacterial and Antifungal Assays). 
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Tab. 29 1H-NMR spectral data of compound D5G2 and D6.1G2 (δ ppm, m, J in Hz) 
proton D5G2 D6.1G2 
H-1 2.43, m, 1H; 1.13, m, 1H 2.35, m, 1H; 1.85, m, 1H 
H-2 2.35, m, 1H; 2.20, m, 1H 1.96, m, 1H; 1.60, m, 1H 
H-3 6.85, t, J = 3.8, 1H 4.54, m, 1H 
H-6 1.68, m, 1H; 1.57, m, 1H 2.05, m, 1H; 1.47, m, 1H 
H-7 1.47, m, 2H 1.71, m, 1H; 1.38, m, 1H 
H-8 1.58, m, 1H 1.71, m, 1H 
H-10 1,40, m, 1H  2.40, m, 1H 
H-11 1.71, m, 1H; 1.50, m, 1H 5.35, m, 1H 
H-12 2.30, m, 1H; 2.22, m, 1H 2.25, m, 1H; 2.15, m, 1H 
H-14 6.25, d, J = 0.9, 1H 6.30 d, J = 0.9, 1H 
H-15 7.34, t, J = 1.6, 1H 7.38, t, J = 1.6, 1H 
H-16 7.20, br s, 1H  7.38, br s, 1H 
H-17 0.83, d, J = 6.5, 3H 0.80, d, J = 6.5, 3H  
H-19 1.26, s, 3H 5.13, s, 1H 
H-20 0.76, s, 3H 5.27, s, 1H 
The more polar compound D6.1G2, a white amorphic powder; m.p. ± SD: 152.4 ± 0.071°C; 
UV: λmax 235 nm, was also identified as a neoclerodane derivative with furan moiety by 
1H-and 13C-NMR analysis. The low resolution EI-MS showed a molecular ion peak at m/z 374 
indicating together with the 13C-NMR spectrum a molecular formula of C21O6H26. Interestingly 
in both spectra the proton and carbon signals of the methyl groups C-19 (δC 20.6, δH 1.26, s, 
3H) and C-20 (δC 20.6, δH 0.76, s, 3H) were lacking and substituted by two methine signals 
resonating at δC 100.7 (δH 5.27, s, 1H) δC 104.3 (δH 5.13, s, 1H). Further remarkable 
differences were the lacking of a double bond between C-3 and C-4, the presence of a 
methyl ester (OCH3 resonating at δH 3.70, s, 3H and δC 51.6) and a downfield shift of C-5 (δC 
44.0 instead of δC 37.8) and C-9 (δC 50.3 instead of δC 38.6), as well as the presence of an 
hydroxyl substitution in the side chain which shifted the signal of H-11/C-11 from δH to and 
from δC 17.5 to 74.9. Extensive 2D NMR analysis (1H,1H-COSY, 1H,13C-HSQC, 1H,13C-HMBC 
and 1H,1H-ROESY) revealed the presence of the structure given in Fig. 41. This is to the best 
of our knowledge a new natural compound, which we named baccauric acid methyl ester. 
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Fig. 41 D6.1G2, baccauric acid methyl ester 
Tab. 30 13C-NMR spectral data of compound D5G2 and D6.1G2 (δ ppm, m) 
carbon D5G2 D6.1G2 
C-1 35.8, t 20.2, t 
C-2 18.3, t 26.5, t 
C-3 140.2, d 75.7, d 
C-4 141.5, s 54.0, d 
C-5 37.8, s 44.3, s 
C-6 38.8, t 31.5, t 
C-7 27.3, t 30.4, t 
C-8 36.3, d 37.4, d 
C-9 38.6, s 50.3, s 
C-10 46.7, d 38.8, d 
C-11 17.5, t 74.9, d 
C-12 27.5, t  38.5, t 
C-13 125.6, s 127.1, s 
C-14 111.0, d 108.6, d 
C-15 142.7, d 143.4, d 
C-16 138.4, d 139.3, d 
C-17 16.0, q 16.9, q 
C-18 172.8, s 170.7, s 
C-19 20.6, q 104.3, d 
C-20 18.2, q 100.7, d 
OCH3 - 51.6, q 
For all other isolated compounds mentioned in the extraction scheme (Fig. 14) structure 
elucidation is in progress. 
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DISCUSSION, CONCLUSION AND PERSPECTIVES 
This thesis combines an ethnobotanical survey on a South Pacific island with molecular 
structure elucidation and modern pharmacological screening methods. During five months of 
fieldwork plants traditionally used in Vanuatu’s ethnopharmacopoeia were documented. 27 
healers were interviewed about plants, treatment methods, healing concepts, and diseases. 
The correct identification of the species in the field, essential for their selection for the 
screening regimen, was performed using a self-made field guide, because identification 
literature is barely available for this region. This situation was complicated by discrepancies 
between our Linnean and the folk taxonomy system, as the healers classified the plants 
exclusively by their leaves and were not able to give information on flowers, which some 
plants were lacking. The disease aetiology of Vanuatu’s ethnomedicine is also quite different 
from the Western one; so sometimes careful questioning was necessary to find suitable 
Western counterparts for some folk diseases. Nevertheless, 420 individual use reports on 
130 taxa were documented and subjected to a qualitative and quantitative analysis. The 
reports were divided into 17 categories of use and grouped according to their medicinal 
affiliation or sociocultural relevance, showing that dermatological and gastrointestinal 
complaints, followed by respiratory ailments and diseases related to the urogenital system 
were illnesses most commonly indicated, reflecting a prevalence of these illnesses in the 
study areas. 18 plants with indications towards immunomodulatory effects were selected on 
site and material of 21 plant parts was collected  
One of the plants collected, Baccaurea stylaris MUELL. ARG. (Phyllanthaceae) was also 
selected for a phytochemical investigation yielding seven pure compounds. Two of these 
compounds could be identified to date as diterpenoids with a neoclerodane skeleton. Among 
them, the already known hardwickiic acid first isolated from Hardwickia pinnata 
(Leguminosae - Caesalpinioideae) and a new compound, also a neoclerodane derivative 
with a furan moiety which we named baccauric acid methyl ester. The structural relative 
Salvinorin A from Salvia divinorum which is said to be the first naturally occurring 
non-nitrogenous opioid-receptor subtype-selective agonist.466 is the most potent naturally 
occurring hallucinogen known to date.467 It would now be highly interesting to investigate, if 
the pure compounds isolated from B. stylaris would be able to show similar effects on 
κ-opioid receptors.  
The screening regimen performed in this study comprised - besides a preliminary screening 
for drugs which may be effective against Alzheimer’s disease - antibacterial, antifungal, and 
antiprotozoal assays, and a cytotoxicity screening on a variety of human cancer cell lines. 
Although the preliminary data for the cholinesterase assays look promising, the results 
should be viewed as work in progress data only, since there is no sufficient statistical basis to 
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them yet. However, alkaloids already isolated as natural AChE- and BChE inhibitors may 
contribution to the effects observed for some of the extracts tested, as alkaloids either 
actually were isolated from one species (Bidens pilosa456), or are most likely to be present in 
the plants tested due to their occurrence in other members of the same genus or close 
relatives: e.g. Dracontomelon mangiferum457 in case of D. vitiense, Dysoxylum lenticellare440 
for D. arborescens, Syzygium jambos458 in case of S. malaccense, Piper methysticum459 for 
Macropiper latifolium, and Euodia rutaecarpa301, 304 (in case of E. latifolia), which already 
provided the potent AChE inhibitor dehydroevodiamine. Although no alkaloids have been 
isolated from members of the genera Macaranga and Pipturus yet, when performing a TLC 
and spraying the plates with Dragendorff’s reagent, alkaloids could be detected in the 
methanolic extracts of both Macaranga dioica and Pipturus argenteus.  
None of the extracts has shown significant antibacterial activities, neither against the 
Gram-positive Staph. aureus nor the Gram-negative E. coli, only Dracontomelon vitiense has 
displayed moderate activity against Staph. aureus in a pre-screening, which did not qualify it 
for a second screen. Unfortunately it was not possible to include other bacteria into the 
screening regimen, which would have been more promising, like Streptococcus pyogenes, a 
very common cause of skin infections, Haemophilus influenzae, Streptococcus pneumoniae, 
or Pneumococcus sp., possible agents for respiratory complaints, or Shigella sp., 
Campylobacter sp., Salmonella sp., Vibrio cholerae, or Yersinia sp. which may be causes of 
severe forms of diarrhoea. Antibacterial264 and antifungal263 activities, as demonstrated for 
Dracontomelon dao could not be observed in the same intensity for D. vitiense, but as 
already mentioned the bacteria most likely causing that form of diarrhoea against which D. 
vitiense is used in Vanuatu’s ethnopharmacopoeia could not be included into the screening 
regimen, so the efficacy of the folk use could neither be proven nor disproven. Antimicrobial 
and antifungal effects as demonstrated for P. albidus224, 225 could not be shown for Pipturus 
argenteus, but the sticky sap which is applied to wounds may contribute to the healing by 
formation of an occlusive layer like a band-aid.224, 225 
Furthermore none of the extracts was able to significantly inhibit the growth of Aspergillus 
fumigatus and Microsporum canis, only the inner bark of Macaranga dioica has shown 
moderate activity against Candida albicans, and both, inner bark and leaves of Baccaurea 
stylaris against Trichophyton rubrum, but did not qualify for a second screen. Fungal 
infections seem to be rather uncommon in Vanuatu and were never mentioned by a healer. 
Only one case of ringworm, which is predominantly caused by Trichophyton rubrum, was 
observed in Ambrym, but this disease was not believed to be treatable with traditional 
medicine, but only by Western medicine. 
All five extracts being moderately effective against Trypanosoma brucei brucei have only 
shown very low selectivity as they exhibited moderate or good activities against 
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Trypanosoma cruzi and Plasmodium falciparum as well. Gyrocarpus americanus was the 
most active plant in this context with an IC50 of 6.46 ± 0.55 µg/mL, perhaps due to alkaloids 
already isolated from this species and other members of the Hernandiaceae203-205. The use in 
Vanuatu’s ethnopharmacopoeia to tame pigs may also be a result of a high content of 
alkaloids in this species. 
Extracts of Tabernaemontana pandacaqui II, Intsia bijuga, and Macropiper latifolium 
displayed good and selective impact against Trypanosoma cruzi, but the high cytotoxicity of 
the first two extracts suggest that the observed activity is perhaps only a result of their strong 
cytotoxicity against the host cell line MRC5-SV2. Only the methanolic extract of Macropiper 
latifolium with an IC50 of 4.87 ± 0.67 µg/mL showed no cytotoxic effects and might warrant 
further investigations. The EtOAc-extracts of Tabernaemontana pandacaqui I (7.27 ± 
1.21 µg/mL), and Macropiper latifolium  (6.61 ± 0.40 µg/mL) demonstrated moderate but 
specific activity which is not caused by cytotoxic effects, so these extracts should also be 
investigated further. The two Tabernaemontana pandacaqui probes, initially collected as 
different species in Loh or Ambrym, respectively have displayed differing spectra of efficacy, 
most likely being due to variabilities in the composition of secondary plant metabolites often 
developed by species growing in a differing ecologic environment.  
Extracts of Baccaurea stylaris (as previously shown for other members of the tribe 
Antidesmatoideae),90, 91, 468 Dysoxylum arborescens, and Gyrocarpus americanus were 
strongly but aspecifically active against Plasmodium falciparum with IC50s of 
4.30 ± 0.43 µg/mL, 2.58 ± 0.78 µg/mL, or 1.59 ± 0.38 µg/mL, respectively, with the second 
and third extract displaying no cytotoxicity. Antimalarial activity has previously been observed 
for another member of the genus Dysoxylum, D. fraseranum and said to be due to the 
presence of limonoids often found in this family.469 The extract of G. americanus whose 
antimalarial activity may be due to alkaloids already isolated from this species and other 
members of the Hernandiaceae,203-205 which only showed moderate effects on the two 
Trypanosoma species, but very good antiplasmodial activity, should be investigated further to 
isolate the active compounds and test their impact in against P. falciparum. Extracts of 
Dracontomelon vitiense (8.18 ± 1.03 µg/mL) and Acalypha grandis (11.80 ± 2.04 µg/mL) 
were only moderately active, but at least displayed specific activity with the extract of A. 
grandis showing no cytotoxic potential. Antimalarial effects were previously described for 
other members of the Anacardiaceae, where D. vitiense belongs to,264 perhaps due to 
triterpenoids and flavonoids often found in Anacardiaceae469, 470 and also for another member 
of the genus Acalypha, A. guatemalensis,294 so this could be an interesting candidate for 
further investigation with the aim to isolate the active principle, too.  
At last, the extracts were subjected to a molecular targeted screening on various human 
cancer cell lines, a smaller version of the NCI60 screen.  
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15 extracts displayed significant cytotoxic activities specific for only one cell line. Extracts of 
Tabernaemontana pandacaqui II and Gyrocarpus americanus displayed cytotoxic effects 
selective for the renal cell line 786-0. Here again it was also seen, that the two T. pandacaqui 
probes exhibited different activities against the eight tumour cell lines tested. A brief literature 
research comparing the relevant oncogenic mutations of these cell lines revealed, that only 
here the von Hippel-Lindau (VHL) tumour suppressor gene which is involved in angiogenesis 
is silenced471. A shortage of oxygen causes the increase of the active form of HIF-1 (hypoxia-
inducible factor 1) which in turn stimulates the transcription of VEGF (vascular endothelial 
growth factor) and other genes that play a key part in angiogenesis. VHL among others is 
involved in the degradation of HIF-1. A loss-of-function of this gene leads to high levels of 
HIF 1, which in turn trigger the continual overproduction of VEGF, resulting in the 
development of in particularly hemangioblastomas, tumours containing dense masses of 
blood vessels472. Although the molecular mechanisms by which VHL loss leads to 
tumorigenesis are not yet fully understood, it may be a possible target of compounds present 
in the extracts in the future.  
T. pandacaqui I was shown to selectively decrease the viability of lung cancer cell line A549 
cells. In this cell line a gain-of-function of the K-Ras (v-Ki-ras2 Kirsten rat sarcoma viral 
oncogene homologue) gene, involved in receptor tyrosine-kinase signalling and a loss-of-
function mutation of STK11, a gene coding for a serine/threonine kinase were observed.471  
Extracts of Dysoxylum arborescens, Allophylus timoriensis, and Grewia inmac have 
demonstrated selective cytotoxic effects on colon cancer HT-29 cells, with G. inmac with an 
IC50 of 4.57± 0.408 µg/mL showing the best effect. Loss-of-function mutations of both the 
tumour suppressor gene SMAD4 MAD, mothrs against DPP homologue 4), playing a role in 
TGFβ (transforming growth factor β) signaling and APC (adenomatous polyposis coli), 
involved in the Wnt signaling pathway were found to be specific for this cell line471. The 
extract of Dysoxylum kuskusense442, 443 has also previously demonstrated the cytotoxicity 
against HT-29, with diterpenoids isolated as the active principle. It would be interesting to 
research, if the same or related compounds could be responsible for the effect observed 
here. Another member of the genus Grewia, G. bilamellata has shown cytotoxic effects 
against KB-cells398, with triterpenoids and lignans isolated as the active compounds, which 
could be expected in G. inmac, too, therefore a bio-activity guided fractionation of this extract 
would be highly interesting. 
Extracts of Acalypha grandis, Allophylus timoriensis, and Pipturus argenteus were shown to 
significantly and specifically decrease the viability of breast cancer MCF7 cells, P. argenteus 
showing the best effects with an IC50 of 1.63 ± 0.221 µg/mL. Acalypha. wilkesiana, is used in 
the Nigerian ethnopharmacopoeia for the empirical treatment of breast cancer236 and so a 
further investigation of A. grandis, perhaps in comparison with A. wilkesiana could be 
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interesting. Cytotoxicity against murine P388 lymphoma cells has been demonstrated for A. 
siamensis, with a tetraterpene isolated as the active principle, therefore tetraterpenoids could 
be suspected in A. grandis, too.295 By comparison of the eight cell lines tested no mutation 
specific for this cell line was found. The same was observed for the prostate cancer cell line 
PC-3, where the extracts of Baccaurea stylaris leaves and bark displayed good cytotoxic 
effects, with the extract of the inner bark being more effective with an IC50 of 
5.043 ± 0.337 µg/mL.  
Only the methanolic extract of Tabernaemontana pandacaqui showed cytotoxic effects 
against the melanoma cell line SK-Mel-28 with an IC50 of 14.52 ± 0.296 µg/mL. Interestingly 
the latex of this plant is indeed used to cure “skin cancer” in Vanuatu’s ethnopharmacopoeia, 
which in this case might argue for cancer in terms of cancer known in the Western medicine. 
Even more interesting, only in this cell line the EGFR (epidermal growth factor receptor) 
tyrosine kinase domain is affected by two in-frame deletions471, leading to an constant 
over-activation and thus rendering the receptor independent from normal EGF signalling 
necessary for growth control. Similar mutations have been found in different non-small cell 
lung cancer cell lines and some gliomas.473, 474. One could now assume, that SK-Mel-28 cells 
are dependent on this oncogenic signalling of the EGFR and that compounds in the plant 
extract were somehow able to inhibit this signalling process. A quick approach to test this 
hypothesis would be to make use of the commercially available EGFR inhibitor erlotinob 
(Roche) to verify the prediction of a strong sensitivity to such drugs. Also the molecular tools 
to further decipher the mode of action within the EGF signalling pathway (such as antibody 
against phosphorylated EGFR and downstream MAPKinases) are already at hand. 
These results nicely demonstrate the power of screening of well characterized cancer cell 
lines, as they provide the unique opportunity for the fast connection of effects from novel 
chemical compounds to the wealth of readily available molecular knowledge. 
We could show in this study that the approach of finding active leads on an ethnobotanical 
basis was successful, as many plants open up new opportunities for further investigations. Of 
particular interest would be the isolation of structures responsible for the strong antimalarial 
activity of Gyrocarpus americanus and the anti-trypanosomal of Macropiper latifolium and the 
investigation of molecular mechanisms forming the basis of the effects of D. arborescens and 
G. inmac on HT-29-, A. grandis on MCF7-, and T. pandacaqui II on SK-Mel-28-cells. 
Furthermore the pure compounds isolated from B. stylaris should be tested for their ability as 
κ-opioid receptor agonists. 
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KEY TO PLANT LIST AND PLANT LIST 
Abbreviations of the plant parts used, the preparations and application modes as follows: 
 
Abbreviations of the plant parts used 
dd/rw  dewdrops/ rainwater 
Fl  flower  
Fr  frond 
Frt  fruit 
iB  inner bark 
L  leaf 
Lat  latex 
LG  leaf gall 
oB  outer bark 
Rh  rhizome 
Rt  root 
sap  sap (watery) 
Sd  seed 
Sh  shoot 
St  stalk/ stem 
W  wood 
wP  whole plant 
yL  young leaves
 
Abbreviations of preparations
BL  boil 
BN  burn 
CH  chew 
CHL  chill 
CK  cook 
CLL  collect liquid 
F  fresh 
G  ground 
MwCM  mix with coconut milk 
Mw CW mix with coconut water 
MwS  mix with saltwater 
MwW  mix with water 
RbH  rub in hands 
SKC  special Kastom ceremony 
SQ  squeeze 
SQiCW squeeze in coconut water 
SQiS  squeeze in saltwater 
SQiW  squeeze in water 
T  toast 
WiL  wrap into leaf
 
Abbreviations of application modes 
AF  add food 
AO  add oil 
AS  apply steam 
B  bath 
C  cataplasm 
CH  chew 
CHS  chew and spit (healer) 
CHwCM chew with coconut milk 
HD  hair dye 
HW  head wash 
KHG  Kastom, house & garden 
L  local 
MW  mouth wash 
P  plant 
D  drink 
E  eat 
EW  eye wash 
R  rub (massage) 
SKC  special Kastom ceremony 
Sm  smell
KEY TO PLANT LIST AND PLANT LIST 
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Abbreviations of origins
AA Aneityum Anelghowhat 
APP Aneityum Port Patrick 
BML Banks Islands (Moto Lava) 
NA North Ambrym 
SWA Southwest Ambrym 
TLL Torres Islands (Loh, Lungharigi) 
TLT Torres Islands (Loh, Telaklak)
 
Abbreviations of languages 
B  Bislama 
E  English 
F  French 
IK  Indass Khermo (language of Aneityum) 
LBML  language Banks Moto Lava 
LNA  language North Ambrym 
N  Newaweteme (language in Lungharigi and Telaklak, Loh, Torres Islands) 
R  Rallglëin (language Southwest Ambrym) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  157
FAMILY                               
SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
ACANTHACEAE                 
L SQiW D hypotension 
wP  -  P protection against black 
magic 
Graptophyllum pictum (L.) GRIFF.           
[3076-10]              
G. pictum var. pictum, G. 
hortense, Justicia pictum 
limälar, limilar (R) caricature plant (E) SWA 
sap MwW D anaemia 
NA L SQiW D anaemia Strobilanthes reptans ENGL red variety       
[0386-2.2].                             
Hemigraphis reptans rämämap (LNA)  blakgras (B) 
TLL L SQiW D tonic for children 
AGAVACEAE                 
AA L F CH leprosy in the mouth 
TLL L SQiW HD Kastom plant (dye for hair 
when gaining rank) 
Cordyline fruticosa (L.) A. CHEV.            
[1786-10] 
C. terminalis, Taetsia 
fruticosa, Convallaria 
fruticosa 
nitschatimi (IK), 
neggurrie (N) 
cordyline, ti, ki, lily-palm, 
dracaena palm, good luck 
plant, tree-of-kings (E), nara 
(B) 
TLL/SWA/AA wP  -  P several Kastom purposes 
AMARANTHACEAE                 
AA L RbH, SQ D asthma Achyranthes aspera L.                    
[2286-1.2.1] 
 A. indica nabudschata (IK)  chaff-flower weed, 
achyranthes weed (E), 
nokorin (B) APP L SQ L boils 
Achyranthes aspera L. (red variety)          
[2286-1.2.2] 
A. indica nabudschata (IK)  chaff-flower weed, 
achyranthes weed (E), 
nokorin (B) 
AA L SQiW D increases fertility in 
woman 
AMARYLLIDACEAE                 
SWA/NA L SQiW D indigestion 
Lat MwW D to cause emesis SWA 
Lat F L ear ailments 
Crinum asiaticum L.                      
[2176-17] 
C. pedunculatum wael litainbop (R), 
naha (IK) 
grand crinum, white crinum, 
white crinum-lily, Asiatic lily, 
poison-bulb lily, beach lily (E), 
lili (B) 
AA Rt BL  MW toothache 
St G, SQiW HW headache TLL 
L T, SQ L ear ailments 
L T, SQ D asthma AA 
sap MwW D ciguatera 
St F C fractures 
Crinum xanthophyllum HANNIBAL, 1972        
[2966-7] 
C. pedunculatum var. 
xanthophyllum, C. 
asiaticum (misapplied) 
nemuelake (N), naha 
(IK), litainbop (R) 
golden-leaf crinum-lily, 
golden-leaf crinum (E), lili (B) 
SWA 
Lat F L warts 
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FAMILY                               
SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
Hippeastrum puniceum (LAM.) URBAN         
[2966-1] 
 -  nemwelaque (N) no popular name TLL L T, SQ L ear ailments 
ANACARDIACEAE 
iB WiL, T, SQiW D                  severe illness with bloody 
faeces 
Dracontomelon vitiense ENGL.              
[0186-12] 
 -  rämil (LNA) dragon plum (E), prunier 
dragon (F), nakatambol (B) 
NA 
Frt F E edible 
ANNONACEAE                 
TLL L BL, CHL B scabies 
SWA L BL, CHL B scabies 
Annona muricata L.                      
[1176-2]  
 -  no local name soursop, guanabana, (prickly) 
custard apple, bullock’s heart 
(E), cachiman, corossol (F), 
saosop, korosol, karasol (B) TLL Frt F E edible 
Fl F AO scents coconut oil Cananga odorata (LAM.) HOOK.F. & THOMSON   
[1176-4] 
Canangium odoratum  neviaou (N) ylang ylang, perfume tree (E), 
ylang ylang (F), nandingori, 
nidingro (B) 
TLL 
iB SQiW D postpartum abdominal 
pain (to expulse placenta) 
APOCYNACEAE                 
Alstonia vitiensis SEEM.                   
[1786-3] 
 -  nätiädäl (IK)  no popular name AA L SQiW D contraceptive 
Kopsia flavida BL.                       
[0176-4] 
 -  tewawetäl (N) no popular name TLL yL F CH cough 
TLL (I) Lat F L centipede bites 
SWA  (II) Lat F D tuberculosis 
L F L wounds 
L SQiW D "skin cancer" (severe 
wounds?) 
Tabernaemontana pandacaqui LAM.         
[2966-2] and [2576-10] 
T. obtusciuscula, T. 
excavatia, T. orientalis, 
Ervatamia obtusciuscula, 
Ervatamia orientalis, 
Ervatamia pandacaqui 
newawedäl (N), "wael 
litschi" ("R"), 
inmathethi (IK) 
no popular name 
AA 
St F CH influences sex of embryo 
during pregnancy  in 
favour of girl 
ARACEAE                 
TLL/ TLT St  SQ L stops bleeding 
SWA L SQiW D amenorrhoea 
Epipremnum pinnatum (L.) ENGL.           
[2866-7] 
E. aureum, E. mirabilis, 
Dracontium pertusum, 
Pothos pinnatum, Pothos 
aureum, Rhaphidophora 
pertusa, Rhaphidophora 
vitiensis, Scindapsus 
aureus   
nekamuro/nekaumro 
(N) 
philodendron, devil's ivy, taro 
vine, pothos, golden pothos 
(E), rop blong pik (B)  
TLL Sh F CH abortive 
ARALIACEAE                 
L F E edible 
wP  -  P hedge plant 
Polyscias cumingiana (C.PRESL) FERN.-VILL.    
[2176-13.1] 
P. filicifolia (MOORE EX 
FOURNIER) BAILEY 
räpi (R) (fern leaf) panax, angelica, 
chotto, fern leaf aralia (E), 
nalaslas, nanalas (B) 
SWA 
L CK E influences sex of embryo 
during pregnancy  in 
favour of girl 
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FAMILY                               
SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
Polyscias samoensis (A.GRAY) HARMS        
[1886-5.1] 
 -  näthoiatmas (IK) no popular name AA L G, MwCW D ciguatera 
L CK E edible 
wP  -  P hedge plant 
L BN AF poisoned food 
L F KHG to stimulate fruiting of a 
banana plant 
Polyscias scutellaria (BURM.F.) FOSB.         
[2176-13.2] 
P. pinnata J.R. & 
G.FORST., P. balfouriana 
(HORT. EX ANDRE) BAILEY, 
P. tricochleata (MIQ.) 
FOSB., Nothopanax 
tricochleatum MIQ. 
räpi (R) large-leaf panax (E), nalaslas 
(B) 
SWA 
L CK E influences sex of embryo 
during pregnancy  in 
favour of girl 
ARECACEAE                 
NA oB BN L wounds 
  F KHG carving 
Sd F E, D edible 
TLL/TLT/SWA/NA/AA/APP
Frt F E, D edible 
Cocos nucifera L.                       
[0386-2.1] 
 -  lihol, natora (LNA) coconut palm, coco palm, 
coco tree, coconut tree, 
cocoa nut (old English), 
cocoanut (old English), 
porcupine wood (E), cocotier 
(nucifère/ porte-noix), noix de 
coco (F), natora, kokonas, 
kavra, kavura, navara, 
samsam (B) 
SWA iB SQiW D back pain 
ASCLEPIADACEAE                 
Hoya vanuatensis                       
[2576-9] 
 -  rämümürtschul (R) no popular name SWA L SQiW D facilitates childbirth 
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FAMILY                               
SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
ASTERACEAE                 
Ageratum conyzoides L.                   
[1786-15] 
 -  noragidi (IK)  ageratum, goat weed (E) AA L SQ L wounds 
Bidens pilosa L.                         
[1686-1.2] 
 -  nilbuthou (IK) beggar's-tick, Spanish 
needles, cobbler's pegs (E) 
AA Sh SQiW D cough 
L SQ L conjunctivitis 
sap SQ L boils 
L SQiW D fever 
L SQiW D dengue fever 
SWA 
L SQiW D diarrhoea 
L G, SQiW L scabies TLL 
L G, SQiW L insect bites 
L F L wounds 
L RbH L wounds 
BML 
L WiL, T L wounds 
L BL AS cold AA 
L SQiW D cough 
Mikania micrantha KUNTH.                
[3076-3] 
 -  no local name mile a minute, mikania weed 
(E), maelminit, (grew) wandei, 
amerika, merikanrop, tudei, 
rop blong amerika (B) 
TLL/NA wP SQ L stops bleeding 
Synedrella nodiflora (L.) GAERTN.            
[1686-1.1] 
S. vialis, Calyptocarpus 
nodiflora, Verbesina 
nodiflora 
intäbasiät itounga 
(IK) 
nodeweed, synedrella, 
cinderella weed (E) 
AA L RbH L toothache 
L SQ L boils Vernonia cinera (L.) LESS.                 
[1886-1.1] 
V. cinerea var. parviflora, 
V. parviflora, Conyza 
cinerea 
 -  little ironweed (E) AA 
L SQ L wounds 
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SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
ATHYRIACEAE         
Diplazium latifolium MOORE                
[0386-1.9] 
 -  libarr (R) no popular name SWA Fr F C wounds 
BURSERACEAE                 
L G, MwCM, MwS D diarrhoea AA 
L G, MwCM D ciguatera 
TLL/TLT/SWA/NA/AA/APP Sd F E edible 
Canarium vulgare LEENH.                  
[1886-5.3] 
C. indicum, C. commune nangae, nang(a)i, nat 
tri (IK) 
pili/ kanari nut, Java/ native 
almond (E), nangae, nang(a)i, 
nat tri (B) 
APP L CH, MwCW D ciguatera 
Garuga floribunda DECNE.                 
[2966-6] 
G. abilo MERR., G. 
littoralis MERR., G. 
pacifica BURKILL 
neradou (N) namalaos/ namalaus (B) TLL L CK AF ciguatera 
CARICACEAE                 
SWA Fl BL D hepatitis 
Rt F CHwCM "HIV" 1st stage BML 
Frt F E edible 
Carica papaya L.                        
[3076-8] 
C. vulgaris hialwi (N), nässä (IK) pawpaw, papaya (E), 
papaye(r) (F), popo, papae 
(B) 
AA Fl F CH ciguatera 
COMBRETACEAE                 
TLL L BL MW toothache Terminalia catappa L.                      
[2966-3] 
 -  netelihe (N) sea/ tropical/ Indian/ country/ 
coastal/ Malabar almond, 
olive bark tree (E), badamier, 
myrobolan (F), natapoa, 
natavoa, natalie (B) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Sd F E edible 
CONVOLVULACEAE                 
TLL wP SQ D cough 
Lat MwW D laxative 
Lat MwW D poisoned food 
SWA 
Fl SQiW D facilitates childbirth 
Ipomoea indica (Burm.f.) MERR.             
[3066-3] 
I. indica var. indica, I. 
acuminata, I. congesta, I. 
insularis, I. learii, 
Pharbitis insularis, 
Convolvulus indica 
nagawul (N), hauwä 
(R), inmouwat (IK) 
common morning-glory, blue 
morning-glory, blue dawn-
flower (E) 
AA Lat F L stops bleeding 
L SQiW D cough Ipomoea littoralis (L.) BL.                  
[0876-1.2] 
I. denticulata, I. forsteri, 
Convolvulus littoralis 
nerauwul (N) coastal morning-glory (E) TLL 
L SQiW D bronchitis 
TLL L T C boils Ipomoea pes-caprae (L.) R. BR.            
[2866-4] 
 I. biloba, I. (pes-caprae) 
brasiliensis 
nerre (N), nahou (IK) beach morning glory (E), 
kabis blong solwota (B) 
AA St F SKC severe abdominal pain 
during pregnancy caused 
by spirits 
Merremia peltata (L.) MERR.                 
[3066-1] 
M. nymphaeifolia, 
Ipomoea peltata, 
Operculina peltata, 
Convolvulus peltata 
negedenuo (N) peltate morning glory (E) TLL St G KHG fish poison 
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SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
Operculina turphetum (L.) SILVA MANSO        
[0876-2.10] 
O. turpethum var. 
Ventricosa, O. ventricosa 
netekulkwäl (N) ventricose morning-glory (E) TLT Sh F CH abdominal pain 
L SQiW D pain of the spleen SWA 
L SQiW D tonic for babies 
St BN L "skin cancer" (severe 
wounds?) 
St BN L wounds 
Stictocardia campanulata (HALLIER F.) MERR.   
[2176-11] 
Ipomoea campanulata  haubahub (R), räbau 
(LNA) 
no popular name 
NA 
St BN, MwW D inflammation in the 
urogenital system 
CUCURBITACEAE                 
L RbH, SQ L ear ailments BML 
St T AS ear ailments 
Cucurbita pepo L.                       
[2766-8] 
 -  nevinrao (LBML) ( autumn/ summer) pumpkin, 
winter squash, bapken (E), 
citrouille (F), pamken (B) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt CK E edible 
L SQiW D "cancer" Luffa cylindrica (LOUR.) ROEM.              
[3076-5] 
L. aegyptiaca, L. 
insularum, Momordica 
cylindrica L., Momordica 
luffa 
haukonkon, 
lärumohonon (R) 
 smooth (loofah),  dishcloth/ 
rag gourd, vegetable sponge 
(E), loofah (F) 
SWA 
iB SQiW D lovesickness 
Luffa sp.                               
[0186-7] 
 -  haukonkon (LNA)  no popular name NA L F L scabies 
L SQiW D cough Zehneria sp.                            
[2176-6] 
 -  rärumohonon/ räparip 
hangal (R) 
no popular name SWA 
L SQiW D facilitates childbirth 
CYCADACEAE                 
Cycas seemannii A.BRAUN                
[0876-2.4] 
C. circinalis nepäpä (N) queen sago-palm, sago palm, 
cycad (E) 
TLT L T, G L sting of stonefish 
Cycas weinmannii                       
[2966-5] 
 -  namwale (N) no popular name TLL L T, SQ L centipede bites 
DIOSCOREACEAE                 
TLT St WiL, T CHS ear ailments 
L WiL, T, SQiW B wounds 
Dioscorea bulbifera L.                    
[0876-2.7] 
D. sativa nerachamete (N), 
woyip (LNA) 
(aerial/bitter/ air/ bulbil/ 
common) yam, devil's/ air-
potato (E), igname (F), yam 
(B) 
NA 
L CK E edible 
DRACAENACEAE                 
Dracaena angustifolia ROXB.               
[1686-1.12] 
 -  nisbähäin (IK)  no popular name AA L SQiW D ciguatera (to stimulate 
emesis)  
Dracaena fragrans (L.) KER - GAWL.          
[2176-5] 
  litoltol (R) no popular name SWA yL SQiW D poisonous plant used to 
commit suicide 
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Sansevieria trifasciata PRAIN               
[2186-1.1] 
Sansevieria trifasciata 
var. trifasciata, 
Sansevieria trifasciata 
var.  laurentii (yellow 
margins), Sansevieria 
zeylanica 
 -  snake plant, Angola hemp, 
bowstring hemp, devil's-tongue, 
mother-in-law's tongue, good-
luck plant, lucky plant (E) 
AA L T, SQ L ear ailments 
EUPHORBIACEAE                 
BML L F CH sore throat Acalypha grandis BENTH.                  
[2766-1.1] 
 -  yangyang (LBML), 
ringring (N) 
navlag (B) 
TLT L SQiW D gonorrhoea 
TLL L F CH aphthous ulcers 
AA L SQ L aphthous ulcers 
Acalypha wilkesiana MUELL. ARG.           
[2766-1.2] 
A. tricolor ringring, neljaboth 
(N), yangyang 
(LBML)  
beefsteak plant, copperleaf 
,Fijian fire bush, Jacob’s coat (E) 
BML L SQ L conjunctivitis 
Chamaesyce hirta L.                    
[2286-1.1] 
Euphorbia pilulifera, 
Euphorbia hirta 
dissä (IK) hairy spurge, garden spurge, 
asthma plant (E), red gras (B) 
AA L F CH asthma 
AA L T, SQiW D migraine headache Codiaeum variegatum (L.) BL.              
[1786-7] 
C. variegatum var. 
variegatum, Croton 
variegatum, Croton 
pictum 
inlobot tschaub (IK) (variegated) croton, croton shrub 
croton (E), nanggaria, nagiria, 
nagaria, lif kala, kala lif (B) AA/ APP/ NA/ SWA/ TLL/ 
TLT 
wP  -  P Kastom plant 
Euphorbia cyathophora L., MURR.             
[2286-2] 
E. heterophylla , 
Poinsettia cyathophora 
no local name Mexican fire-plant, Mexican 
fireweed, wild poinsettia (E) 
AA Frt F E diarrhoea 
Excoecaria agallocha L.                  
[1886-4.1] 
 -  nedet-he (IK) palétuvier, aveuglant (F), 
natongtong blong solwota (B) 
AA Lat F L wounds 
iB F SKC migraine headache AA 
yL WiL, T C wounds 
yL WiL, T, SQ D hypertension 
iB SQiW B wounds 
L SQ L wounds 
SWA 
L WiL, T C wounds 
Macaranga dioica MUELL. ARG.              
[2176-7L2] 
Mappa tannaensis, 
Ricinus dioicus 
nähäwanatschill, 
nähiväing (IK), 
leviunu/ livinu hanläla 
(R) 
navenu(e), brata blong 
burao,nafanhu, nafenua (B)   
NA yL SQiW D hypertension 
yL WiL, T C sunburn SWA/NA 
yL WiL, T C wounds 
SWA yL SQ C stops bleeding 
AA iB BL, CHL MW toothache 
Macaranga tanarius (L.) MUELL. ARG.        
[2176-7L1] 
 -  livinu/ leviunu tahor 
(R), nehivaing (IK), 
nevingne (N) 
navenu (B) 
TLL L RbH, SQ D asthma (babies) 
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L SQiW C boils 
L SQiW C sunburn 
scientific plant name not known 1           
[0276-2] 
 -  nehiäm (N)  -  TLL 
L SQiW C various skin diseases 
scientific plant name not known 2           
[1176-10] 
 - nemeturiäm (N)  -  TLL L SQiW C boils (painful) 
GOODENIACEAE                 
TLL L BL, CHL B scabies 
L BL D tonic 
Scaevola taccada ROXB.                  
[2866-3] 
S. frutescens, S. koenigii, 
S. sericea, Lobelia 
taccada 
nenglau (N), nanath 
(IK) 
half flower shrub, sea lettuce 
shrub, scaevola (E) 
AA 
iB BL D tonic 
GUTTIFERAE                 
Fl F AO scents coconut oil 
Frt G AO Tamanu oil (anti-
inflammatory properties) 
Frt F KHG game "sut 'em" 
Calophyllum inophyllum L.                 
[2866-8] 
 -  nepugure (N) tamanu, beach mahogany, 
pacific mahogany, Polynesian 
mahogany, beauty leaf, 
Alexandrian laurel, kamani 
(E), tamanou (F), tamanu 
(blong solwota), nambakura, 
na(m)bangura (B)  
TLL 
Sd F KHG toxic for chicken 
Garcinia sp.                           
[1786-4] 
 -  inmobolhat (IK)  no popular name AA L F CH liver pain 
HERNANDIACEAE/ GYROCARPACEAE                 
L SQ L wounds TLL 
iB SQ AF used to tame pigs 
Gyrocarpus americanus JACQ.              
[0476-2.1] 
 -  nowe (N) canoe tree (E), kanutri, 
kenutri, naove (B) 
TLL/TLT/SWA/NA/AA/APP W F KHG carving 
LAMIACEAE                 
Hyptis pectinata (L.) POIT.                 
[1786-16] 
  -  nälchagbäw (IK)   no popular name AA L SQ C circumcision wounds 
wP BL, CHL D indigestion 
wP BL, CHL D gastritis, stomach-ache, 
ulcers 
wP BL, CHL B scabies 
wP BL, CHL B boils 
wP BL, CHL B wounds 
Salvia sp.                              
[1176-12] 
 -  no local name stinggras (B) TLL 
wP BL, CHL D menses pain 
  165
FAMILY                               
SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
L RbH C fractures 
L SQiW D anaemia 
TLL 
L SQ D leukaemia and sepsis 
Solenostemon scutellarioides L.            
[2766-10]  
Coleus blumei, Coleus 
scutellarioides, Ocymum 
scutellarioides, 
Plectranthus 
scutellarioides 
nemeligevot (N) coleus (E), lif kala, kala lif (B) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
wP  -  P ornamental plant 
LAURACEAE                 
Cassytha filiformis L.                     
[0576-1] 
 -   -  cassytha, devil's twine, love 
vine, dodder laurel (E) 
TLL wP G, T, SQiW D postpartum abdominal 
pain (to expulse placenta) 
LECYTHIDACEAE                 
TLL/AA Sd G KHG fish poison 
AA Frt G KHG fish poison 
Barringtonia asiatica (L.) KURZ              
[2866-6] 
B. butonica, B. speciosa, 
Mammea asiatica 
nüt (N), neteng (IK) barringtonia, box-fruit tree, 
heart tree, poison fish tree, 
sea putat,  yum-yum tree (E), 
chapeae d'évêque (F), 
fisposentri, navele blong 
solwota (B) 
AA iB SQiW MW toothache 
iB BL, CHL MW toothache 
Frt F E edible 
Barringtonia edulis SEEM.                  
[2876-1] 
 -  livuwob (R), fetofeto 
(IK)  
bush nut, edible barringtonia, 
nut tree (E), navel, noix de 
brousse (F), navel(e) wud (B) 
SWA 
iB BL, CHL D cough 
LEGUMINOSAE - CAESALPINIOIDEAE                 
L SQiS, WiL D to defeat infections 
L SQiS, WiL D diabetes 
iB SQiS, WiL D to defeat infections 
iB SQiS, WiL D diabetes 
SWA 
iB SQiCW D asthma 
Intsia bijuga (COLEBR.) O. KTZE.             
[2176-1] 
Afzelia bijuga, Intsia 
madagascariensis 
lehumo (R) cohu,  ifil/ ipil (tree), 
(Moluccan) ironwood, kwila, 
(island/ pacific) teak (E), 
cohu, faux teak (F), natora, tik 
(B)  
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W F KHG carving 
LEGUMINOSAE – MIMOSOIDEAE 
L SQiW D severe pain during 
pregnancy 
Entada pursaetha DC.                    
[1786-13] 
 -  inhätäliñga (IK)  no popular name AA 
Frt F E edible 
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LEGUMINOSAE – PAPILIONOIDEAE 
L F CHS boils 
L F CHS carbuncles  
TLL 
L F CHS  abscesses 
Derris trifoliata LOUR.                     
[0876-1.1] 
D. uliginosa netüwe (N) Kastom penicillin (B) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
St F KHG rope for firewood 
Desmodium incanum (SW.) DC.             
[1886-2.3] 
D. canum,  Hedysarum 
incanum 
nälnjabuit (IK)  creeping beggarweed, kaimi 
clover, Spanish clover (E) 
AA L F CH diarrhoea 
SWA L SQiW D cough 
iB SQiW D chest pain (adiposity; 
angina pectoris?) 
iB T, SQ D asthma 
Erythrina variegata L.                     
[2176-8] 
E. indica, E. picta, E. 
variegata orientalis, E. 
variegata parcellii 
rärar/ lirar (R), nerare 
(N) 
  coral bean, (Indian) coral 
tree, crab's claw, tiger's claw 
(E), narara (B) TLL 
yL F CH postpartum abdominal 
pain (to expulse placenta) 
TLL Sd G, SQiW D protein intoxication after 
consumption of too much 
seafood (flatulence + 
pain) 
Inocarpus fagifer PARK.                   
[3066-6] 
I. edulis, I. fagiferus nemegwe (N) Polynesian/ Tahitian chestnut 
(E), châtaignier (de tahiti), 
mapé (F), namamb(w)e, 
nawemba, nawembe (B)   
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Sd CK E edible 
Mucuna gigantea (WILLD.) DC.             
[2576-6] 
Mucuna gigantea 
gigantea, Dolichos 
gigantea 
habba (R)  sea bean (E) SWA sap F L sting of Dendrocnide 
moroides 
SWA yL SQiW D pain 
AA iB BL D anaemia 
Pterocarpus indicus WILLD.                
[2176-18] 
 -  läsumol (R), 
nagautewa (IK) 
blue water, narra tree, new 
guinea rosewood, padouk, 
sang dragon (E), bluwota, 
nananar(a), navilae (B) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W F KHG carving 
TLL L G, MwCW, BL D asthma Pueraria lobata (WILLD.) OHWI               
[3066-4] 
P. harmsii, P. montana 
var. lobata 
netü (N), ya (R) no popular name 
SWA L SQiW D hepatitis 
L SQiW D hepatitis Vigna luteola (JACQ.) BENTH.               
[0386-1.7] 
Phaseolus luteolus ya (R) (string) bean (E), haricot 
(vert), flageolet (F), ariko, 
(wael) bin (B) 
SWA 
Sd CK E edible 
MALVACEAE                 
Fl BL, CHL EW conjunctivitis TLL 
Fl F AF children, that don't speak 
Hibiscus rosa-sinensis L.                 
[2966-4] 
 -  (ne)tewäwiäiw (N) red hibiscus, Chinese 
hibiscus, Chinese rose-
mallow, blacking plant (E), 
haebiskis (B) AA/ APP/ NA/ SWA/ TLL/ 
TLT 
wP  -  P ornamental plant 
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AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W F KHG carving 
BML Sh F CH gastritis, stomach-ache, 
ulcers 
TLL Sh G CH constipation/ ileus 
iB WiL, T, SQiW D "cancer" 
L WiL, T, SQiW D "cancer" 
Sh SQ C stops bleeding 
Hibiscus tiliaceus L.                      
[3076-1] 
H. tiliaceus tiliaceus, H. 
tiliaceus 
hastatus,Talipariti 
tiliaceum, Talipariti 
tiliaceum var. tiliaceum 
lipolwär  (R), nevar 
(N) 
burao, cottonwood, beach/ 
tree hibiscus (E), bourao (F), 
b(u)rao (B) 
SWA 
Sh SQ C wounds 
Sida rhombifolia L.                       
[1886-2.2] 
S. microphylla, S. 
rhombifolia rhombifolia 
uagas (IK)  broom weed, Cuba jute, tall-
flower sida, paddy's lucerne, 
Queensland hemp (E) 
AA L BL D diarrhoea 
MARANTACEAE                 
Donax cannaeformis (G. FORST.) K. SCHUM.    
[0186-5] 
Actoplanes cannaeformis libällabo (LNA)  no popular name NA dd/rw CLL D children, that don't speak 
MARATTIACEAE                 
Marattia smithii METT. EX. KUHN             
[1786-1] 
 -  äminäkäi (IK) no popular name AA L BL, CHL B neurodermatitis, infantile 
eczema 
MELIACEAE                 
Dysoxylum arborescens (BL.) MIQ.            
[0476-1.6] 
 -  nemawte (N) no popular name TLL iB T, SQiW D kidney pain 
MORACEAE                 
Frt CK E edible AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Sd T E edible 
Sh F SKC migraine headache 
Artocarpus altilis (PARK.) FOSB.               
[2286-1.3.2] 
A. communis, A. incisa, 
A. incisus 
inma (IK) breadfruit (E), fruit de baobab, 
pain de singe (F), bredfrut (B) 
AA 
Lat F L wounds 
AA St F CH headache Ficus adenosperma MIQ.                  
[1686-1.3] 
 -  nithidao (IK), linum 
(R)  
no popular name 
SWA sap CLL, MwW D albuminuria 
Ficus aspera FORST.                      
[1786-17] 
 -  nautschärob abäng 
(IK) 
no popular name AA L SQ L conjunctivitis 
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L SQiW D asthma 
dd/rw CLL L conjunctivitis 
dd/rw CLL D tonic for children 
L T, SQiW D children's' diseases 
caused by spirits 
SWA 
yL F CHS headache 
Ficus septica BURM.F.                    
[2176-2] 
 -  libälä (R), nälmaha 
(IK) 
no popular name 
AA St F CH headache 
SWA Lat SQiW D postpartum abdominal 
pain (to expulse placenta) 
Ficus sp.                               
[2576-5] 
 -  liwirim (R), lipüru 
(LNA)  
no popular name 
NA iB F C burns 
Ficus wassa ROXB.                       
[0876-2.12] 
 -  newuo (N) nasis, (nam)balanggo (B) TLT St F KHG to stimulate fruiting of a 
watermelon plant 
MYRSINACEAE                 
SWA Frt F E to initiate the menopause Maesa ambrymensis GUILL.                
[2576-1] 
 -  liputu (R), 
tilalamnumnu (LNA) 
no popular name 
NA L SQiW D infant crying caused by 
magic 
MYRTACEAE                 
BML L F CH diarrhoea 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt F E edible 
Psidium guaJava L.                      
[2766-5] 
 -  guap (N), guava 
(LNA) 
apple/ common/ yellow guava 
(E), gwava (B) 
NA L SQiW       D                  severe illness with bloody 
faeces 
TLL L F CH mouth infections 
SWA L F CH abdominal pain (to cause 
emesis) 
AA iB SQiW D ciguatera 
Syzygium malaccense (L.) MERR. & L.M. 
PERRY                                 
[3066-2] 
Eugenia malaccensis, 
Jambosa malaccensis 
negebige (N), hawei 
(R), injähäl (IK) 
Malay/ mountain/ rose apple 
(E), pommier (canaque) (F), 
(na)kavika (B) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt F E edible 
PANDANACEAE                 
Freycinetia tannaensis MARTINELLI           
[1786-2] 
 -  näbägchat (IK)  no popular name AA L G L fractures 
L F SKC headache TLL 
Rt G L lice 
Frt CK E edible 
Pandanus tectorius PARK.                 
[2866-5] 
P. odoratissimus, P. 
chamissonis 
nerongän (N) pandanus (palm), screw pine/ 
palm (E), wael pandanas, 
grastri (B) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
L F KHG weaving 
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PHYLLANTHACEAE                 
L BL, CHL B asthma 
iB BL, CHL B asthma 
L BL, CHL B cough 
Baccaurea stylaris MUELL. ARG.            
[1786-6] 
 -  nithtschaub (IK)  no popular name AA 
iB BL, CHL B cough 
PIPERACEAE                 
St SQ L conjunctivitis 
St SQiW D panacea 
Frt F E black magic 
SWA 
St F C to draw a splinter 
TLL Rt SKC D ciguatera 
L F SKC Kastom plant 
Macropiper latifolium (L.F.)                
[2176-10] 
Piper latifolium libärarmen (R), 
newureri (N) 
wild kava (E), kava sauvage 
(F), wael kava (B) 
NA 
LG F E influences sex of embryo 
during pregnancy  (girl or 
boy) 
SWA L WiL, T, SQiW D appendicitis 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Rt SKC D folk drug 
L SQiW D cough 
Piper methysticum J. R. & G. FORST.         
[3076-6] 
Macropiper methysticum injäjajän (IK) kava (B) 
AA 
Rt SQiW D cough 
POACEAE                 
Digitaria radicosa PRESL                   
[2766-7] 
D. sanquinalis, D. 
timoriensis, Panicum 
radicosa 
no local name large crab-grass (E), gras (B) BML sap F L wounds 
Oplismenus hirtellus (L.) P.BEAUV.           
[1886-2.1] 
 -  "gras" (IK)  -  AA Sh F CH cough 
Saccharum robustum BRAND. & JESW. EX 
GRASSL F.                              
[0386-1.6] 
 -  tschib (R) sugaken (B) SWA St F CH ciguatera 
POLYPODIACEAE                 
Drynaria rigidula (SW.) BEDD.               
[1786-11] 
 -  nässäi (IK) no popular name AA L BN L hair loss 
Pyrrosia confluens (R.BR.) CHING           
[0876-2.8] 
 -  nobody could 
remember the 
vernacular name 
no popular name TLT Frt BL, CHL MW toothache 
RUBIACEAE                 
Aidia racemosa (CAV.) D.D. TIRVENG.          
[0476-1.2] 
Randia racemosa nenieum/ nenyeung 
(N) 
nakumlum (B) TLL L BL, CHL B scabies 
Gardenia tannaensis GUILL.                
[0876-2.3] 
 -  nerukka (N) no popular name TLT L F AF constipation 
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L BL D panacea 
Frt CLL D panacea 
L BL D tonic 
SWA 
Frt CLL D tonic 
Morinda citrifolia L.                      
[3076-9] 
M. citrifolia var. citrifolia lihokon (R), nouras 
(IK)  
awl tree, Indian mulberry, 
noni, yaw bush, yellow tree 
(E), fromager, mûrier Indien, 
nono (F), yelowud (B) 
AA Frt F E constipation 
RUTACEAE                 
Citrus aurantifolia CHRISTM.                
[nVS] 
C. limetta, C. medica 
acida, Limonia 
aurantifolia 
no local name lemon (tree), lime (E), laem 
(B) 
TLL Frt SQ L scabies 
Euodia latifolia DC.                       
[0276-1] 
Euodia latifolia, Melicope 
latifolia 
nehine (N) no popular name TLL L SQiW D cough 
Micromelon minutum (FORST.F.) WIGHT & 
ARN. [0876-2.6] 
M. pubescens  nerrenärre (N) wael pima (B) TLT L F CH toothache 
SAPINDACEAE                 
Allophylus timoriensis DC. BL.              
[0476-1.5] 
Al. sublaxus,  A. vitiensis, 
Rumphia timoriensis 
nerriä (N) allophylus (E) TLL L T, SQ D kidney pain 
yL T C pain caused by magic SWA 
iB SQiW D asthma 
iB SQ L boils TLL 
yL F CH bloody urine + pain 
TLT/ SWA L F CH jealousy (of women) 
Pometia pinnata J.R. FORST. & G. FORST.      
[2176-9] 
Nephelium pinnata lirra (R), neta(u)we 
(N) 
 langsir, native/ oceanic/ 
pacific lychee, taun (E), 
nandao, nandau, natau (B)  
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt F E edible 
SOLANACEAE                 
L F R muscle pain AA 
L F R rheumatism 
Capsicum frutescens L.                   
[1686-1.5] 
 -  no local name bird's-eye chilli, bird's-eye 
pepper, bird pepper, chilli 
(pepper), chilli pepper 
(alternate spelling), hot 
pepper (E), petit piment, pim 
d'oiseau, poivre (F), (wael) 
pima, pimang, tsil (B)  
APP Frt F L boils 
Physalis angulata L.                     
[2576-11] 
P. minima  -  annual ground-cherry, cape 
gooseberry weed wild cape 
gooseberry (E) 
SWA L BL D dengue fever 
SPARRMANNIACEAE                 
Grewia inmac GUILL.                     
[1686-1.13] 
 -  nämdokai (IK) Kastom penicillin (B) AA L SQ, BL D pain/"aelan panadol" 
TECTARIACEAE                 
Tectaria latifolia (FORST.) COPEL.            
[2576-8] 
 -  räbabagongon (R)  no popular name SWA Fr F O wounds 
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SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
THELYPTERIDACEAE                 
Sphaerostephanos invisus (FORST. F.) 
HOLTTUM                                    
 [2766-2] 
Cyclosorus invisus, 
Nephrodium invisus, 
Dryopteris invisus 
fern (LBML) no popular name BML Frt SQ L conjunctivitis 
ULMACEAE                 
Trema orientalis (L.) BL.                   
[0186-3] 
T. orientalis var. viridis lirpüu (LNA)  trema (E) NA iB SQiW D and C fractures 
URTICACEAE                 
L BL D hepatitis 
sap CLL D panacea 
Sh SqiW D tonic for children 
SWA 
iB SQiW D abortive 
BML iB F C boils 
Pipturus argenteus WEDD.                 
[2766-1.9] 
P. argenteus var. 
argenteus, P. propinquus, 
P. velutinus, Urtica 
argenteus 
lärumo, lirumo (R), 
nehieungwi (N) 
pipturus (E) 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
Frt F E edible 
VERBENACEAE                 
Lantana camara L.                      
[1786-9] 
L. aculeata no local name lantana (weed) (E), blakberi, 
lantan(a), blarvari (B) 
AA L SQ L wounds 
Stachytarpheta cayennensis (RICH.) VAHL      
[1786-5] 
S. jamaicensis, S. 
urticifolia (some authors), 
S. urticaefolia (some 
authors, alterative 
spelling), Verbena 
cayennensis 
inchäi unasuandan  
(IK) 
blue rat's tail, cayenne/ dark 
blue snakeweed, false 
verbena, nettle leaf velvet 
berry (E), bluflaoa, suga (B) 
AA L SQ L wounds 
SWA L F Sm infant crying Vitex trifolia L. ssp. trifolia                 
[2176-14] 
 -  limadnobnob (R) no popular name 
AA/ APP/ NA/ SWA/ TLL/ 
TLT 
W F KHG outrigger canoes 
VITACEAE                 
L SQiW D „cancer“ (heart burn?) 
sap F L "skin cancer" (severe 
wounds?) 
Cayratia trifolia (L.) DOMIN.                
[0186-2] 
 -  awür (LNA)  no popular name NA 
sap F L wounds 
VITTARIACEAE                 
Vittaria lineata (L.) JE. SMITH               
[1786-12] 
 -  nabuthwä (IK)  no popular name AA L G D ciguatera 
ZINGIBERACEAE                 
St G L toothache Alpinia novae-pommeraniae K. SCHUM.       
[2576-2] 
 -  libadumäla (R)  no popular name SWA 
St G, MwW D chest pain (angina 
pectoris?) 
Zingiber zerumbet (L.) SM.                 
[2576-4] 
Z. fairchildii, 
Amomumzerumbet; 
Scitaminea 
liwolängdob, billo (R)  -  SWA Rh G, MwW D diabetes 
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FAMILY                               
SCIENTIFIC NAME                      
[VOUCHER NO.] 
SYNONYM(S) VERNACULAR NAME(S) POPULAR NAME(S) ORIGIN PPU PREPARATION 
MODE OF 
APPLICATION USES 
Alpinia sp.                            
[1176-3] 
 -  no local name  wael jinja (B) TLL Rh G, MwW D "cancer" 
Hornstedtia lycostoma (LAUTERB. & K. SCH.) 
K. SCH.                                 
[1176-8] 
 -  nehärrdelit (N) no popular name TLL L SQiW D tonic 
Rh G, MwW D tonic 
Rh G, MwW D diabetes 
Rh G, MwW D "cancer" 
Hornstedtia sp.                          
[1586-1] 
 -    nitschisäi (IK)  
 
no popular name APP 
L F KHG grass skirts 
PLANT FAMILY NOT KNOWN 
not known 3                            
[2286-1.4.1] 
 -  nälmaha (IK) no popular name AA L F SKC severe abdominal pain 
during pregnancy caused 
by spirits 
not known 4                            
[2286-1.4.2] 
 -  näüsärop (IK) no popular name AA L F SKC severe abdominal pain 
during pregnancy caused 
by spirits 
L BL          D ciguatera not known 5                            
[1886-5.2] 
 -  nanathoba (IK)  no popular name AA 
L G, MwCW D ciguatera 
                                                             QUESTIONNAIRES 
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QUESTIONNAIRES 
1. PLANT SPECIFIC PART 
date 
 
voucher specimen number 
 
informant-/ collector information 
name 
 
 
gender 
 
 
age 
 
 
profession 
 
 
taxonomic information 
popular name/s 
 
 
 
scientific name/s 
 
 
 
synonym/s 
 
 
 
plant family 
 
 
 
taxonomic indicator (e.g. endemic, invasive) 
  
 
information on the specimen 
short description of the plant 
 
 
 
geographical/ geological information 
island 
 
 
village name 
 
 
habitat/ vegetation type 
  
 
ethnological information 
clan name 
  
 
chief name 
 
  
medicinal/ pharmaceutical information 
uses 
 
 
plant part/s used 
 
 
importance 
 
 
preparation 
 
 
dosage 
 
 
application form 
 
 
application time 
 
 
effect/s 
 
 
observation/s 
 
 
side effect/s 
 
 
contraindication/s 
 
 
illustration or picture 
 
 
 
  
notes 
 
 
 
 
Fig. 42 Questionnaire on the plants and their uses 
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2. INFORMANT-SPECIFIC PART 
healers (ethnological aspects)         
Which kind of healer is asked?           
              
How to become this kind of healer?        
          
selection of plants           
Why is a plant used in medicine?         
      
        
What are the criteria for plant 
selection?        
 
         
         
How are medicinal and non-medicinal plants 
classified?       
How are medicinal plants classified?   Are non-medicinal plants also classified? 
           
           
classification of illnesses           
Which illnesses does the healer know? 
      
diagnosis        
cause/s       symptom/s     
              
concerned persons     prevention     
           
Who may medicate the patient and why?   healing ceremony   
           
Fig. 43 Questionnaire on healers and illnesses 
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WORD LISTS 
INDASS KHERMO, NEWAWETEME, AND RALLGLĖIN 
ENGLISH 
 
black 
white 
blue 
green 
brown 
red 
yellow 
 
bark 
leaf 
flower 
stem 
root 
tree 
sea 
bush 
 
yes 
no 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
 
I 
you 
he/ she/ it 
we 
you 
they 
 
big 
small 
quick 
 
come 
go 
good morning 
good afternoon 
good night 
good bye 
My name is... 
Thank you 
OK 
What? 
white man 
 
 
INDASS KHERMO 
 
napäng 
náhi 
nämälmát 
nämälmát 
numdschin 
ingap 
injáng 
 
narasinchräi 
nerin 
 
nowún 
nowán 
chräi 
íntschab 
inlíllidäi 
 
maja 
äo 
 
ití 
ärron 
ässätch (miti) 
 
 
 
 
 
 
 
 
ánjak 
ák 
án 
átschama 
´tschoña 
árra (>2), ákatscha (2) 
 
albass upni 
haklin 
árauru (ak) 
 
ajak 
áthiak 
nujaläng dupni 
 
intschupura dupni 
intschupura dupni 
nithák... 
nahauriníng albáss 
dádo (dupni) 
nividäi iä? 
natimiahí 
 
 
NEWAWETEME 
 
namededüt 
nalül 
namelerükä 
namelerükä 
 
namemi 
naieng 
 
neviurerra 
nekórrera 
tewäherera 
nedédrerra 
negerrérra 
dedrerra 
nebäéwonnä 
ligaiwón 
 
ää 
dadrä 
 
duwä 
vürruä 
wetäl 
wewät 
tewälímä 
livíssä 
levürruä 
lewedäl 
liviwät 
hängewúl 
 
nokkä 
nikkä 
njä 
deöjöl 
gomarr 
nihe 
 
naluwó 
narríri 
 
 
vinwe/ vinhe 
vene/ alleven! 
 
 
 
 
 
 
 
näwe 
salül 
 
 
RALLGLĖIN 
 
märmär 
fifiu 
näbnäb 
girri 
jäbobo 
fifíri 
ngúngo 
 
hallulíhä 
räsorro 
 
bädschidä 
líbidi 
lihä 
dä 
bubuhórr 
 
mafíttin 
mangalás 
 
súpp 
ru 
tschull 
wírr 
limm 
milipdsché 
milibrú 
milipdschul 
milifärr 
sangawül 
 
ni 
näk 
ngai 
ränämdschul 
ngärie 
närrilgäbäni 
 
moúgormär 
magegéi 
korrkorr 
 
mä 
jann 
fangfang ränändú 
dábliäländú 
fángrän 
 
 
sippan tuñgórr/ món 
mókonon 
mimbä 
vändän fifiu 
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